data_5jyt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jyt _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.003 0.43 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.47 122.4 85.89 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -59.3 141.58 97.94 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 0.0 112.692 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.8 mt -109.01 143.1 38.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.418 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -95.94 138.52 33.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.597 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.6 -70.75 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.876 0.735 . . . . 0.0 111.819 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -79.29 126.75 31.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.0 111.499 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -116.11 153.93 30.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.598 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.61 123.68 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.53 129.74 56.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.4 mttt -116.2 133.3 56.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.733 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.16 126.89 55.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.369 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 98.6 m-85 -99.86 118.78 37.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 21' ' ' SER . 19.5 m -125.99 160.34 33.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.29 102.85 9.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.16 -132.7 48.69 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.699 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -129.96 45.84 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.692 0.282 . . . . 0.0 111.403 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -71.27 155.89 92.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.7 Cg_exo -54.47 -37.21 89.82 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 121.997 1.798 . . . . 0.0 112.703 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -64.97 -44.95 87.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.584 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . 78.8 p -70.52 -40.48 73.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.503 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 53.5 t -64.42 -44.54 97.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.052 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.0 tpt180 -61.86 -47.21 86.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.411 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.7 95.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.869 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 66.1 mt -63.63 -42.93 98.1 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 22' ' ' VAL . 75.8 mmtt -64.85 -40.9 95.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.246 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.406 HG21 ' CG2' ' A' ' 86' ' ' VAL . 91.4 m -65.9 -49.68 67.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.317 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.4 tp -68.99 -46.62 67.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' LEU . . . -62.83 -43.81 97.82 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -41.59 92.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.876 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.508 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 75.9 mt -63.94 -44.99 98.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.0 110.751 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.96 -36.01 79.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.0 mt-10 -70.2 -27.4 64.46 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -115.51 -56.01 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -65.55 -40.85 93.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.9 29.9 6.89 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.57 125.96 25.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.487 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.34 -7.16 82.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.439 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 7' ' ' THR . 46.1 t -106.09 -42.19 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.374 0.587 . . . . 0.0 111.535 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' OH ' HD11 ' A' ' 97' ' ' ILE . 41.1 m-85 -116.25 144.17 44.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.37 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.13 124.99 50.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.59 130.64 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.681 0.753 . . . . 0.0 113.029 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.26 133.03 51.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.22 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -119.96 128.96 75.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.424 0.63 . . . . 0.0 110.663 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -111.38 114.81 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.901 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.09 101.52 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' VAL . 24.3 m -64.35 -34.79 71.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.36 -39.37 71.31 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.069 -0.394 . . . . 0.0 111.792 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.95 -40.87 71.75 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -128.65 73.63 80.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -23.05 76.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.735 2.29 . . . . 0.0 112.701 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.25 -41.3 99.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.01 -36.69 72.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.31 98.1 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.201 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.92 -38.73 86.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.239 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.3 mm-40 -60.94 -40.25 92.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.4 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.28 9.2 41.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.945 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.91 51.9 16.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.23 107.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.98 2.45 23.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.743 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.33 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 111.34 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.0 p -148.26 140.16 14.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.635 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.5 Cg_endo -80.07 151.95 84.11 Favored 'Cis proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.888 -1.713 . . . . 0.0 112.674 -1.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -125.32 129.87 50.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.398 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.6 tp -99.94 120.31 39.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.108 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.67 134.06 26.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 111.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 29.0 ttpt -95.17 103.7 15.56 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG13 ' N ' ' A' ' 69' ' ' LEU . 2.1 p -77.36 -30.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.671 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.7 mt -137.44 139.59 27.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.58 150.84 84.61 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.576 -1.427 . . . . 0.0 112.784 -1.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.7 152.42 74.19 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.89 160.79 87.81 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 124.765 -0.931 . . . . 0.0 113.558 0.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 97.0 t -71.65 125.93 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 38.3 mmt180 -97.37 113.81 25.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -100.49 120.45 40.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 HD12 HG22 ' A' ' 76' ' ' ILE . 55.7 mt -110.42 118.24 56.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.87 126.82 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.981 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.21 -163.07 36.78 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -81.76 99.9 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -85.68 -7.18 58.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.189 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.0 m -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.0 110.158 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -83.8 117.87 23.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.311 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.05 -35.44 75.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.657 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.25 -44.45 95.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -41.43 96.04 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' CG2' HG21 ' A' ' 27' ' ' THR . 74.6 t -63.69 -46.54 94.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.424 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.88 -47.43 77.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.96 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.87 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.81 99.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.324 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.33 -38.96 91.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.569 0.223 . . . . 0.0 110.775 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.24 -46.37 87.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.64 -40.03 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.7 mt -65.63 -40.28 92.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.67 92.05 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.72 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.75 -38.68 88.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 110.207 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.87 -41.05 99.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.288 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.411 HD11 ' OH ' ' A' ' 40' ' ' TYR . 92.7 mt -65.86 -45.41 91.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.68 92.34 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.589 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.19 -39.54 93.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.739 0.304 . . . . 0.0 111.519 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -78.93 113.61 17.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.124 0.488 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -111.92 141.53 45.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.22 -42.84 99.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -156.67 155.71 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.286 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.56 43.08 23.19 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.577 179.576 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.998 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.45 113.11 66.04 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.861 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -60.07 147.2 94.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.973 2.448 . . . . 0.0 112.674 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.95 2.66 56.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.827 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 161.48 34.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.819 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -91.31 -3.02 57.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -87.71 126.88 35.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.624 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.07 152.37 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.432 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.45 124.53 70.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.136 0.493 . . . . 0.0 111.082 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -112.52 132.0 55.31 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.1 mttt -112.67 126.56 55.52 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.724 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.36 123.16 47.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.199 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' CD2' HG13 ' A' ' 59' ' ' ILE . 93.2 m-85 -99.51 119.68 38.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.1 m -124.79 159.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.981 0.42 . . . . 0.0 111.587 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.65 102.89 9.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.247 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -135.49 49.14 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -124.2 44.63 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.016 0.436 . . . . 0.0 110.669 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -70.94 154.99 93.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.696 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.38 -34.34 97.77 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.139 1.893 . . . . 0.0 112.259 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -65.92 -43.09 89.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -70.02 -42.72 72.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.065 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.76 -43.96 96.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.6 tpt180 -62.29 -47.76 82.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.374 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.73 99.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.59 -47.8 83.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.534 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.77 97.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 HG23 ' CG2' ' A' ' 86' ' ' VAL . 85.6 m -66.0 -45.43 81.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.539 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -50.44 43.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.607 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.91 -44.6 96.46 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -65.24 -42.8 93.02 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.247 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.27 -44.56 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.004 0.43 . . . . 0.0 111.095 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.8 mt -71.47 -26.31 62.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.607 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -89.66 -2.71 58.37 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.042 -0.411 . . . . 0.0 112.01 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -131.15 -62.09 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.916 0.389 . . . . 0.0 111.314 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.98 -41.42 95.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.606 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.76 30.2 6.27 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 29.8 ttpp -61.06 127.5 31.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.037 0.446 . . . . 0.0 111.309 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.25 -8.01 80.54 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.957 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.43 -41.98 6.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 117.051 0.425 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.416 ' OH ' HD13 ' A' ' 97' ' ' ILE . 35.4 m-85 -116.24 144.99 43.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.275 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.45 125.06 50.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -96.19 128.35 43.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.346 0.593 . . . . 0.0 112.13 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -126.3 112.21 15.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.189 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -99.57 128.7 51.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.591 0.71 . . . . 0.0 111.028 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.8 mm -111.43 116.74 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.752 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.1 104.98 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 14' ' ' VAL . 19.4 m -68.26 -18.86 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.63 -38.66 12.97 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.875 -0.516 . . . . 0.0 112.244 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.201 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.32 76.66 72.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.691 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.3 -20.29 70.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.541 2.16 . . . . 0.0 112.599 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.743 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 24.3 mp0 -62.84 -41.76 99.47 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.6 -36.6 73.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.85 98.29 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.815 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.4 mt-10 -60.34 -39.92 88.85 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.57 7.84 45.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.73 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 49.04 53.46 12.55 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.842 0.714 . . . . 0.0 112.852 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 HG13 ' CD2' ' A' ' 13' ' ' TYR . 47.1 mm -87.27 108.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.602 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -109.31 4.19 22.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.64 148.49 40.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.493 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 p -148.49 141.92 15.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.047 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.37 149.11 85.66 Favored 'Cis proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.661 -1.391 . . . . 0.0 111.826 -2.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.7 m -127.45 129.49 47.57 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.78 118.5 36.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.538 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.56 132.73 35.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.323 0.582 . . . . 0.0 111.02 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -95.01 104.0 15.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -80.61 -27.62 11.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.457 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -136.62 138.8 27.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.484 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HD2' ' HE2' ' A' ' 67' ' ' LYS . 16.7 Cg_exo -71.6 153.13 96.88 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.362 -2.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.11 156.81 61.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.655 2.237 . . . . 0.0 111.892 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.12 165.78 83.36 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.201 -1.166 . . . . 0.0 113.43 0.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 96.6 t -69.46 126.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.145 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -105.93 115.14 29.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -96.81 125.09 41.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.184 0.516 . . . . 0.0 110.118 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.3 mt -109.7 117.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.872 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.8 mm -117.77 127.06 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.829 0.347 . . . . 0.0 110.799 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.62 -166.37 39.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.817 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -82.46 99.86 9.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.28 -5.13 59.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.278 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -23.98 64.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.243 0.544 . . . . 0.0 109.899 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -84.34 118.61 24.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.191 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.1 -35.68 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.664 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.74 -43.73 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -40.61 95.67 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.73 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.442 ' CG2' HG23 ' A' ' 27' ' ' THR . 73.3 t -64.14 -42.59 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.841 0.353 . . . . 0.0 110.27 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -48.46 63.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.475 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.58 -46.75 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.538 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -63.62 -41.25 98.3 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.531 0.205 . . . . 0.0 111.185 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -37.98 82.81 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.08 -46.87 82.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.08 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.29 -39.57 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.44 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.529 HD21 ' O ' ' A' ' 89' ' ' ALA . 3.8 mm? -67.4 -39.55 85.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.602 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.36 89.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.398 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.36 -38.41 86.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.51 -40.87 98.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 HD13 ' OH ' ' A' ' 40' ' ' TYR . 94.7 mt -65.88 -45.33 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.09 92.97 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.465 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.16 -39.79 95.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.426 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -80.07 114.83 19.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.262 0.553 . . . . 0.0 110.795 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -111.5 144.59 40.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.585 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.54 103.25 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -90.97 107.66 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.25 -29.09 69.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.725 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -85.42 104.96 15.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.507 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.013 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.633 0.254 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.28 63.18 10.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.333 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.55 150.86 64.08 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.381 2.054 . . . . 0.0 112.677 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.41 143.03 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -106.07 -70.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.445 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.08 -12.78 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.72 127.69 36.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.338 0.589 . . . . 0.0 111.102 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' HB1' ' CD2' ' A' ' 40' ' ' TYR . . . -113.26 152.89 29.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.783 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.62 124.25 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.96 130.08 56.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.3 mttt -115.76 130.76 56.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.638 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.78 124.57 50.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.0 m-85 -100.9 119.84 39.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 m -126.55 160.33 34.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.001 0.429 . . . . 0.0 111.628 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HB1' ' OG1' ' A' ' 62' ' ' THR . . . -115.45 104.48 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.413 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' N ' HD11 ' A' ' 48' ' ' LEU . . . 62.29 -129.79 43.4 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.075 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -136.61 53.23 1.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.175 0.512 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -75.88 158.11 82.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.995 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.49 -37.46 89.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.129 1.886 . . . . 0.0 112.647 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 32.5 m120 -64.66 -44.96 88.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 109.931 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -66.69 -43.77 83.53 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.925 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.97 -45.72 93.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -62.3 -46.25 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.398 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -63.26 -42.74 99.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.173 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.86 -46.87 87.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.303 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.47 -40.04 96.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.662 0.268 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.426 HG22 ' CG2' ' A' ' 86' ' ' VAL . 90.5 m -63.89 -45.89 87.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -50.46 54.55 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.526 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.17 -43.91 97.78 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.48 -46.43 90.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 70.6 mt -64.13 -44.99 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.665 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.1 mt -68.16 -34.59 76.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.629 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 98.5 mt-10 -66.41 -35.84 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -110.62 -56.63 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.592 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.2 mp0 -63.38 -42.0 98.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.09 29.96 6.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 30.1 ttpp -60.96 127.75 33.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 111.464 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.12 -7.88 80.82 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.151 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.1 -42.84 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 117.219 0.51 . . . . 0.0 111.469 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD2' ' HB1' ' A' ' 8' ' ' ALA . 57.0 m-85 -116.4 145.13 43.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.487 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.86 125.36 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -96.23 129.05 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.42 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -127.26 135.54 50.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.809 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.15 129.75 75.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.383 0.611 . . . . 0.0 110.983 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.67 116.26 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.651 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.57 103.51 15.14 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 14' ' ' VAL . 22.6 m -66.68 -32.43 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD11 ' N ' ' A' ' 16' ' ' GLY . 80.7 mt -70.24 -38.77 75.26 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.69 -37.53 73.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.725 0.298 . . . . 0.0 111.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -129.73 85.51 58.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.85 -27.84 80.76 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.033 2.488 . . . . 0.0 112.579 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.734 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 70.4 tp60 -63.05 -42.24 99.67 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.54 -36.57 73.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.033 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.623 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.28 -38.11 84.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.337 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.734 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.0 mt-10 -60.42 -40.86 92.54 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -99.82 13.23 34.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.928 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 48.8 52.27 14.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.75 106.17 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt -105.8 -6.24 19.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.939 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.98 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 0.0 111.182 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.463 ' OG1' ' HB1' ' A' ' 15' ' ' ALA . 60.8 p -136.19 148.7 65.56 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.417 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.0 Cg_endo -75.16 151.77 97.11 Favored 'Cis proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.855 -1.727 . . . . 0.0 112.628 -1.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.85 124.68 45.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.499 178.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.0 tp -104.95 116.96 32.85 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.14 138.43 35.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.484 0.659 . . . . 0.0 111.916 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.0 ttpp -96.37 104.47 16.44 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.04 -28.3 11.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.253 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.95 139.11 29.47 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.049 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.97 155.1 91.53 Favored 'Cis proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.466 -1.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.77 151.35 77.42 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.997 2.464 . . . . 0.0 112.132 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.43 166.75 81.06 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.531 0.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 99.2 t -71.93 127.04 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -110.51 117.76 34.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.553 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -101.02 119.68 39.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.803 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 76' ' ' ILE . 71.4 mt -102.49 115.55 44.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.834 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.01 127.74 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.863 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.74 -158.86 31.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.07 86.64 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.31 -14.87 61.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.097 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.5 m -67.9 -20.57 65.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 110.402 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -84.87 117.6 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.96 -35.34 74.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.686 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.98 -44.41 94.51 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.66 -41.38 96.14 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.028 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' CG2' HG22 ' A' ' 27' ' ' THR . 68.1 t -64.11 -46.53 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.641 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 53.2 tp -64.59 -47.5 78.44 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.67 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.51 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.427 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.49 -42.63 98.54 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.06 -38.54 88.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.603 0.24 . . . . 0.0 110.587 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -64.76 -44.79 88.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.81 -40.07 94.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.918 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.8 mt -65.08 -40.2 94.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 109.976 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.09 89.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.618 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.31 -39.57 90.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 109.946 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.9 mt -68.69 -44.41 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.034 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.3 91.44 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.77 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.83 -39.27 91.24 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.443 0.297 . . . . 0.0 111.593 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -69.62 125.01 25.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.304 0.573 . . . . 0.0 110.606 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -111.45 145.39 39.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.551 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.62 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.131 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.65 108.58 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.898 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.97 -29.44 70.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.747 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -87.55 102.13 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.379 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.926 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.016 0.436 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.2 111.91 64.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.62 144.13 99.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.898 2.398 . . . . 0.0 112.587 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.0 mt -106.53 136.19 46.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -128.84 161.34 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.579 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -62.0 -39.14 91.23 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.44 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.89 123.21 28.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.191 0.52 . . . . 0.0 110.916 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . . . -98.01 152.53 19.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -111.27 124.04 67.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.315 0.579 . . . . 0.0 110.327 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.75 131.18 55.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.4 mttt -113.8 129.37 56.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.25 121.87 46.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.113 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.459 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 94.6 m-85 -99.22 120.97 40.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.8 m -125.93 160.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 111.365 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.93 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.521 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 61.76 -131.4 46.33 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.296 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -135.39 50.74 2.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.206 0.527 . . . . 0.0 110.083 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.2 p -75.12 158.69 83.91 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.4 Cg_exo -54.2 -37.47 87.74 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.035 1.823 . . . . 0.0 112.626 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.0 -45.18 90.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 109.89 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.8 m -66.9 -43.26 83.84 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.076 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.35 -44.45 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.403 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.91 -48.6 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.4 96.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.441 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 62.9 tp -62.27 -47.6 83.62 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.421 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.95 -44.34 96.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.443 HG21 ' CG2' ' A' ' 86' ' ' VAL . 86.3 m -64.93 -45.28 86.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.495 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.51 -50.95 40.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.56 -44.86 96.25 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.08 -41.44 86.36 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.145 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.4 mt -63.56 -43.79 98.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 0.0 110.703 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.5 mt -70.5 -27.76 64.44 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 98.9 mt-10 -86.12 -12.8 49.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.99 -61.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 111.372 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 77.6 mm-40 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.569 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.12 30.64 6.73 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.33 126.68 27.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.57 -0.3 89.38 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.528 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.8 -43.03 6.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 117.421 0.61 . . . . 0.0 111.408 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' HD12 ' A' ' 97' ' ' ILE . 39.9 m-85 -115.9 144.66 43.73 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.396 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.63 124.27 49.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -95.58 129.2 42.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.276 0.56 . . . . 0.0 112.042 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.1 mptm? -126.35 109.73 12.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.336 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.4 t -98.27 128.54 49.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.617 0.722 . . . . 0.0 110.987 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.65 116.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.77 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -86.63 103.44 15.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 14' ' ' VAL . 24.2 m -67.29 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.3 mt -70.17 -39.41 75.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.88 -37.35 73.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.388 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -128.82 86.31 57.84 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.067 0.46 . . . . 0.0 110.302 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.96 -27.96 80.3 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.017 2.478 . . . . 0.0 112.464 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.672 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.9 mt-30 -63.25 -42.04 99.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.02 -36.98 75.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.014 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.02 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.09 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.26 -38.9 85.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.44 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.5 mm-40 -60.95 -40.78 94.62 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.49 9.66 41.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.035 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 49.88 52.05 15.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.52 106.31 16.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.467 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.08 -5.97 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.819 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.47 141.19 30.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.1 p -134.43 151.13 75.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.953 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.19 149.13 93.69 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.1 -1.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.04 119.65 34.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -105.66 116.87 32.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.67 139.44 34.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.536 0.684 . . . . 0.0 112.005 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -96.57 104.72 16.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.38 -28.72 10.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.951 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.73 135.02 19.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.933 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.65 152.21 89.66 Favored 'Cis proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.66 -1.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.46 159.09 52.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.834 2.356 . . . . 0.0 111.869 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -65.9 158.21 77.93 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 124.886 -0.881 . . . . 0.0 113.665 -0.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 90.7 t -70.04 127.13 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.771 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -108.24 119.03 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtm-85 -101.3 121.81 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.244 0.545 . . . . 0.0 110.594 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.3 mt -105.11 115.24 46.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.702 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.74 126.97 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -161.84 35.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.677 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -81.83 99.37 8.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.3 mt -89.36 -3.17 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.143 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.7 m -70.33 -20.24 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.447 0.641 . . . . 0.0 109.787 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.3 t-20 -86.02 117.28 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.375 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.72 -37.18 78.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.206 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.427 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 42.9 mt-10 -60.17 -44.86 94.71 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.82 97.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' CG2' HG21 ' A' ' 27' ' ' THR . 66.3 t -63.09 -47.16 93.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.836 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.6 tp -64.27 -47.7 78.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.808 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.7 mt -63.61 -45.74 96.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.69 99.4 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.029 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.2 mt -66.45 -36.07 81.87 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -61.62 -46.08 91.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.829 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.47 -39.7 92.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.9 -41.09 95.89 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.32 90.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.38 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.56 -37.84 85.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.091 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.53 -40.95 98.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.441 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.475 HD12 ' OH ' ' A' ' 40' ' ' TYR . 83.3 mt -69.82 -44.06 79.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.57 -35.31 91.63 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.844 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.38 -39.51 90.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -70.76 125.41 26.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.332 0.587 . . . . 0.0 110.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -111.39 145.14 39.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -91.16 109.27 20.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.5 -28.99 70.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.661 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -87.55 100.61 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.549 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.86 110.37 62.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.031 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -60.15 146.11 96.98 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.968 2.445 . . . . 0.0 112.76 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.14 136.78 48.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.08 164.23 31.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.601 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -65.91 -38.16 87.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 110.872 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.55 122.25 28.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.218 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.63 152.43 22.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.89 121.9 64.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.281 0.562 . . . . 0.0 109.995 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.55 127.08 55.97 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.1 mttt -110.13 129.09 55.76 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.302 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.81 123.8 49.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.602 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.71 119.58 38.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 47' ' ' VAL . 25.1 m -126.46 160.7 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' OG1' ' A' ' 62' ' ' THR . . . -120.75 96.46 5.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.671 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -153.35 52.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.033 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -113.58 39.12 2.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 111.186 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -69.13 157.98 87.81 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.918 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.3 -36.74 79.46 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.419 2.08 . . . . 0.0 113.649 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 8.9 p-10 -69.23 -46.0 68.41 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.364 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.6 m -65.06 -43.92 90.68 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.53 -45.73 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.713 0.292 . . . . 0.0 111.045 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 64.4 ttt180 -61.93 -46.25 90.14 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' ASN . . . -63.57 -42.8 98.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.154 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.71 -47.03 87.14 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.752 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.758 0.313 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.452 HG21 ' CG2' ' A' ' 86' ' ' VAL . 87.1 m -66.08 -45.08 82.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.363 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.76 -51.02 29.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.495 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.51 -45.08 95.71 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.55 -42.24 92.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.191 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.567 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 70.9 mt -63.66 -46.07 95.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.163 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.03 -37.35 81.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.33 -36.39 76.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.47 -55.31 2.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -64.48 -39.99 94.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.6 m-85 -117.84 29.41 7.84 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.9 ttmt -51.36 123.43 9.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 112.091 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.91 -0.61 88.24 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.465 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.77 -42.77 5.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.024 0.912 . . . . 0.0 111.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' OH ' HD11 ' A' ' 97' ' ' ILE . 28.9 m-85 -115.43 143.92 44.58 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.102 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.78 123.49 48.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.06 127.63 39.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.4 104.89 8.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.09 127.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.657 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.1 mm -109.96 115.7 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.756 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -85.94 103.08 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.6 m -66.56 -32.29 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.4 -40.51 73.87 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -71.21 -37.45 72.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.315 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -125.54 82.37 63.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.67 -31.53 92.17 Favored 'Trans proline' 0 C--O 1.23 0.083 0 C-N-CA 123.22 2.613 . . . . 0.0 112.337 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.732 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.1 mp0 -63.17 -42.11 99.35 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.568 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.37 -37.08 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.02 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.66 97.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.742 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.17 -38.1 84.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.477 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.3 mt-10 -60.68 -40.75 93.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.325 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 9.54 41.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.982 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 50.47 51.78 16.14 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.811 0.694 . . . . 0.0 112.708 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.0 106.24 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.58 0.59 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.626 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.49 149.64 36.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.399 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 15' ' ' ALA . 39.6 p -147.15 143.94 18.97 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.602 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.9 Cg_endo -79.67 151.61 85.28 Favored 'Cis proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.931 -1.696 . . . . 0.0 112.652 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.4 m -126.04 130.09 50.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.387 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.3 tt -103.79 119.58 39.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.29 137.69 34.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.431 0.634 . . . . 0.0 111.77 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -99.99 104.67 16.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.99 -28.73 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.42 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -135.34 136.85 25.11 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.461 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -75.14 156.27 99.76 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.49 -1.046 . . . . 0.0 112.388 -2.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.49 156.61 61.09 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.701 2.268 . . . . 0.0 111.861 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.65 164.61 86.9 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.234 0.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 98.6 t -70.28 125.84 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.962 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -106.82 117.09 33.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.682 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -103.37 124.47 48.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.122 0.486 . . . . 0.0 110.03 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 76' ' ' ILE . 50.8 mt -111.18 119.99 60.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.308 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.31 125.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.65 -165.96 38.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.845 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -82.53 102.77 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.71 -3.28 58.28 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.446 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 49.5 m -69.49 -21.54 63.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.169 0.509 . . . . 0.0 110.344 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -86.66 120.07 27.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.166 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.16 -36.35 77.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.79 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.77 -44.03 97.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.67 -40.39 95.32 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.468 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 27' ' ' THR . 71.0 t -63.42 -43.95 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.29 -47.92 66.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.796 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.9 mt -60.91 -46.85 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 122.938 0.149 . . . . 0.0 111.364 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.71 97.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.687 0.279 . . . . 0.0 111.162 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.1 mp -68.26 -40.41 81.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.162 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.78 -41.74 95.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.281 0.086 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.14 -39.71 94.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.16 -39.9 86.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.388 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.18 90.14 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.634 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.34 -38.11 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.187 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.3 -40.85 97.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.399 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.462 HD11 ' OH ' ' A' ' 40' ' ' TYR . 83.4 mt -70.0 -42.54 79.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.43 -35.5 91.13 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.501 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.08 -40.29 95.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.714 0.293 . . . . 0.0 111.412 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -92.12 110.33 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.96 135.43 51.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -111.32 107.36 16.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.437 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -155.94 153.19 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.38 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.39 -30.01 67.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.972 0.415 . . . . 0.0 111.179 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -91.27 106.03 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.481 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.935 0.398 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 122.87 88.45 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.54 141.9 98.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.817 2.345 . . . . 0.0 112.875 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.2 mt -115.48 150.77 35.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -103.61 135.14 45.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.453 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mttp 69.99 -67.65 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.864 0.727 . . . . 0.0 112.002 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -77.26 127.25 32.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.435 0.636 . . . . 0.0 111.385 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . . . -116.8 153.66 32.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.753 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.63 123.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.231 0.539 . . . . 0.0 110.337 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 129.95 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.2 mttt -115.25 131.53 56.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.7 125.23 51.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.44 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.38 117.32 34.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 30.6 m -125.95 160.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 0.0 111.891 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.35 97.95 5.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' N ' HD11 ' A' ' 48' ' ' LEU . . . 67.29 -149.71 51.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.138 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -114.55 43.49 1.91 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -69.88 157.76 88.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.401 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 13.0 Cg_endo -57.13 -33.82 96.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.001 1.801 . . . . 0.0 112.414 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -68.75 -43.85 74.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.284 0.564 . . . . 0.0 109.566 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.536 ' OG ' ' HB ' ' A' ' 14' ' ' VAL . 43.5 t -64.54 -47.96 76.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.014 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.88 96.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpt180 -62.41 -48.96 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.59 99.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.438 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.44 -47.54 85.24 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.475 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.09 -40.32 95.97 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.773 0.32 . . . . 0.0 111.089 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.5 m -65.39 -45.45 83.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.591 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.66 -49.0 51.99 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.28 -45.25 95.25 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.7 -39.87 91.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.675 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.7 mt -64.57 -45.21 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.321 0.582 . . . . 0.0 110.824 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.0 mt -71.33 -29.49 65.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.2 mt-10 -90.29 -1.77 57.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -131.2 -61.96 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.621 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.45 -42.43 95.96 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CD1' HD11 ' A' ' 90' ' ' LEU . 98.0 m-85 -124.45 30.67 5.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttpt -60.14 129.63 42.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.085 0.469 . . . . 0.0 111.255 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.98 78.84 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' THR . 52.4 t -105.32 -40.97 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 110.95 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.555 ' OH ' HD12 ' A' ' 97' ' ' ILE . 49.6 m-85 -117.08 144.95 44.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.394 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.07 123.15 47.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 tp -95.2 127.65 41.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.367 0.603 . . . . 0.0 112.429 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.0 mptp? -122.84 137.28 54.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.045 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.45 130.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.686 0.755 . . . . 0.0 110.662 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -113.26 103.73 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.409 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.72 104.75 7.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.5 m -68.33 -32.04 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD11 ' N ' ' A' ' 16' ' ' GLY . 82.7 mt -70.08 -39.78 75.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.92 -37.63 72.92 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -129.7 85.86 57.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.072 0.463 . . . . 0.0 110.454 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.09 -28.07 79.66 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.028 2.485 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.741 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.4 tt0 -62.53 -42.95 99.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.13 -36.14 74.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.18 97.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.38 -38.15 84.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.559 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.741 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.57 -40.41 91.56 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.76 9.67 42.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.007 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 50.89 51.77 16.34 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.721 0.638 . . . . 0.0 112.668 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.3 mm -86.21 106.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.8 mt -107.73 1.33 22.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.502 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.24 147.82 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 111.321 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -148.07 139.15 13.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.474 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 76.8 Cg_endo -79.93 152.32 85.12 Favored 'Cis proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.061 -1.641 . . . . 0.0 112.76 -1.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.2 m -127.02 130.26 49.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.341 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -104.86 117.79 34.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.777 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -138.18 135.22 35.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 17.0 ttpp -96.11 104.53 16.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.4 m -80.52 -28.65 11.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.754 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -136.91 138.09 25.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.419 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.89 152.69 96.95 Favored 'Cis proline' 0 C--N 1.35 0.61 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.454 -1.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.46 157.12 59.98 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.57 2.18 . . . . 0.0 111.746 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.11 166.17 82.3 Favored 'Cis proline' 0 C--N 1.352 0.716 0 C-N-CA 124.313 -1.12 . . . . 0.0 113.4 0.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 87.6 t -70.12 126.08 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.345 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 52.0 tpt85 -102.3 113.93 27.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.494 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -101.19 122.75 44.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.71 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 76' ' ' ILE . 66.2 mt -106.37 118.59 54.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.198 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 77' ' ' ILE . 47.6 mm -116.59 125.8 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.664 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.45 -166.95 39.63 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.774 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -82.86 102.73 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.42 -2.42 58.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.155 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.0 m -68.53 -21.72 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.493 . . . . 0.0 110.161 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.1 118.82 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.259 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -36.22 76.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.635 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.73 -44.11 97.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.64 -40.75 96.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.509 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 74.0 t -64.92 -42.29 94.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.32 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.01 -46.64 67.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.52 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.65 -46.45 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.553 0.216 . . . . 0.0 110.816 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.9 95.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -66.7 -41.9 87.29 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.384 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.44 -45.8 89.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.279 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.53 -39.65 94.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.614 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.28 -40.8 94.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 110.704 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.56 91.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.965 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.6 -38.65 88.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 110.184 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.96 -41.47 99.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.53 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.555 HD12 ' OH ' ' A' ' 40' ' ' TYR . 84.2 mt -71.0 -44.1 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.215 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.45 -35.62 91.98 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.781 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.88 -40.16 94.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 111.454 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -83.54 111.1 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.21 0.529 . . . . 0.0 110.543 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -111.73 145.8 38.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.732 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -88.36 99.57 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -125.26 112.3 16.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.181 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.37 -29.27 69.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.414 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.78 105.57 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.437 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.09 128.81 87.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.123 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -58.81 143.66 98.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.979 2.453 . . . . 0.0 112.895 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 mp -108.1 139.95 42.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -127.96 160.37 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.22 -39.34 92.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.342 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.51 117.6 21.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.253 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 40' ' ' TYR . . . -98.23 152.6 19.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.075 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.78 125.18 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -113.73 128.27 56.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.3 mttt -112.83 128.52 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.362 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.9 123.25 47.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.9 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.5 m-85 -101.0 119.34 38.6 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 47' ' ' VAL . 20.3 m -125.8 160.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.558 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' A' ' 62' ' ' THR . . . -118.27 98.96 6.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.83 -152.77 52.57 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.764 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -115.03 43.45 1.99 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.966 0.412 . . . . 0.0 110.601 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -71.47 158.24 88.34 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.789 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.53 -37.36 82.65 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.152 1.901 . . . . 0.0 112.714 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 36.3 m120 -65.5 -46.04 81.22 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.274 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.8 m -66.24 -44.07 84.76 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.272 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.07 -45.88 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.871 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -62.26 -46.97 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -63.86 -42.56 97.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.175 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.76 -46.3 90.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.502 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.54 -41.31 98.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 0.0 110.754 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.3 m -64.46 -44.65 90.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD23 ' CG1' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -72.39 -50.0 29.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.44 97.36 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.482 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 28.3 t-20 -64.74 -43.31 93.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.082 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -63.87 -45.41 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.009 0.433 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 76.5 mt -69.4 -35.82 76.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 30' ' ' ASN . 15.6 pt-20 -74.27 -18.64 60.7 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 33' ' ' GLU . 75.5 mmtt -120.06 -61.76 1.56 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 111.818 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.18 -39.24 93.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.439 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.431 ' HZ ' ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -114.02 22.49 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.29 126.32 26.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.047 0.451 . . . . 0.0 112.016 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.23 -9.23 78.09 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.968 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.26 -44.62 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.672 0.736 . . . . 0.0 112.352 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -111.39 141.09 45.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.779 -178.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.97 125.62 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 tp -97.12 129.86 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.481 0.657 . . . . 0.0 112.741 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.58 133.0 51.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.221 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.8 t -120.37 129.34 75.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -112.32 116.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.923 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -86.59 102.08 13.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 14' ' ' VAL . 23.0 m -66.2 -34.71 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.53 -36.67 73.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.069 0.395 . . . . 0.0 111.826 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.92 -40.47 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.76 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -129.76 86.51 55.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 109.977 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.27 -29.07 85.63 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.036 2.49 . . . . 0.0 112.676 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 24.4 mp0 -62.8 -42.09 99.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.754 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.08 -36.94 75.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.03 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.17 97.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.197 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.41 -38.41 84.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.406 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.7 -40.77 93.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -99.4 14.09 30.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.838 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 47.45 54.41 9.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.666 0.786 . . . . 0.0 113.058 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.9 mm -88.94 108.43 18.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.56 -8.9 16.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.88 139.69 36.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.603 0.24 . . . . 0.0 111.335 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 15' ' ' ALA . 61.0 p -135.36 148.61 66.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.5 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 58.8 Cg_endo -75.13 151.49 96.81 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.729 -1.779 . . . . 0.0 112.649 -1.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -116.11 124.28 49.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.543 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 tp -102.7 115.17 30.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.61 30.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 112.299 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.4 ttpp -99.55 104.32 16.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.837 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -81.15 -28.72 10.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.229 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -137.3 142.09 36.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.44 156.61 93.38 Favored 'Cis proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.418 -1.493 . . . . 0.0 112.239 -1.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.41 150.37 81.17 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.956 2.438 . . . . 0.0 112.181 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.6 167.62 78.53 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.172 -1.178 . . . . 0.0 113.501 0.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 94.9 t -73.08 127.12 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.817 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -110.75 118.97 37.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.074 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.7 mtm105 -103.13 121.61 42.98 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.435 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 76' ' ' ILE . 64.9 mt -106.14 117.74 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.544 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.35 125.23 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.162 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.86 -170.41 43.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.29 107.59 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.0 mt -90.15 -0.71 57.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.93 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -67.85 -18.8 64.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -92.6 120.48 33.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.77 -36.53 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.567 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.62 -44.11 96.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.7 -40.59 95.63 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.49 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' CG1' HD23 ' A' ' 28' ' ' LEU . 68.2 t -63.72 -44.13 98.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.337 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -47.96 64.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.93 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.67 -45.82 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 123.016 0.197 . . . . 0.0 111.3 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.4 99.13 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.16 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 86.6 mt -66.32 -39.82 89.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.329 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.42 -41.28 93.72 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.36 -37.16 86.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.24 -38.57 91.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' CB ' ' HZ ' ' A' ' 36' ' ' PHE . . . -62.1 -38.91 90.69 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.999 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -38.79 89.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.42 -40.9 96.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.497 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -69.29 -43.32 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.3 -32.65 81.55 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.147 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.42 -39.09 82.36 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.377 0.271 . . . . 0.0 111.623 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -70.6 122.44 19.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -110.92 139.59 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -102.77 -52.07 3.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.753 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -94.09 107.63 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -66.88 -29.54 69.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t0 64.59 -170.11 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.419 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.33 179.759 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.993 0.425 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.28 121.74 78.76 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 150.71 61.94 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.599 2.2 . . . . 0.0 112.791 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -97.81 -0.63 44.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.155 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.99 138.84 35.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -19.41 62.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.455 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 p -87.9 123.93 33.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.495 0.664 . . . . 0.0 112.316 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB3' ' CE2' ' A' ' 40' ' ' TYR . . . -90.63 154.18 19.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.914 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -107.36 123.18 62.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.326 0.584 . . . . 0.0 110.92 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.47 126.7 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.4 mttt -110.63 130.53 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.515 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.82 122.27 47.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.4 m-85 -99.65 119.87 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' O ' HG22 ' A' ' 47' ' ' VAL . 18.8 m -126.18 161.21 32.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.408 . . . . 0.0 111.803 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB3' ' OG1' ' A' ' 62' ' ' THR . . . -117.03 101.32 8.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.59 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 59.69 -134.59 51.29 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.0 36.45 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 111.035 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p -63.89 151.74 88.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.758 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.565 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 15.2 Cg_endo -57.25 -31.79 91.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.404 2.069 . . . . 0.0 112.788 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.3 p-10 -70.63 -42.47 70.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.427 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 73.9 m -70.17 -42.83 71.96 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.58 -44.21 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.738 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -61.45 -47.9 83.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.224 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.576 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.72 -47.47 85.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -63.82 -42.47 97.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.889 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.461 HG21 ' CG2' ' A' ' 86' ' ' VAL . 86.1 m -65.34 -44.87 86.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.396 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.56 -50.74 34.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.59 -45.33 94.57 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -66.48 -39.75 88.92 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.394 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -65.17 -43.86 95.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.665 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.93 -28.33 64.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.9 mt-10 -89.45 -1.47 58.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -132.05 -62.31 0.85 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.19 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.8 mm-40 -65.19 -41.15 94.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.5 29.94 6.44 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.1 ttpt -61.92 129.43 40.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.45 . . . . 0.0 111.246 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.47 -8.91 78.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.029 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.87 -44.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.206 0.503 . . . . 0.0 111.375 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.4 m-85 -113.02 141.43 46.86 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.057 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.54 124.85 50.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -97.21 128.27 43.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 112.281 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptp? -125.55 110.37 13.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.026 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.15 128.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.538 0.685 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -111.36 116.55 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.738 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -86.4 103.37 14.9 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.4 m -67.33 -32.44 57.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.4 mt -70.13 -39.2 75.56 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.87 -37.25 73.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.409 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -129.2 86.42 56.84 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.349 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.88 -28.42 81.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.985 2.457 . . . . 0.0 112.619 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 64.4 tt0 -62.72 -42.25 99.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.388 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.02 -36.68 75.26 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.671 -0.411 . . . . 0.0 109.926 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.17 97.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.038 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.56 -38.62 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.8 mm-40 -60.86 -40.68 93.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.497 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.37 9.7 41.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.076 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.11 52.39 14.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 59' ' ' ILE . 47.9 mm -87.93 108.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.571 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.33 -11.52 15.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.839 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.46 139.6 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.552 0.215 . . . . 0.0 111.168 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 15' ' ' ALA . 57.9 p -132.78 148.55 69.96 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.64 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 63.0 Cg_endo -75.47 151.95 96.86 Favored 'Cis proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.893 -1.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -117.91 122.78 44.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.228 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.5 tp -104.86 114.33 28.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -139.59 137.24 35.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 112.201 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 17.2 ttpp -96.64 104.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.5 m -81.14 -28.59 10.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.531 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.33 137.39 22.31 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.56 152.66 96.44 Favored 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.254 -1.144 . . . . 0.0 112.461 -1.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.35 156.61 61.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.716 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 167.63 79.24 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.317 -1.118 . . . . 0.0 113.387 0.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 87.5 t -70.67 126.38 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -106.85 117.88 35.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.52 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -101.72 123.07 45.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 76' ' ' ILE . 69.5 mt -105.51 117.08 50.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.597 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 77' ' ' ILE . 47.3 mm -117.23 126.13 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.48 -166.95 40.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.771 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.93 101.77 11.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.76 -0.69 57.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.09 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -68.37 -24.17 64.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.514 . . . . 0.0 110.0 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -84.0 119.13 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.443 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.23 -36.15 77.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.577 -178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.24 -46.51 88.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.8 -40.23 96.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.7 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 27' ' ' THR . 68.6 t -62.6 -43.81 98.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.14 -44.89 78.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.402 0.144 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.8 97.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.248 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.42 -38.46 81.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.803 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.02 -46.52 88.83 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.46 -39.69 94.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.556 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 87.3 mt -65.29 -40.98 94.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.21 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.82 92.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.6 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.96 -38.15 87.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.1 -40.06 94.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.5 mt -67.77 -44.37 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.14 -35.62 91.77 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.777 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -96.16 17.47 15.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 111.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -92.71 118.6 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.319 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.32 142.54 43.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.687 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.69 -43.38 98.97 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.23 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -91.47 103.97 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.16 -29.22 68.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.157 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t0 66.77 -175.23 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.312 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.522 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.138 0.495 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.18 110.88 64.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.04 143.18 99.58 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.859 2.372 . . . . 0.0 112.771 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.22 149.27 37.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -62.61 -38.04 88.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.446 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -62.24 -38.73 90.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.893 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -79.37 123.54 27.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB1' ' CD2' ' A' ' 40' ' ' TYR . . . -86.29 151.92 23.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.24 126.6 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 25.6 mt -115.67 134.95 54.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.072 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.1 mttt -115.0 126.36 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.82 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 122.72 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.7 m-85 -99.65 118.47 36.25 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.428 ' O ' HG22 ' A' ' 47' ' ' VAL . 28.3 m -126.5 160.82 33.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.002 0.43 . . . . 0.0 111.503 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.17 104.4 11.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' N ' HD13 ' A' ' 48' ' ' LEU . . . 60.8 -130.78 48.4 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.415 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -131.66 50.27 2.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.23 0.538 . . . . 0.0 110.289 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 52.1 p -73.15 156.0 89.72 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.818 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.6 Cg_endo -57.77 -34.64 98.5 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.103 1.869 . . . . 0.0 112.353 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.29 -42.79 87.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.0 m -70.05 -42.38 72.96 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.809 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.68 -44.29 96.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.66 -49.31 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.644 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.75 97.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.473 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 64.2 tp -61.84 -47.68 83.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.238 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -62.45 -44.76 95.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.741 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.1 m -63.05 -49.45 74.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.983 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.96 -46.18 72.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 25' ' ' LEU . . . -62.29 -42.86 99.71 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.95 -42.07 97.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.69 -44.29 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.537 . . . . 0.0 110.493 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.8 -35.6 80.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 77.7 mm-40 -87.88 -1.27 57.87 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -129.91 -64.09 0.88 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.593 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.55 -42.11 95.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.42 30.05 6.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 64.7 tttp -60.39 129.52 42.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 111.247 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.25 -8.33 79.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.769 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.15 -41.59 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.886 0.343 . . . . 0.0 111.036 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.49 ' OH ' HD13 ' A' ' 97' ' ' ILE . 39.7 m-85 -115.18 143.79 44.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.171 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.82 126.38 51.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.7 tp -97.51 129.5 44.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.622 0.725 . . . . 0.0 112.922 -178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -126.02 132.4 52.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.114 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -120.65 129.96 75.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.383 0.611 . . . . 0.0 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -112.4 116.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.932 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.12 103.6 14.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 14' ' ' VAL . 23.8 m -66.71 -33.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 16' ' ' GLY . 81.6 mt -70.24 -39.68 74.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.76 -37.57 73.41 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.382 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -129.04 86.55 56.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.097 0.475 . . . . 0.0 110.321 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.82 -28.44 81.59 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.92 2.413 . . . . 0.0 112.466 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.732 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.21 -42.26 99.26 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.785 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.16 -36.93 75.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.034 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.73 98.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.693 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.23 -38.3 85.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.322 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.732 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.5 mt-10 -60.73 -40.81 93.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -97.69 9.62 42.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.094 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.04 52.02 15.51 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.383 0.673 . . . . 0.0 112.707 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mm -87.48 107.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.77 1.37 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.58 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.1 148.7 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.701 0.286 . . . . 0.0 111.437 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.9 p -147.43 142.66 17.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.328 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.76 151.05 84.26 Favored 'Cis proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.927 -1.697 . . . . 0.0 112.578 -1.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -128.16 130.94 48.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.519 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.21 120.44 41.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.77 136.38 37.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 0.0 111.39 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.4 OUTLIER -93.45 103.94 16.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.0 m -80.97 -28.09 11.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.879 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -136.97 138.37 25.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.089 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.74 148.31 79.45 Favored 'Cis proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.41 -1.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -61.57 153.69 64.97 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.957 2.438 . . . . 0.0 111.864 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -69.05 160.81 85.3 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.974 -0.844 . . . . 0.0 113.742 0.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 90.2 t -72.31 126.27 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.732 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -106.78 118.24 36.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -100.43 125.72 46.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.2 0.524 . . . . 0.0 110.4 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 66.2 mt -107.79 116.55 51.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.708 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.89 126.42 75.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.49 -164.88 38.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.635 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.66 100.06 9.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.11 -2.37 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.065 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.0 m -68.63 -20.91 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.24 0.543 . . . . 0.0 110.267 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -87.9 120.46 29.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.542 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.37 -37.48 80.88 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -61.17 -43.24 99.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.5 mttm -64.59 -40.96 96.45 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.713 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.62 -42.58 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.227 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.38 -49.55 54.35 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.017 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.68 -47.53 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 85' ' ' LYS . . . -63.44 -41.64 98.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.9 tp -67.41 -40.49 85.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.869 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -62.64 -43.84 97.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.819 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.63 -38.9 92.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.712 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.29 -40.3 93.66 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.847 0.356 . . . . 0.0 110.675 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.36 90.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.845 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.6 -38.44 87.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 110.066 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.74 -41.08 99.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.464 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.49 HD13 ' OH ' ' A' ' 40' ' ' TYR . 85.3 mt -69.83 -43.75 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.67 91.97 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.805 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.93 -39.81 93.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.784 0.326 . . . . 0.0 111.532 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -84.68 117.35 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.81 137.14 48.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.736 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -163.01 -51.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -88.92 106.14 18.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.635 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 106' ' ' LYS . 33.6 t70 -67.15 -29.57 69.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.143 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.3 t0 56.59 46.61 20.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.862 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HB2' ' OD2' ' A' ' 104' ' ' ASP . 15.9 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.04 63.88 9.06 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 123.818 0.699 . . . . 0.0 112.388 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 143.3 99.59 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.757 2.305 . . . . 0.0 112.64 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -89.61 -10.4 46.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.876 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -79.08 143.71 35.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.524 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -87.15 -11.5 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -90.82 123.76 34.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.55 153.16 22.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.55 121.23 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.472 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 50.2 tp -113.99 126.37 55.06 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 99.4 mttt -110.95 135.25 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.324 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.57 123.77 51.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.924 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' CD2' HG13 ' A' ' 59' ' ' ILE . 97.7 m-85 -98.28 121.86 40.73 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.2 m -124.84 159.02 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.568 0.223 . . . . 0.0 110.559 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 18' ' ' THR . . . -125.72 96.56 4.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.62 88.37 Favored Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.583 -0.818 . . . . 0.0 114.883 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.01 47.44 9.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.591 0.71 . . . . 0.0 110.326 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 15' ' ' ALA . 68.1 p -72.26 165.48 50.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.022 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.96 -37.72 67.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.119 1.88 . . . . 0.0 112.909 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -64.48 -44.7 90.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -65.31 -43.55 90.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.15 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.96 -44.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 109.991 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -61.56 -47.69 84.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.224 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.18 99.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.244 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 tp -61.83 -47.81 83.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.352 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.66 -40.18 96.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.792 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.5 m -64.6 -46.5 82.37 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.222 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.01 -47.02 63.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.07 -42.65 98.9 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.58 -44.55 96.04 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 77.6 mt -63.73 -45.83 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.621 0.724 . . . . 0.0 111.04 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.4 mt -69.63 -32.52 71.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.313 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.63 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.7 mt-10 -84.16 -10.14 58.0 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -125.78 -62.04 1.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.223 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.6 mm-40 -63.66 -42.37 98.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CD1' HD13 ' A' ' 90' ' ' LEU . 97.8 m-85 -123.89 31.31 5.88 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.3 128.1 34.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.022 0.439 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.63 -0.22 89.65 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.655 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.96 -44.75 6.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 117.327 0.563 . . . . 0.0 111.603 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -114.02 142.13 46.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.579 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 126.0 51.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.1 tp -96.35 125.05 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 111.279 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.2 mptp? -125.08 113.0 17.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.519 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -98.64 128.67 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.542 0.687 . . . . 0.0 111.033 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.6 mm -111.14 116.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.897 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.54 104.13 15.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 14' ' ' VAL . 28.8 m -67.64 -33.64 63.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.47 -39.86 73.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.06 -36.27 72.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -124.78 81.72 61.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.811 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.56 -32.81 93.93 Favored 'Trans proline' 0 N--CA 1.466 -0.099 0 C-N-CA 123.307 2.671 . . . . 0.0 112.267 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.675 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 mp0 -63.15 -41.97 99.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.23 -37.37 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.937 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.58 97.07 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.42 -38.7 88.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.395 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.675 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -60.76 -40.55 92.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.81 9.53 42.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.009 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? 49.87 51.97 15.54 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 13' ' ' TYR . 43.3 mm -91.45 108.2 19.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.696 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -110.63 2.94 18.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.729 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.58 36.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.812 0.339 . . . . 0.0 111.516 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB1' ' A' ' 15' ' ' ALA . 63.5 p -147.6 148.8 32.02 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.74 146.26 81.32 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.518 -1.451 . . . . 0.0 111.571 -2.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -128.41 130.08 47.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.163 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.8 mt -102.52 125.26 49.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -143.17 127.36 17.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.014 0.435 . . . . 0.0 110.767 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.5 OUTLIER -98.6 101.35 12.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' HA ' ' CG2' ' A' ' 73' ' ' VAL . 74.3 t -71.81 -39.05 67.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.582 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.7 134.39 26.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 0.0 112.334 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.42 ' HD2' ' NZ ' ' A' ' 67' ' ' LYS . 83.6 Cg_endo -76.5 154.48 97.65 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.374 -1.511 . . . . 0.0 112.475 -1.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 155.46 66.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.58 2.187 . . . . 0.0 112.017 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.3 164.59 86.65 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.446 0.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 61.0 t -70.6 125.7 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.871 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.3 mmm180 -94.37 114.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -101.29 120.69 40.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.323 0.582 . . . . 0.0 110.55 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.5 mt -111.38 118.74 58.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.169 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.61 127.37 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.865 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.81 -162.53 35.98 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -81.33 100.53 9.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.71 -4.08 57.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.2 m -70.27 -22.35 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.093 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.2 t-20 -81.63 117.99 22.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -60.41 -36.74 78.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.082 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 41.3 mt-10 -60.63 -44.87 95.85 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.31 -41.64 96.74 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.959 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 69.8 t -63.79 -45.68 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.548 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -65.04 -46.87 79.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.297 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -62.57 -47.09 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.49 0.186 . . . . 0.0 111.229 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.98 97.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -67.28 -40.04 86.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.196 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.28 -44.54 94.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.02 -39.75 95.68 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.855 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.09 -41.22 95.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.681 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.8 92.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.34 -38.61 90.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.884 0.373 . . . . 0.0 110.319 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.52 -40.42 96.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.95 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.0 mt -64.57 -45.02 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.665 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.56 91.92 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.514 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.53 -40.59 97.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.047 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.37 125.87 28.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.911 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.39 135.65 47.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.943 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -110.94 -51.52 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.65 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -91.97 109.92 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -95.51 14.62 22.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.86 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -138.74 163.18 32.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.77 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 3' ' ' PRO . . . -62.18 -50.39 80.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 2' ' ' ALA . 67.8 Cg_endo -71.54 154.72 60.09 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.971 1.781 . . . . 0.0 112.82 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.9 -11.47 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 57.55 -131.12 1.47 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.842 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.05 0.7 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.677 0.275 . . . . 0.0 111.244 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.4 130.51 36.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.611 0.719 . . . . 0.0 111.987 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.5 153.47 22.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.626 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -108.31 124.53 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.207 0.527 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -112.79 127.35 56.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' HD13 ' A' ' 10' ' ' LEU . 98.5 mttt -115.03 132.21 56.67 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.773 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.7 124.75 50.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.005 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -98.41 118.94 36.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.2 m -125.58 160.3 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.368 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.35 104.19 10.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.556 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.77 -129.9 44.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.088 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -134.22 53.06 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.5 . . . . 0.0 110.3 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -74.34 157.56 86.35 Favored Pre-proline 0 CA--C 1.515 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.859 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.89 -33.72 97.39 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -67.24 -43.57 81.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -67.76 -43.02 80.82 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.7 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.95 -44.0 96.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.905 0.383 . . . . 0.0 110.438 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.534 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 tpt180 -63.42 -49.67 72.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.507 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.45 98.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 63.4 tp -62.0 -46.56 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.294 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -64.69 -42.31 95.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.725 0.298 . . . . 0.0 110.97 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.2 m -63.04 -49.12 75.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.2 tp -67.58 -45.1 76.53 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.18 -42.87 99.69 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.48 -44.64 96.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 110.797 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 78.0 mt -63.54 -45.54 97.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.029 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 70.9 mt -66.48 -37.34 84.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.8 mt-10 -65.09 -36.31 83.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -114.13 -53.12 2.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.8 mm-40 -65.78 -41.6 91.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 90' ' ' LEU . 96.4 m-85 -123.66 29.56 6.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 13.8 tmtt? -60.01 127.21 30.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.023 0.439 . . . . 0.0 111.324 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.61 -8.04 80.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.675 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.76 -46.06 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.511 0.656 . . . . 0.0 111.561 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.03 141.86 46.9 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.46 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.81 128.38 49.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.8 tp -98.52 126.36 44.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptm? -124.67 139.2 54.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.854 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.69 132.79 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.583 0.706 . . . . 0.0 110.925 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.11 104.73 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.72 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -77.52 102.02 6.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 14' ' ' VAL . 25.5 m -66.71 -34.18 68.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.49 -37.36 74.21 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.776 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -70.42 -40.58 73.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.571 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -126.14 83.09 64.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 -33.04 95.56 Favored 'Trans proline' 0 CA--C 1.527 0.132 0 C-N-CA 123.218 2.612 . . . . 0.0 112.576 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.686 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 53.4 tt0 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.72 -37.12 76.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.04 -42.01 97.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.125 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.76 -38.21 86.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.532 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.686 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.1 mm-40 -60.6 -40.36 91.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.03 8.96 43.36 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.884 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 51.35 50.92 17.93 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.75 104.93 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.48 2.82 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.639 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.38 149.66 38.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.444 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -148.0 145.55 21.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.046 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.75 148.68 83.71 Favored 'Cis proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.464 -1.473 . . . . 0.0 111.622 -2.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -123.78 128.57 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.1 tp -102.59 119.18 38.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.472 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.83 139.31 30.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.527 0.679 . . . . 0.0 112.258 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.3 105.01 16.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.42 -28.85 10.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.907 -178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -135.83 139.07 29.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.394 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.44 152.18 78.85 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.432 -1.487 . . . . 0.0 112.596 -1.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.17 153.11 67.15 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.987 2.458 . . . . 0.0 112.03 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -68.87 158.99 87.62 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.915 -0.869 . . . . 0.0 113.727 0.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.3 t -74.21 126.6 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.58 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -105.82 120.12 40.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.014 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -103.82 126.11 50.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.21 0.528 . . . . 0.0 110.082 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.53 117.97 56.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.847 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.0 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.022 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.95 -166.36 39.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.801 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -82.26 101.91 10.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.9 -1.29 57.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.327 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.6 m -68.86 -21.59 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -87.2 120.29 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.253 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -36.06 76.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.643 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.68 -44.32 96.66 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 68.4 mttm -65.23 -41.33 94.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.204 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.18 -45.92 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.239 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.29 -48.76 72.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.003 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.85 -47.69 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.459 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -64.35 -41.91 96.51 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.675 0.274 . . . . 0.0 111.471 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.421 HD23 ' CD1' ' A' ' 36' ' ' PHE . 53.1 tp -65.6 -39.98 92.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.347 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.8 -43.96 97.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.689 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp -61.62 -41.73 97.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.684 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 89' ' ' ALA . 3.9 mm? -65.94 -41.79 90.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.618 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.57 91.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.563 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.74 -38.94 89.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.809 0.338 . . . . 0.0 110.459 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.58 -40.35 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 91.8 mt -66.04 -44.65 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.867 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.16 -35.79 92.04 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.603 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.48 -39.73 94.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.303 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -85.28 114.01 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -87.09 134.74 33.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.619 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.1 110.39 6.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.928 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t0 55.8 51.3 12.55 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.61 0.568 . . . . 0.0 111.652 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.6 -29.91 70.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.674 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -91.46 100.98 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.603 179.672 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.51 117.16 65.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.974 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.21 152.89 62.15 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.716 2.278 . . . . 0.0 112.797 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -110.79 133.76 53.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -125.14 -68.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.535 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -93.52 -4.76 50.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -90.32 124.55 35.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.25 152.48 22.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.675 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.6 t -108.88 121.38 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.188 0.518 . . . . 0.0 109.951 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 90' ' ' LEU . 43.5 tp -113.5 126.8 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.8 mttt -111.43 133.33 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.786 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.31 124.72 53.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.6 m-85 -100.17 119.41 38.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 21' ' ' SER . 15.7 m -125.61 160.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.891 0.377 . . . . 0.0 111.167 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.24 102.93 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.558 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.02 -133.19 50.99 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -125.83 38.08 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -67.76 154.35 93.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.34 -37.76 81.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.048 1.832 . . . . 0.0 112.872 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 35.1 m120 -65.18 -44.5 88.25 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.262 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 75.6 m -68.46 -43.9 76.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.289 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.3 -45.81 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 110.614 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -62.34 -46.18 89.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.72 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 20' ' ' ASN . . . -63.46 -43.07 98.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.811 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.2 mt -63.03 -41.88 99.64 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.62 -40.0 95.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.0 110.291 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.9 m -66.57 -45.22 80.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.468 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -51.55 21.59 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.521 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.57 -43.77 98.25 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.01 -43.43 95.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.232 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.2 mt -64.14 -45.15 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.951 0.405 . . . . 0.0 111.148 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.79 -35.64 77.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.9 mt-10 -71.66 -24.63 61.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -114.48 -59.75 1.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.315 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.87 -40.94 95.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -122.32 29.58 6.91 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 59.5 tttp -62.12 127.73 32.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 111.318 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.42 79.84 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.139 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.49 -43.28 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 117.168 0.484 . . . . 0.0 111.37 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' OH ' HD13 ' A' ' 97' ' ' ILE . 32.3 m-85 -114.53 143.63 44.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.004 -0.679 . . . . 0.0 112.107 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 123.86 48.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.76 127.73 40.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.347 0.594 . . . . 0.0 112.039 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.25 108.83 12.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.214 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.87 127.86 47.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.764 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -110.95 115.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.871 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -86.15 101.19 12.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 14' ' ' VAL . 24.0 m -64.31 -34.79 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -71.33 -37.89 71.7 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.32 -41.24 73.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.94 0.4 . . . . 0.0 110.627 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.17 79.1 62.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.32 -20.05 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.418 2.079 . . . . 0.0 112.777 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.748 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.2 mt-30 -63.28 -41.75 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 99.9 mt -70.97 -36.38 72.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.782 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 -42.04 98.55 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.2 85.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.162 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.748 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.2 mt-10 -60.89 -40.4 92.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.66 9.82 40.45 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.965 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.87 51.85 16.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.49 0.716 . . . . 0.0 112.925 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.6 mm -88.55 107.24 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.563 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.98 1.41 24.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.57 149.31 37.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 111.314 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -147.42 143.05 17.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.55 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.99 150.62 82.63 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.886 -1.714 . . . . 0.0 112.576 -1.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -127.47 131.22 50.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.443 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -105.2 120.84 42.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.112 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.44 135.96 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.419 0.628 . . . . 0.0 111.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -101.23 104.59 15.64 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.9 m -79.94 -28.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.145 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -134.72 139.02 31.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.439 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.23 152.88 84.6 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.569 -1.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.55 71.13 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.995 2.463 . . . . 0.0 112.038 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.1 160.29 89.28 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 124.894 -0.878 . . . . 0.0 113.668 0.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.89 127.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -106.05 118.88 37.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -104.43 124.38 49.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.108 0.48 . . . . 0.0 109.769 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 76' ' ' ILE . 64.1 mt -109.33 117.59 54.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.418 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.26 127.72 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.541 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.42 -158.8 31.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.19 86.38 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mp -77.26 -10.01 59.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.765 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.0 p -67.94 -19.11 64.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.861 0.362 . . . . 0.0 111.007 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.09 120.71 30.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.84 -35.8 75.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.596 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.3 -44.76 95.13 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -64.42 -41.24 96.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.947 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.38 -47.2 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.686 0.279 . . . . 0.0 110.571 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.07 -47.61 76.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.749 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.68 -46.06 97.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.85 -41.32 99.31 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.479 0.18 . . . . 0.0 111.248 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.448 HD22 ' CD2' ' A' ' 10' ' ' LEU . 89.1 mt -66.32 -38.3 87.38 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.064 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.29 -42.41 96.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.441 0.162 . . . . 0.0 110.942 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.3 -40.03 95.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.722 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.2 mt -66.93 -40.49 87.63 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.93 0.395 . . . . 0.0 110.59 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.31 90.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.575 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.45 -37.68 84.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.139 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.76 -40.7 98.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.46 HD13 ' OH ' ' A' ' 40' ' ' TYR . 84.1 mt -70.02 -43.67 79.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.47 -22.05 72.89 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.841 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.41 -39.65 93.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 111.016 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.66 126.15 28.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.098 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -97.86 148.35 23.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -153.82 158.11 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -88.76 104.42 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.28 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -94.89 6.94 47.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.62 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.1 t0 55.91 43.77 26.89 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.639 0.587 . . . . 0.0 111.798 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.65 179.665 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 146.71 62.3 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.59 149.99 56.37 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.738 2.292 . . . . 0.0 112.974 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.21 137.23 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -130.39 149.44 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.83 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.8 -40.13 95.9 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.199 0.523 . . . . 0.0 110.698 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.745 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB1' ' CE2' ' A' ' 40' ' ' TYR . . . -95.69 152.3 18.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.155 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.4 t -111.62 124.02 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 130.35 56.16 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.7 mttt -115.63 131.29 56.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.47 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.43 124.75 51.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.8 m-85 -100.51 119.8 39.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.4 m -126.99 160.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 111.682 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.449 ' HB2' ' OG1' ' A' ' 62' ' ' THR . . . -115.65 105.57 12.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.657 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.75 -130.29 45.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.09 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -136.56 52.22 1.96 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.38 158.02 84.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.952 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 74.5 Cg_exo -54.31 -37.16 88.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.702 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -64.79 -45.23 87.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 110.002 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -66.84 -43.12 84.51 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.6 -44.62 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.589 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.9 tpt180 -62.01 -47.66 83.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.17 -42.74 99.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.65 -47.74 83.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.514 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.7 97.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 HG22 ' CG2' ' A' ' 86' ' ' VAL . 87.4 m -65.42 -45.47 83.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -50.0 43.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.78 -45.6 93.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.78 -43.34 93.56 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.22 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.5 mt -63.6 -44.81 98.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.004 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.8 mt -71.2 -27.9 63.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.591 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -88.85 -4.36 58.5 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.94 -62.13 1.02 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.268 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.298 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.27 30.2 6.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.53 126.29 26.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.44 83.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.335 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.88 -41.38 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.19 0.495 . . . . 0.0 111.486 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CE2' ' HB1' ' A' ' 8' ' ' ALA . 37.8 m-85 -116.1 144.31 44.31 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.481 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.65 124.57 49.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -97.04 129.82 44.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.464 0.649 . . . . 0.0 112.533 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -125.8 134.33 51.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.442 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -120.48 129.56 75.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.412 0.625 . . . . 0.0 110.774 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -112.49 116.21 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.806 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -86.34 104.62 16.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 14' ' ' VAL . 17.5 m -68.22 -21.16 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.53 -38.42 17.23 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.387 0.54 . . . . 0.0 111.873 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.86 -37.37 73.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.412 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -132.9 77.01 69.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.63 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.53 -19.3 67.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.604 2.202 . . . . 0.0 112.718 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.677 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.7 mt-30 -63.13 -41.04 99.24 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.75 -36.16 73.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.8 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.45 97.68 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.132 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.63 86.62 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.172 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.88 -40.32 92.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.344 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.47 10.27 40.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.994 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 50.18 52.68 14.26 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 48.8 mm -88.84 109.23 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.34 -7.2 17.82 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.11 142.99 30.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.495 0.188 . . . . 0.0 111.22 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 15' ' ' ALA . 68.0 p -135.25 149.91 71.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.637 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.8 Cg_endo -75.84 151.36 95.58 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.608 -1.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.02 123.63 44.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.426 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -104.23 116.84 32.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -141.27 136.63 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.196 0.522 . . . . 0.0 111.605 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.658 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.3 ttpp -99.37 101.29 12.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -71.5 -39.24 70.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.257 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -128.71 140.66 39.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.856 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.37 153.5 98.63 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.391 -1.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -60.62 149.9 84.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.959 2.44 . . . . 0.0 112.246 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.67 169.13 73.41 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.417 0.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 70.9 t -72.95 124.92 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.416 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.6 mmm180 -100.54 114.01 27.28 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -98.06 118.63 35.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 110.443 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.1 mt -106.6 116.48 50.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.508 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.48 127.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 111.305 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.79 -165.4 38.68 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.613 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -80.51 101.73 9.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.96 -3.5 58.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -68.12 -21.37 64.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.309 0.576 . . . . 0.0 110.0 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -84.18 116.76 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.34 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.0 mtm-85 -60.47 -37.24 80.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.5 -44.2 96.23 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -63.75 -40.81 97.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.419 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' CG2' HG22 ' A' ' 27' ' ' THR . 65.2 t -63.48 -44.3 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.452 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -46.67 72.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.536 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.1 mt -61.73 -46.11 97.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.345 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.24 98.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.258 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.76 -38.24 86.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.722 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -62.18 -46.3 89.53 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.803 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.3 -39.47 92.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.373 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.44 -41.07 96.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.895 0.378 . . . . 0.0 110.336 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.52 91.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.512 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -38.27 88.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.996 0.427 . . . . 0.0 110.039 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.74 -40.65 97.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.423 HD12 ' OH ' ' A' ' 40' ' ' TYR . 86.3 mt -68.38 -44.27 83.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.881 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.07 -24.94 70.64 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.11 -38.63 89.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 111.131 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -85.89 107.98 17.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -84.49 143.36 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.99 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -159.6 161.18 35.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -87.23 106.16 17.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.26 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.81 -29.26 69.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.68 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.79 102.91 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 110.632 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.755 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.36 63.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.74 155.52 58.38 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.752 2.302 . . . . 0.0 112.647 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.0 mt -107.84 138.55 43.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.664 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -95.47 151.96 18.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -65.8 -38.52 89.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.677 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.77 122.07 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.989 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.57 152.33 21.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.137 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.78 121.78 63.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.16 127.59 55.63 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.4 mttt -113.59 132.94 55.54 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.883 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.9 124.05 51.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.975 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -98.96 118.91 36.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 47' ' ' VAL . 33.5 m -125.63 160.22 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.441 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.49 103.94 10.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 61.72 -129.53 44.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.264 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.22 52.68 1.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.802 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -74.91 158.36 84.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.704 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.09 -37.01 86.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.482 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 36.3 m120 -65.9 -45.79 80.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.8 0.333 . . . . 0.0 110.117 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.0 m -65.75 -44.25 86.49 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.15 -45.81 92.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.749 0.309 . . . . 0.0 110.877 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -62.63 -46.81 86.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 20' ' ' ASN . . . -63.58 -42.89 98.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.178 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 64.8 tp -61.56 -47.42 85.61 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.726 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -63.04 -41.16 99.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 110.761 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.6 m -65.16 -49.51 69.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.073 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.67 -46.5 68.9 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.539 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.8 -44.6 95.73 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.15 -41.07 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.873 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 76.7 mt -64.01 -44.38 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.13 -34.45 75.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 48.7 mt-10 -81.88 -11.86 58.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -122.26 -61.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.4 mm-40 -64.69 -40.56 95.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.37 29.82 7.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -56.79 128.07 34.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 111.719 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 -1.89 88.36 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.559 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.61 -41.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.486 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' HD12 ' A' ' 97' ' ' ILE . 38.0 m-85 -115.55 144.44 43.87 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.294 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.93 124.78 50.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -95.39 129.95 42.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.372 0.606 . . . . 0.0 112.455 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.6 mptp? -127.87 114.55 17.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.207 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -102.47 128.05 55.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.518 0.675 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -109.96 115.88 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -86.99 102.04 14.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 14' ' ' VAL . 24.4 m -65.27 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 16' ' ' GLY . 81.7 mt -70.3 -39.38 74.85 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.81 -37.81 73.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.646 0.26 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -129.01 86.33 57.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.48 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -61.52 -29.0 83.99 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.891 2.394 . . . . 0.0 112.579 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.737 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.9 tt0 -62.42 -43.8 97.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.63 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.16 -36.58 74.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.177 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.87 -41.85 97.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.615 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.17 -38.51 85.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.408 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.84 -40.65 93.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.303 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -97.15 9.84 41.06 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.907 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm 50.56 51.39 16.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.694 . . . . 0.0 112.843 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.02 105.51 15.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.11 1.45 24.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.18 150.54 36.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -146.21 146.88 29.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.981 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.12 148.25 81.66 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.404 -1.498 . . . . 0.0 111.791 -1.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -123.49 128.74 50.22 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.7 tp -102.6 120.36 40.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.895 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.65 136.05 28.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.43 0.633 . . . . 0.0 111.881 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.4 ttpp -99.83 104.66 16.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.2 m -80.31 -28.73 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.675 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.7 mt -136.93 138.29 25.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.66 157.4 97.69 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.481 -1.466 . . . . 0.0 112.305 -1.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.92 154.69 70.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.662 2.241 . . . . 0.0 111.927 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.86 164.99 86.13 Favored 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 124.138 -1.192 . . . . 0.0 113.412 0.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 96.5 t -71.29 127.49 33.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.058 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 mmm180 -102.01 114.03 27.78 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -101.2 121.81 42.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 109.655 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.0 mt -111.87 118.18 56.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.041 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.06 125.24 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.55 -165.32 38.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.715 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.26 101.64 11.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.6 mt -89.84 -0.26 57.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.955 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 m -71.0 -15.96 62.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.202 0.525 . . . . 0.0 110.135 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -91.66 119.18 31.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.202 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.617 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.74 -46.08 90.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.28 -40.21 95.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.4 t -62.71 -43.13 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -67.54 -45.48 75.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.682 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.58 -47.36 93.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.549 0.214 . . . . 0.0 111.361 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.06 -41.36 97.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.557 0.218 . . . . 0.0 111.276 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.8 -39.66 83.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.885 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.89 -45.8 90.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.89 -40.18 94.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.354 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.93 -41.0 95.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.954 0.407 . . . . 0.0 110.297 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.18 90.15 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.483 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.72 -38.32 87.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.049 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.15 -40.77 98.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.358 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.475 HD12 ' OH ' ' A' ' 40' ' ' TYR . 86.2 mt -69.41 -43.73 80.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.92 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.51 -22.9 71.76 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.748 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.46 -39.2 92.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -69.21 123.88 22.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -89.75 147.18 23.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.54 -42.5 99.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.252 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.38 158.13 36.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.093 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.26 -30.53 70.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.383 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.96 -75.77 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.673 0.608 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.797 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.015 0.436 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.68 110.72 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.92 145.25 98.78 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.949 2.433 . . . . 0.0 112.557 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.7 mt -106.29 142.48 35.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -104.98 157.04 17.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.69 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -63.05 -38.71 92.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -77.86 123.29 26.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.259 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.15 152.4 22.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.929 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 69' ' ' LEU . 63.2 t -112.04 124.44 68.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.089 0.471 . . . . 0.0 110.32 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.14 132.68 55.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.0 mttt -115.69 129.08 56.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.329 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.29 123.88 49.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.5 m-85 -100.71 119.51 38.7 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.57 161.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.946 0.403 . . . . 0.0 111.635 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' OG1' ' A' ' 62' ' ' THR . . . -116.72 103.53 10.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.889 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.45 48.35 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.713 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.55 50.19 2.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.62 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.501 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.6 p -72.99 154.02 90.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.736 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.62 -32.68 95.13 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.8 p-10 -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.9 m -67.81 -42.74 81.06 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.19 -45.72 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 63.6 ttt180 -62.39 -46.75 87.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.28 94.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.533 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.2 tp -61.94 -46.05 91.01 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.22 -41.3 99.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 110.543 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.9 m -63.92 -45.71 88.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.132 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -50.31 52.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.89 -43.97 97.76 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.46 85.62 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.219 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.21 -43.94 97.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.789 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.25 -26.63 62.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.0 mt-10 -89.2 -3.51 58.55 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -130.25 -61.88 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 111.084 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.1 mm-40 -65.04 -41.17 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.524 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.58 30.06 6.37 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.0 ttpt -61.81 127.95 33.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.13 80.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.905 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.58 -40.55 5.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.951 0.376 . . . . 0.0 111.403 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -115.84 144.88 43.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.393 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.21 125.1 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.7 tp -97.58 127.88 43.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.4 mptt -122.6 136.97 55.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.953 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.9 132.37 70.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.734 0.778 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.79 105.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.173 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -77.25 103.14 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.29 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.113 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.64 -37.39 79.65 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.0 -41.12 74.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.896 0.379 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -126.92 82.78 67.22 Favored Pre-proline 0 CA--C 1.517 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 110.867 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.85 -32.82 95.93 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.253 2.635 . . . . 0.0 112.632 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.746 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.14 -42.23 99.43 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.5 -37.53 74.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.081 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.1 -41.6 97.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.985 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.57 -36.37 80.78 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.663 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 96.2 mt-10 -59.58 -39.28 83.6 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -98.29 7.83 45.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.578 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 49.72 53.34 12.92 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 59' ' ' ILE . 48.1 mm -84.81 107.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.586 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -104.98 -10.86 16.96 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.905 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.04 137.39 39.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 0.0 111.023 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 15' ' ' ALA . 68.6 p -134.41 148.48 67.78 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.0 Cg_endo -76.27 152.4 96.16 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.777 -1.759 . . . . 0.0 112.717 -1.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.62 123.95 45.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.275 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.7 tp -105.01 117.75 34.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.19 137.18 34.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.564 0.697 . . . . 0.0 111.816 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.3 ttpp -93.23 103.35 15.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 69' ' ' LEU . 2.1 p -79.24 -30.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' N ' HG11 ' A' ' 68' ' ' VAL . 91.1 mt -138.04 143.0 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.02 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.74 156.4 95.37 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.476 -1.468 . . . . 0.0 112.353 -1.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.4 150.48 80.57 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.398 . . . . 0.0 112.146 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.85 166.82 80.17 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.507 0.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 86.5 t -73.17 125.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -108.54 117.42 34.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -99.89 121.65 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.686 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.486 HD13 HG23 ' A' ' 76' ' ' ILE . 67.9 mt -104.26 116.03 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.623 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.99 125.7 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.864 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.17 -162.47 36.25 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.609 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.39 99.12 9.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.88 -5.8 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.792 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 48.7 m -68.56 -19.88 64.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.479 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.36 120.07 30.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.929 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.4 -44.47 95.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 62.0 mttp -64.42 -41.25 96.71 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.024 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.08 -46.14 94.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.677 0.275 . . . . 0.0 110.559 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.01 -47.63 76.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.717 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.31 -46.85 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 85' ' ' LYS . . . -63.35 -41.04 98.83 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.538 0.209 . . . . 0.0 111.4 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.92 -39.0 87.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.588 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -64.07 -45.25 89.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -39.66 95.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.42 -40.33 93.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 110.549 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.56 91.64 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.851 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.93 -39.18 91.17 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.92 -40.82 97.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.466 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.47 -45.57 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.736 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -36.2 93.04 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.86 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -106.61 35.82 2.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -88.7 118.6 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.29 142.84 42.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.29 103.35 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.539 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.11 103.21 15.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.799 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -96.16 7.71 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 t70 69.79 -65.85 0.29 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.417 0.687 . . . . 0.0 111.911 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.75 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 120.84 79.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.691 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.53 142.6 99.15 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.833 2.355 . . . . 0.0 112.777 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.99 152.65 19.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -77.95 125.99 30.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.652 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm 69.63 -49.03 0.62 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.655 0.782 . . . . 0.0 112.999 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -82.71 127.01 33.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.381 0.61 . . . . 0.0 111.972 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' CB ' HD12 ' A' ' 97' ' ' ILE . . . -104.39 153.84 20.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.345 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.0 t -108.15 123.67 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.273 0.558 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.6 tp -114.91 126.1 54.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.7 mttt -114.07 138.37 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.382 0.61 . . . . 0.0 111.635 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.18 124.43 52.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.399 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.8 m-85 -99.32 119.93 38.73 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 47' ' ' VAL . 23.1 m -127.17 161.48 34.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.95 0.405 . . . . 0.0 111.792 -178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' OG1' ' A' ' 62' ' ' THR . . . -117.41 104.1 10.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.198 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 60.78 -131.82 49.13 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.755 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -129.68 48.28 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.368 0.604 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.508 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.8 p -71.95 153.63 92.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.72 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 16.1 Cg_endo -57.86 -32.1 94.14 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.396 2.064 . . . . 0.0 112.679 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.508 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.3 p-10 -69.8 -42.86 73.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.5 m -69.13 -42.15 76.39 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.69 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.7 t -64.51 -45.05 96.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.338 . . . . 0.0 110.545 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.5 tpt180 -61.39 -47.62 84.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.69 98.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.277 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.74 -46.39 89.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.254 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -64.13 -40.76 96.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.1 m -65.02 -45.29 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.255 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.94 -50.2 51.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.86 -44.03 97.65 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -62.33 -45.43 93.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.769 0.318 . . . . 0.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.632 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.6 mt -64.1 -45.74 95.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.804 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.38 -35.04 77.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.0 mt-10 -67.82 -34.13 76.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.61 -55.83 2.45 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.632 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.3 mp0 -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.7 m-85 -122.13 29.03 7.21 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.634 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 65.4 tttm -58.6 124.85 21.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 -7.48 81.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.8 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.41 -44.65 7.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.535 0.668 . . . . 0.0 111.762 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.437 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -113.7 142.09 46.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.763 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.17 124.61 48.92 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 66.2 tp -96.01 125.67 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -123.07 138.64 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.027 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.5 131.56 72.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.673 0.749 . . . . 0.0 110.992 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.36 103.85 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.343 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -76.59 103.89 6.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.5 m -67.48 -33.1 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 16' ' ' GLY . 82.8 mt -71.37 -38.27 71.58 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.948 -0.47 . . . . 0.0 111.623 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -70.38 -41.53 72.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -129.29 73.94 81.33 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.68 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.29 -22.76 75.53 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.812 2.342 . . . . 0.0 112.715 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.679 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.37 -40.73 98.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.15 -36.27 71.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.802 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.46 97.7 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.13 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.89 -38.36 86.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.97 -40.17 92.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -96.83 8.68 43.8 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.957 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.59 53.06 13.4 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.8 mm -89.07 109.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.6 mt -106.98 -5.64 18.02 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.39 143.23 30.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.562 0.22 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 ' OG1' ' HB2' ' A' ' 15' ' ' ALA . 60.4 p -136.44 148.84 65.61 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.584 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.5 Cg_endo -76.4 152.19 95.72 Favored 'Cis proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.801 -1.749 . . . . 0.0 112.698 -1.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.89 124.67 45.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.466 178.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.0 tp -104.52 118.73 37.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.502 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.35 138.63 31.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.494 0.664 . . . . 0.0 111.973 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 3.3 ttpp -99.68 104.28 16.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 29.7 m -78.7 -29.06 14.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.812 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.65 136.11 24.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.028 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.83 147.37 77.45 Favored 'Cis proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.454 -1.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.84 154.62 59.9 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.052 2.502 . . . . 0.0 111.74 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -68.71 159.84 85.65 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.997 -0.835 . . . . 0.0 113.747 0.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 99.5 t -72.72 126.97 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.62 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -105.88 118.88 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.077 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -104.73 124.2 48.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 76' ' ' ILE . 71.3 mt -105.74 117.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.013 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.94 127.64 75.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.751 0.31 . . . . 0.0 110.879 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.48 -158.91 32.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -82.76 97.09 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.04 -5.95 59.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.1 m -69.16 -21.46 63.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.235 0.54 . . . . 0.0 110.11 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -85.14 118.63 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.602 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.1 mtp180 -60.36 -37.08 79.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.272 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.49 -43.79 96.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.15 97.34 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.17 -43.54 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.816 0.341 . . . . 0.0 110.517 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.91 -48.5 65.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.31 -46.19 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.26 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.34 -40.87 98.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.038 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.7 mp -67.58 -38.35 83.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.23 -42.18 96.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.43 -39.7 94.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.282 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 86.7 mt -65.49 -40.75 93.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.747 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.1 93.54 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.717 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.77 -37.99 88.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.31 -39.6 93.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.35 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 HD12 ' CB ' ' A' ' 8' ' ' ALA . 76.0 mt -62.56 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.023 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.71 93.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.415 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.72 -40.57 92.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.775 0.322 . . . . 0.0 111.404 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.79 109.56 17.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -111.05 127.98 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.523 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.59 106.77 4.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.607 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -89.49 105.23 17.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.75 13.19 31.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -90.45 103.64 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.608 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.412 179.807 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.87 71.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.59 156.88 57.12 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.742 2.295 . . . . 0.0 112.776 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.8 mt -104.22 137.59 41.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.67 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -76.45 151.91 36.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.52 -39.13 93.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.77 123.6 30.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -96.31 153.73 17.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.076 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.19 122.34 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.55 . . . . 0.0 110.408 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.7 tp -114.13 126.56 55.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.7 mttt -113.3 136.02 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.503 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.37 124.92 53.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.917 178.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.493 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 92.0 m-85 -100.94 120.35 40.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 m -125.18 159.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.85 0.357 . . . . 0.0 111.234 -178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HB3' ' OG1' ' A' ' 62' ' ' THR . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.66 -151.17 50.35 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -115.41 42.4 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 0.0 111.112 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.4 p -70.93 156.92 91.38 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.533 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -53.85 -37.11 84.89 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.172 1.915 . . . . 0.0 112.667 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -65.37 -45.56 83.63 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.234 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -67.13 -43.64 81.88 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.185 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.42 -44.47 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.692 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.4 tpt180 -62.06 -47.06 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.95 94.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.97 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.424 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 58.6 mt -63.49 -43.28 97.74 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.85 -40.74 97.29 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.606 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.1 m -66.68 -44.79 80.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.222 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -50.79 38.08 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.82 -44.88 95.97 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.86 -44.32 93.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.339 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.9 mt -63.28 -45.29 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.368 . . . . 0.0 111.251 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.0 mt -68.46 -35.74 77.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.1 mt-10 -69.82 -29.66 66.98 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -114.2 -55.3 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -65.36 -40.82 94.07 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.36 28.18 7.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.585 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 24.3 tptm -58.62 126.91 29.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 111.631 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -9.22 78.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.735 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.01 -45.08 6.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 117.5 0.65 . . . . 0.0 111.724 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.44 141.7 47.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.685 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.18 126.87 51.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.9 tp -97.65 127.41 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.392 0.615 . . . . 0.0 112.545 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -122.98 137.85 54.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.881 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.37 131.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.816 0.817 . . . . 0.0 110.953 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.94 104.75 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.869 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -77.05 104.65 7.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -61.42 -43.18 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.282 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.23 -40.47 77.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.46 -38.15 71.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.177 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -128.92 72.32 81.77 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.73 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.74 -23.98 76.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.689 2.259 . . . . 0.0 112.808 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.758 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.5 -41.78 98.54 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.11 -37.08 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.57 -42.27 98.32 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.82 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.02 -37.59 84.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.376 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.758 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.6 mt-10 -60.2 -39.62 87.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.003 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.05 10.21 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.809 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.55 52.09 15.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.428 HG21 HD11 ' A' ' 59' ' ' ILE . 50.0 mm -86.15 108.01 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -104.85 -11.0 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.912 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.93 138.68 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.628 0.251 . . . . 0.0 111.057 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 15' ' ' ALA . 61.3 p -133.55 148.71 69.8 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 59.5 Cg_endo -75.03 151.87 97.43 Favored 'Cis proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.79 -1.754 . . . . 0.0 112.665 -1.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.07 124.28 45.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.609 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.49 118.3 36.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.36 138.85 31.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -100.8 105.01 16.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.3 m -80.18 -29.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -135.62 137.18 25.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.202 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.65 156.1 95.59 Favored 'Cis proline' 0 C--N 1.347 0.481 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.538 -1.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.99 156.21 66.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.783 2.322 . . . . 0.0 112.13 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.8 163.11 89.75 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.193 -1.169 . . . . 0.0 113.585 0.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 98.3 t -70.51 127.54 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 17.1 tpt180 -107.04 118.55 37.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -104.4 122.16 44.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.363 0.602 . . . . 0.0 110.395 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.0 mt -104.83 117.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.851 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 HG22 ' A' ' 77' ' ' ILE . 47.2 mm -116.96 126.29 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.71 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.24 -162.95 36.74 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.868 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -82.28 99.91 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.36 -5.41 59.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.187 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.57 -20.0 63.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 110.089 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -87.17 118.26 26.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.339 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.91 -35.87 75.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.707 -178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.14 -44.75 94.7 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -41.2 96.31 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.8 -46.26 94.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.95 -47.6 77.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.671 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.89 -46.8 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.93 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.11 -36.88 82.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.09 -45.83 91.76 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.03 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.4 -39.42 93.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.174 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 86.6 mt -66.47 -40.78 89.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.934 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.45 79.14 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.541 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.53 -41.77 97.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.521 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -62.75 -40.37 97.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.277 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.01 -45.56 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.824 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.8 92.48 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.61 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.17 -39.65 93.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.688 0.28 . . . . 0.0 111.455 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -80.96 115.42 20.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.186 0.517 . . . . 0.0 110.691 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.65 141.99 44.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.672 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -81.16 120.0 24.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.348 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 59.3 52.23 6.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.649 0.593 . . . . 0.0 111.904 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.64 13.35 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.4 103.05 15.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.441 179.867 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.87 121.48 77.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.36 152.43 60.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.62 2.213 . . . . 0.0 112.941 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.09 150.64 35.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -62.35 -38.83 91.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.391 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -63.24 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.982 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -76.3 124.56 27.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.359 0.599 . . . . 0.0 111.709 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HB1' ' CE2' ' A' ' 40' ' ' TYR . . . -92.28 153.26 19.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.619 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.65 127.25 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 111.75 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.1 mt -112.82 133.74 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.0 mttt -113.73 127.36 56.0 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.111 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.08 121.72 44.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.254 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.0 m-85 -98.98 117.34 33.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.436 ' O ' HG21 ' A' ' 47' ' ' VAL . 31.2 m -126.79 160.57 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.063 0.459 . . . . 0.0 111.563 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.47 104.48 11.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.688 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' N ' HD11 ' A' ' 48' ' ' LEU . . . 61.5 -129.24 44.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.204 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.9 52.45 1.99 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.016 0.436 . . . . 0.0 110.89 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -74.11 157.53 86.73 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.479 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -54.22 -36.84 87.31 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.132 1.888 . . . . 0.0 112.608 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.45 -46.23 80.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 110.209 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -66.26 -43.75 85.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.227 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -64.89 -44.36 96.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.833 0.349 . . . . 0.0 110.636 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -62.1 -48.25 81.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.634 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.23 99.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.248 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.52 -47.32 86.14 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.228 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -64.36 -40.39 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.821 0.343 . . . . 0.0 110.95 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 91.2 m -65.22 -45.59 84.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.042 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -45.7 51.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.35 -43.46 98.83 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -64.12 -43.03 96.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.034 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.623 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 64.2 mt -62.88 -45.96 97.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 111.312 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.2 mt -67.87 -37.36 81.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.215 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.13 -37.41 78.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -106.2 -57.47 2.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 21.1 mp0 -62.84 -40.54 97.73 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' CD1' HD12 ' A' ' 90' ' ' LEU . 98.4 m-85 -122.8 31.27 6.11 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttmt -50.22 123.9 9.3 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.392 0.433 . . . . 0.0 112.143 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.78 0.85 89.89 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.358 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -106.9 -44.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.964 0.882 . . . . 0.0 111.7 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.1 m-85 -116.51 144.73 43.97 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.02 125.58 51.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.021 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -98.41 124.54 43.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.503 . . . . 0.0 111.602 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -121.78 118.81 29.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.34 130.56 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.768 0.794 . . . . 0.0 111.174 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -112.91 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.177 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.24 105.07 8.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 14' ' ' VAL . 25.4 m -69.53 -31.64 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 16' ' ' GLY . 82.7 mt -70.19 -39.79 75.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.01 -37.2 72.64 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.273 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -129.09 85.97 58.39 Favored Pre-proline 0 CA--C 1.515 -0.37 0 CA-C-O 121.108 0.48 . . . . 0.0 110.434 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.28 -28.39 78.91 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.999 2.466 . . . . 0.0 112.489 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.67 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.26 -41.75 99.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.46 -36.26 73.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.888 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.11 96.86 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.084 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.28 -38.3 84.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.612 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.31 -40.16 89.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.355 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -98.39 9.12 43.81 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.842 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp 49.03 53.55 12.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.38 0.672 . . . . 0.0 112.81 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.0 mm -87.78 108.22 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.07 1.51 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.69 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.41 148.81 36.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.402 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.0 p -147.31 142.21 16.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.79 151.12 84.23 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.092 -1.628 . . . . 0.0 112.467 -1.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -128.75 131.64 47.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.345 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.27 120.28 41.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -137.77 134.64 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 111.184 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 22.0 ttpp -91.83 104.14 16.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.19 -24.11 9.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.245 -178.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 70' ' ' PRO . 29.6 tp -139.41 131.89 15.29 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.816 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 69' ' ' LEU . 6.0 Cg_exo -81.44 152.02 78.65 Favored 'Cis proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.485 -1.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 59.2 Cg_endo -71.06 159.49 52.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.714 2.276 . . . . 0.0 111.629 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 36.9 Cg_exo -63.69 155.21 71.92 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 125.097 -0.793 . . . . 0.0 113.611 0.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 92.9 t -69.25 124.9 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -102.15 116.15 32.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -99.62 124.97 45.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.272 0.558 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.56 117.48 54.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.837 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.83 126.71 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -163.19 36.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.811 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -82.16 98.81 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.64 -7.68 58.11 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.4 p -68.21 -19.61 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.233 0.539 . . . . 0.0 110.385 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.82 116.8 23.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.112 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.49 -36.91 79.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.091 -177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -60.07 -44.61 94.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.83 -41.31 97.87 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.093 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 79.5 t -64.52 -44.76 96.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.256 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.0 tp -66.01 -45.49 81.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -62.12 -46.44 96.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.586 0.231 . . . . 0.0 110.755 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.04 96.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.588 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.566 HD12 ' CD1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.44 -45.84 91.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.025 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.79 -39.96 95.49 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.217 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.529 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 89.5 mt -65.53 -41.07 93.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.101 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.49 91.19 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.628 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.06 -36.53 81.93 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 110.324 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.27 -40.22 93.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.233 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.59 -43.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.6 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.92 89.81 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.781 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.81 -40.26 92.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.01 107.68 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.809 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.54 142.15 44.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -151.97 173.05 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -101.67 101.92 12.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -104.14 13.22 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.299 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -89.14 103.89 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.69 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.913 0.387 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.74 -50.3 82.4 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.673 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -60.42 143.04 99.45 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.171 1.914 . . . . 0.0 112.729 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.2 145.19 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -126.47 154.08 44.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -64.05 -38.8 92.4 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.108 0.48 . . . . 0.0 110.805 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.96 121.52 27.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.997 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.407 ' HB3' ' CD2' ' A' ' 40' ' ' TYR . . . -87.48 151.9 22.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.077 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.4 t -111.82 124.14 68.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.83 128.06 56.25 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.2 mttt -112.92 130.3 56.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.45 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.48 124.32 49.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.486 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 97.3 m-85 -99.66 117.4 33.94 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.2 m -125.36 161.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.076 0.465 . . . . 0.0 111.628 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.435 ' HB3' ' OG1' ' A' ' 62' ' ' THR . . . -117.13 100.89 8.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.01 -135.51 50.41 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.839 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -123.72 44.67 2.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -70.62 155.2 93.75 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.8 -38.27 85.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.009 1.806 . . . . 0.0 112.805 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.4 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 98.6 m-20 -64.85 -43.8 91.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.342 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -68.41 -43.55 76.96 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.146 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.41 -46.04 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.796 0.331 . . . . 0.0 110.812 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' NE ' ' HB2' ' A' ' 81' ' ' SER . 69.8 ttt180 -61.94 -47.24 85.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.711 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 20' ' ' ASN . . . -64.13 -41.84 97.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.079 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 29' ' ' ALA . 62.5 tp -61.27 -45.45 94.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -63.84 -40.64 97.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.331 . . . . 0.0 110.403 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.409 HG23 ' CG2' ' A' ' 86' ' ' VAL . 88.7 m -66.0 -45.58 81.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.03 -50.2 36.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.37 -43.95 98.0 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.97 -42.63 94.41 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.22 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 -45.04 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.19 -35.17 77.58 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.916 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt-10 -85.78 -5.53 59.24 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -62.21 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.043 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.02 -41.04 97.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.34 30.25 6.37 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.79 128.56 37.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.75 -8.44 79.79 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.178 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.81 -42.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.153 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.489 ' OH ' HD12 ' A' ' 97' ' ' ILE . 34.7 m-85 -115.02 143.61 44.91 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.977 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 125.57 50.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 tp -97.52 126.4 42.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.435 0.636 . . . . 0.0 112.657 -178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -121.74 137.76 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.783 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.37 131.3 72.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.681 0.753 . . . . 0.0 110.998 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.65 104.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.401 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -77.04 103.72 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.0 m -67.94 -33.75 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.53 -37.09 74.05 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.516 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.22 -40.82 74.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -126.97 83.81 64.98 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 -31.67 93.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.363 2.709 . . . . 0.0 112.595 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.742 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -62.98 -41.54 99.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.517 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.5 mt -70.39 -36.63 74.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.85 97.47 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.813 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.22 -38.13 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.382 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.742 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.1 mt-10 -60.57 -40.56 92.15 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.455 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.59 8.93 43.75 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.027 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 50.97 52.01 15.88 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.442 0.697 . . . . 0.0 112.759 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.22 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.03 -6.34 18.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.102 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.16 142.26 30.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.535 0.207 . . . . 0.0 111.191 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 15' ' ' ALA . 61.0 p -137.33 147.69 59.07 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.384 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 66.5 Cg_endo -76.85 152.99 95.92 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.819 -1.742 . . . . 0.0 112.646 -1.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -121.52 129.74 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.131 179.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.62 118.53 36.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -141.93 132.0 24.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.63 0.729 . . . . 0.0 111.518 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.5 ttmt -94.8 104.54 16.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.8 m -80.42 -28.44 11.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.117 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -138.31 140.41 28.34 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -74.78 151.42 96.91 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.289 -1.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.87 151.6 76.3 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.944 2.429 . . . . 0.0 112.001 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.79 169.34 73.79 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.583 0.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 93.0 t -72.75 126.49 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -109.62 119.76 40.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -102.68 122.39 44.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.961 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 74.9 mt -103.57 115.37 45.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.675 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.18 127.68 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.85 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.34 32.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.737 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -81.41 96.03 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -4.57 57.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.394 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.485 ' HB2' ' NE ' ' A' ' 23' ' ' ARG . 97.2 p -68.28 -20.68 64.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -86.72 121.42 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.44 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.0 mtm-85 -60.26 -36.37 77.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.538 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.64 -44.31 96.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 68.3 mttm -65.06 -40.21 94.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.552 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 27' ' ' THR . 67.9 t -63.1 -43.73 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.42 -48.49 64.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.91 -47.52 92.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 85' ' ' LYS . . . -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.668 0.27 . . . . 0.0 111.308 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.43 -39.76 85.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -61.83 -44.38 96.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.581 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.79 -39.1 93.18 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.6 mt -65.64 -40.42 92.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 110.56 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.52 -37.98 89.39 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.704 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.32 -37.71 84.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 110.025 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.14 -41.36 98.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.312 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.489 HD12 ' OH ' ' A' ' 40' ' ' TYR . 84.1 mt -70.52 -43.42 77.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.719 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.09 -35.12 91.01 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.89 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.09 -39.61 90.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.697 0.284 . . . . 0.0 111.484 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.81 117.59 23.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 110.557 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -111.03 138.6 47.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.516 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -139.05 109.08 6.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -156.67 160.19 39.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.0 -29.7 69.6 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -154.36 162.12 41.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.833 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.77 120.78 75.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.134 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.98 154.83 57.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.771 2.314 . . . . 0.0 112.912 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.95 134.48 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 169.91 19.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.655 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -63.39 -39.02 93.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.28 122.2 28.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.358 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.54 18.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.543 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.7 t -108.15 122.07 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.185 0.517 . . . . 0.0 110.559 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 tp -114.24 125.16 53.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.8 mttt -112.29 137.43 50.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.362 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.54 123.8 50.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.11 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.9 m-85 -98.86 120.92 40.12 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.38 160.57 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' ' OG1' ' A' ' 62' ' ' THR . . . -116.36 106.56 13.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.226 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.23 -130.96 47.64 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.536 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -134.86 48.39 2.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -74.37 158.46 85.26 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.779 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -54.11 -37.51 87.08 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.089 1.859 . . . . 0.0 112.658 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 35.1 m120 -65.01 -45.26 86.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.886 0.374 . . . . 0.0 110.02 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.3 m -66.75 -43.69 83.44 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.058 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.08 -46.4 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 0.0 110.486 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -62.4 -46.72 87.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 20' ' ' ASN . . . -63.49 -44.39 94.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.081 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HB1' ' A' ' 29' ' ' ALA . 66.8 mt -63.53 -41.75 98.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.59 -40.46 96.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.291 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.5 m -66.24 -45.1 81.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.48 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -50.9 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.69 -45.23 94.86 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.39 -43.36 94.72 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.213 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.3 mt -63.05 -45.1 99.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.824 0.345 . . . . 0.0 111.071 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.6 mt -68.94 -36.22 77.69 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.3 mt-10 -70.85 -27.31 63.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -114.27 -58.92 2.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.08 -40.93 97.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.83 28.7 7.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 88.2 tttt -58.63 127.65 33.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 111.541 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.13 -8.51 79.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.506 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.5 -44.91 6.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 117.455 0.627 . . . . 0.0 111.611 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.0 m-85 -115.04 143.26 45.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.091 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.97 125.1 50.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 tp -96.89 126.72 42.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.274 0.559 . . . . 0.0 112.023 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 mptp? -123.46 118.13 26.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.951 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.07 129.23 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.761 . . . . 0.0 110.704 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mm -113.45 105.25 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.3 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -77.78 102.76 7.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.67 -33.77 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.57 -38.38 70.95 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.01 -0.431 . . . . 0.0 111.603 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.76 -40.68 72.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.46 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.06 73.67 81.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.612 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.45 -22.91 75.76 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.769 2.313 . . . . 0.0 112.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.676 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.36 -41.04 98.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.18 -36.42 71.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.847 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.32 97.74 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.275 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.97 -38.48 86.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.177 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -61.09 -40.03 92.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -96.68 9.17 42.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.88 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 51.08 52.13 15.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.5 mm -88.23 108.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.28 -6.53 18.34 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.063 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.61 140.3 31.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.522 0.201 . . . . 0.0 111.149 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 15' ' ' ALA . 50.6 p -134.9 149.1 69.58 Favored Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.594 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.9 Cg_endo -75.68 151.29 95.72 Favored 'Cis proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.744 -1.773 . . . . 0.0 112.698 -1.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.89 125.31 48.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.73 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.98 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.31 139.65 31.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.514 0.673 . . . . 0.0 112.079 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.8 ttpp -101.68 104.73 15.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 m -80.02 -28.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -136.1 139.22 29.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.381 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.04 153.11 96.01 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.483 -1.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.69 156.24 64.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 111.795 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.64 166.45 82.01 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.301 -1.124 . . . . 0.0 113.449 0.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 92.9 t -70.3 126.99 31.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -105.59 114.99 29.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -102.87 122.03 43.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.256 0.551 . . . . 0.0 110.863 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 HD12 HG22 ' A' ' 76' ' ' ILE . 66.0 mt -101.91 115.74 44.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.346 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.67 122.84 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.98 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.81 -166.15 38.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.48 96.22 10.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.457 . . . . 0.0 109.856 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.89 11.11 21.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.823 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.6 m -72.66 -21.61 61.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 110.008 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -85.76 124.25 32.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.948 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -60.74 -37.32 81.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.727 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -59.58 -47.59 84.97 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.97 -39.35 93.95 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.749 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.13 -44.2 98.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mt -66.13 -44.33 84.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.318 178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.03 -47.9 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.508 0.194 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.54 -42.44 95.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.458 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.43 -38.23 80.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.77 -46.57 88.99 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.67 -39.74 94.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.527 ' HB3' ' OH ' ' A' ' 40' ' ' TYR . 86.8 mt -66.25 -39.73 89.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.258 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.57 79.1 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.51 -39.39 90.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.41 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.22 -40.29 93.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.708 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.94 -46.54 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.742 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.92 -36.22 93.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.518 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.06 -40.38 96.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -69.84 126.94 31.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.306 0.574 . . . . 0.0 110.637 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -111.28 143.94 41.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.684 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.13 -42.02 99.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -155.26 160.75 41.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.98 -29.82 69.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.416 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -154.89 162.5 41.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.205 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.844 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.003 0.43 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.47 122.4 85.89 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -59.3 141.58 97.94 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 0.0 112.692 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.8 mt -109.01 143.1 38.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.418 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -95.94 138.52 33.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.597 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.6 -70.75 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.876 0.735 . . . . 0.0 111.819 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -79.29 126.75 31.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.0 111.499 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -116.11 153.93 30.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.598 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.61 123.68 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.53 129.74 56.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.677 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.4 mttt -116.2 133.3 56.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.733 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.16 126.89 55.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.369 178.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 98.6 m-85 -99.86 118.78 37.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 21' ' ' SER . 19.5 m -125.99 160.34 33.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.29 102.85 9.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.16 -132.7 48.69 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.699 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -129.96 45.84 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.692 0.282 . . . . 0.0 111.403 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -71.27 155.89 92.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.7 Cg_exo -54.47 -37.21 89.82 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 121.997 1.798 . . . . 0.0 112.703 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -64.97 -44.95 87.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.584 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . 78.8 p -70.52 -40.48 73.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.503 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 53.5 t -64.42 -44.54 97.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.052 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.0 tpt180 -61.86 -47.21 86.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.411 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.7 95.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.869 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 12' ' ' LEU . 66.1 mt -63.63 -42.93 98.1 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' VAL . 75.8 mmtt -64.85 -40.9 95.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.246 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.751 HG23 ' HG2' ' A' ' 83' ' ' ARG . 91.4 m -65.9 -49.68 67.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.317 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' HA ' HG11 ' A' ' 86' ' ' VAL . 59.4 tp -68.99 -46.62 67.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.83 -43.81 97.82 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -41.59 92.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.876 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 75.9 mt -63.94 -44.99 98.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.0 110.751 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 40' ' ' TYR . 84.7 mt -67.96 -36.01 79.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.0 mt-10 -70.2 -27.4 64.46 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -115.51 -56.01 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -65.55 -40.85 93.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.9 29.9 6.89 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.57 125.96 25.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.487 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.34 -7.16 82.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.439 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' THR . 46.1 t -106.09 -42.19 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.374 0.587 . . . . 0.0 111.535 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.1 m-85 -116.25 144.17 44.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.37 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.13 124.99 50.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.59 130.64 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.681 0.753 . . . . 0.0 113.029 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.26 133.03 51.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.22 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -119.96 128.96 75.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.424 0.63 . . . . 0.0 110.663 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -111.38 114.81 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.901 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.09 101.52 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.3 m -64.35 -34.79 71.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.36 -39.37 71.31 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.069 -0.394 . . . . 0.0 111.792 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.95 -40.87 71.75 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -128.65 73.63 80.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -23.05 76.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.735 2.29 . . . . 0.0 112.701 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.25 -41.3 99.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.01 -36.69 72.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.31 98.1 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.201 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.92 -38.73 86.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.239 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.3 mm-40 -60.94 -40.25 92.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.4 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.28 9.2 41.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.945 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.91 51.9 16.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.23 107.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.98 2.45 23.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.743 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.33 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 111.34 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.0 p -148.26 140.16 14.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.635 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.5 Cg_endo -80.07 151.95 84.11 Favored 'Cis proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.888 -1.713 . . . . 0.0 112.674 -1.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HD23 ' A' ' 12' ' ' LEU . 94.5 m -125.32 129.87 50.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.398 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.6 tp -99.94 120.31 39.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.108 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.67 134.06 26.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 111.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 29.0 ttpt -95.17 103.7 15.56 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -77.36 -30.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.671 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.755 ' HG ' HG13 ' A' ' 68' ' ' VAL . 86.7 mt -137.44 139.59 27.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 85.0 Cg_endo -79.58 150.84 84.61 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.576 -1.427 . . . . 0.0 112.784 -1.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 33.5 Cg_exo -61.7 152.42 74.19 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.89 160.79 87.81 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 124.765 -0.931 . . . . 0.0 113.558 0.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 97.0 t -71.65 125.93 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 38.3 mmt180 -97.37 113.81 25.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -100.49 120.45 40.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 93' ' ' LEU . 55.7 mt -110.42 118.24 56.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.87 126.82 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.981 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.21 -163.07 36.78 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -81.76 99.9 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -85.68 -7.18 58.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.189 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.0 m -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.0 110.158 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -83.8 117.87 23.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.311 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.05 -35.44 75.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.657 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.25 -44.45 95.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -41.43 96.04 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 28' ' ' LEU . 74.6 t -63.69 -46.54 94.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.424 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.88 -47.43 77.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.96 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.87 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.81 99.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.324 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.447 HD11 HD12 ' A' ' 28' ' ' LEU . 87.3 mt -65.33 -38.96 91.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.569 0.223 . . . . 0.0 110.775 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.24 -46.37 87.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.64 -40.03 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 76' ' ' ILE . 89.7 mt -65.63 -40.28 92.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.67 92.05 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.72 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.75 -38.68 88.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 110.207 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.87 -41.05 99.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.288 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB2' ' A' ' 8' ' ' ALA . 92.7 mt -65.86 -45.41 91.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.68 92.34 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.589 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.19 -39.54 93.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.739 0.304 . . . . 0.0 111.519 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -78.93 113.61 17.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.124 0.488 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -111.92 141.53 45.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.22 -42.84 99.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -156.67 155.71 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.286 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.56 43.08 23.19 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.577 179.576 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.998 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.45 113.11 66.04 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.861 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -60.07 147.2 94.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.973 2.448 . . . . 0.0 112.674 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.95 2.66 56.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.827 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 161.48 34.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.819 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -91.31 -3.02 57.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -87.71 126.88 35.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.624 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.07 152.37 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.432 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.45 124.53 70.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.136 0.493 . . . . 0.0 111.082 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -112.52 132.0 55.31 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -112.67 126.56 55.52 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.724 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.36 123.16 47.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.199 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' HG13 ' A' ' 59' ' ' ILE . 93.2 m-85 -99.51 119.68 38.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.1 m -124.79 159.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.981 0.42 . . . . 0.0 111.587 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.65 102.89 9.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.247 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -135.49 49.14 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -124.2 44.63 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.016 0.436 . . . . 0.0 110.669 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -70.94 154.99 93.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.696 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.38 -34.34 97.77 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.139 1.893 . . . . 0.0 112.259 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -65.92 -43.09 89.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -70.02 -42.72 72.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.065 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.76 -43.96 96.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.6 tpt180 -62.29 -47.76 82.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.374 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.73 99.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.59 -47.8 83.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.534 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.77 97.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 83' ' ' ARG . 85.6 m -66.0 -45.43 81.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.539 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -69.72 -50.44 43.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.91 -44.6 96.46 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -65.24 -42.8 93.02 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.247 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.27 -44.56 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.004 0.43 . . . . 0.0 111.095 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.671 HD22 ' HB2' ' A' ' 40' ' ' TYR . 78.8 mt -71.47 -26.31 62.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -89.66 -2.71 58.37 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.042 -0.411 . . . . 0.0 112.01 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -131.15 -62.09 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.916 0.389 . . . . 0.0 111.314 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.98 -41.42 95.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.606 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.76 30.2 6.27 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 29.8 ttpp -61.06 127.5 31.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.037 0.446 . . . . 0.0 111.309 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.25 -8.01 80.54 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.957 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.43 -41.98 6.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 117.051 0.425 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.671 ' HB2' HD22 ' A' ' 32' ' ' LEU . 35.4 m-85 -116.24 144.99 43.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.275 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.45 125.06 50.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -96.19 128.35 43.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.346 0.593 . . . . 0.0 112.13 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -126.3 112.21 15.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.189 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -99.57 128.7 51.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.591 0.71 . . . . 0.0 111.028 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.8 mm -111.43 116.74 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.752 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.1 104.98 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 14' ' ' VAL . 19.4 m -68.26 -18.86 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.63 -38.66 12.97 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.875 -0.516 . . . . 0.0 112.244 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.201 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.32 76.66 72.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.691 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.3 -20.29 70.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.541 2.16 . . . . 0.0 112.599 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.74 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 24.3 mp0 -62.84 -41.76 99.47 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.6 -36.6 73.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.85 98.29 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.815 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.4 mt-10 -60.34 -39.92 88.85 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.57 7.84 45.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.73 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 49.04 53.46 12.55 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.842 0.714 . . . . 0.0 112.852 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.449 HG13 ' CD2' ' A' ' 13' ' ' TYR . 47.1 mm -87.27 108.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.602 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -109.31 4.19 22.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.64 148.49 40.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.493 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 p -148.49 141.92 15.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.047 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.37 149.11 85.66 Favored 'Cis proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.661 -1.391 . . . . 0.0 111.826 -2.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.7 m -127.45 129.49 47.57 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.78 118.5 36.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.538 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.56 132.73 35.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.323 0.582 . . . . 0.0 111.02 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -95.01 104.0 15.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.1 m -80.61 -27.62 11.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.457 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -136.62 138.8 27.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.484 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HE2' ' A' ' 67' ' ' LYS . 16.7 Cg_exo -71.6 153.13 96.88 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.362 -2.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.11 156.81 61.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.655 2.237 . . . . 0.0 111.892 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.12 165.78 83.36 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.201 -1.166 . . . . 0.0 113.43 0.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -69.46 126.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.145 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -105.93 115.14 29.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -96.81 125.09 41.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.184 0.516 . . . . 0.0 110.118 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.3 mt -109.7 117.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.872 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.8 mm -117.77 127.06 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.829 0.347 . . . . 0.0 110.799 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.62 -166.37 39.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.817 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -82.46 99.86 9.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.28 -5.13 59.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.278 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -23.98 64.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.243 0.544 . . . . 0.0 109.899 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -84.34 118.61 24.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.191 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.1 -35.68 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.664 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.74 -43.73 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -40.61 95.67 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.73 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.14 -42.59 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.841 0.353 . . . . 0.0 110.27 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -48.46 63.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.475 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.58 -46.75 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.538 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -63.62 -41.25 98.3 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.531 0.205 . . . . 0.0 111.185 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -37.98 82.81 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.08 -46.87 82.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.08 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.29 -39.57 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.44 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 89' ' ' ALA . 3.8 mm? -67.4 -39.55 85.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.602 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.36 89.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.398 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.36 -38.41 86.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.51 -40.87 98.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 8' ' ' ALA . 94.7 mt -65.88 -45.33 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.09 92.97 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.465 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.16 -39.79 95.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.426 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -80.07 114.83 19.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.262 0.553 . . . . 0.0 110.795 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -111.5 144.59 40.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.585 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.54 103.25 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -90.97 107.66 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.25 -29.09 69.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.725 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -85.42 104.96 15.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.507 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.013 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.633 0.254 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.28 63.18 10.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.333 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.55 150.86 64.08 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.381 2.054 . . . . 0.0 112.677 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.41 143.03 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -106.07 -70.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.445 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.08 -12.78 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.72 127.69 36.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.338 0.589 . . . . 0.0 111.102 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -113.26 152.89 29.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.783 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.62 124.25 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.96 130.08 56.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.3 mttt -115.76 130.76 56.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.638 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.78 124.57 50.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.0 m-85 -100.9 119.84 39.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 47' ' ' VAL . 26.9 m -126.55 160.33 34.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.001 0.429 . . . . 0.0 111.628 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 104.48 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.413 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 62.29 -129.79 43.4 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.075 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -136.61 53.23 1.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.175 0.512 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -75.88 158.11 82.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.995 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.49 -37.46 89.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.129 1.886 . . . . 0.0 112.647 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -64.66 -44.96 88.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -66.69 -43.77 83.53 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.925 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.97 -45.72 93.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -62.3 -46.25 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.398 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.74 99.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.173 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.86 -46.87 87.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.303 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.47 -40.04 96.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.662 0.268 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.769 HG23 ' HG3' ' A' ' 83' ' ' ARG . 90.5 m -63.89 -45.89 87.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -50.46 54.55 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.17 -43.91 97.78 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.48 -46.43 90.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 70.6 mt -64.13 -44.99 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.665 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 40' ' ' TYR . 82.1 mt -68.16 -34.59 76.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 98.5 mt-10 -66.41 -35.84 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -110.62 -56.63 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.617 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.2 mp0 -63.38 -42.0 98.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HD23 ' A' ' 32' ' ' LEU . 99.3 m-85 -124.09 29.96 6.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 30.1 ttpp -60.96 127.75 33.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 111.464 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.12 -7.88 80.82 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.151 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.1 -42.84 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 117.219 0.51 . . . . 0.0 111.469 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.682 ' HB2' HD22 ' A' ' 32' ' ' LEU . 57.0 m-85 -116.4 145.13 43.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.487 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.86 125.36 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -96.23 129.05 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.42 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -127.26 135.54 50.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.809 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.15 129.75 75.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.383 0.611 . . . . 0.0 110.983 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.67 116.26 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.651 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.57 103.51 15.14 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.6 m -66.68 -32.43 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.7 mt -70.24 -38.77 75.26 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.69 -37.53 73.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.725 0.298 . . . . 0.0 111.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -129.73 85.51 58.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.85 -27.84 80.76 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.033 2.488 . . . . 0.0 112.579 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.735 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 70.4 tp60 -63.05 -42.24 99.67 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.54 -36.57 73.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.033 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.623 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.28 -38.11 84.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.337 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.0 mt-10 -60.42 -40.86 92.54 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -99.82 13.23 34.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.928 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 48.8 52.27 14.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.75 106.17 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt -105.8 -6.24 19.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.939 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.98 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 0.0 111.182 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.8 p -136.19 148.7 65.56 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.417 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.0 Cg_endo -75.16 151.77 97.11 Favored 'Cis proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.855 -1.727 . . . . 0.0 112.628 -1.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.85 124.68 45.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.499 178.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.0 tp -104.95 116.96 32.85 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.534 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.14 138.43 35.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.484 0.659 . . . . 0.0 111.916 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.0 ttpp -96.37 104.47 16.44 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.605 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.2 m -81.04 -28.3 11.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.253 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.95 139.11 29.47 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.049 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 86.2 Cg_endo -78.97 155.1 91.53 Favored 'Cis proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.466 -1.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 42.5 Cg_exo -60.77 151.35 77.42 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.997 2.464 . . . . 0.0 112.132 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.43 166.75 81.06 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.531 0.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 68' ' ' VAL . 99.2 t -71.93 127.04 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -110.51 117.76 34.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.553 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 89.9 mtm180 -101.02 119.68 39.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 93' ' ' LEU . 71.4 mt -102.49 115.55 44.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.834 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.01 127.74 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.863 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.74 -158.86 31.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.07 86.64 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.31 -14.87 61.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.097 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.5 m -67.9 -20.57 65.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 110.402 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -84.87 117.6 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.769 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.96 -35.34 74.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.686 -178.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.98 -44.41 94.51 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.66 -41.38 96.14 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.028 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.11 -46.53 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.463 HD13 ' HG2' ' A' ' 35' ' ' GLU . 53.2 tp -64.59 -47.5 78.44 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.67 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.51 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.427 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.49 -42.63 98.54 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.06 -38.54 88.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.603 0.24 . . . . 0.0 110.587 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -64.76 -44.79 88.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.81 -40.07 94.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.918 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 76' ' ' ILE . 88.8 mt -65.08 -40.2 94.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 109.976 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.09 89.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.618 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.31 -39.57 90.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 109.946 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 8' ' ' ALA . 88.9 mt -68.69 -44.41 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.3 91.44 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.77 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.83 -39.27 91.24 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.443 0.297 . . . . 0.0 111.593 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -69.62 125.01 25.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.304 0.573 . . . . 0.0 110.606 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -111.45 145.39 39.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.551 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.62 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.131 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.65 108.58 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.898 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.97 -29.44 70.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.747 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -87.55 102.13 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.379 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.926 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.016 0.436 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.2 111.91 64.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.62 144.13 99.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.898 2.398 . . . . 0.0 112.587 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.0 mt -106.53 136.19 46.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -128.84 161.34 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.579 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -62.0 -39.14 91.23 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.44 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.89 123.21 28.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.191 0.52 . . . . 0.0 110.916 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -98.01 152.53 19.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -111.27 124.04 67.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.315 0.579 . . . . 0.0 110.327 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.75 131.18 55.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -113.8 129.37 56.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.25 121.87 46.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.113 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 94.6 m-85 -99.22 120.97 40.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.8 m -125.93 160.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 111.365 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.93 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.521 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 61.76 -131.4 46.33 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.296 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -135.39 50.74 2.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.206 0.527 . . . . 0.0 110.083 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.2 p -75.12 158.69 83.91 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.4 Cg_exo -54.2 -37.47 87.74 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.035 1.823 . . . . 0.0 112.626 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.0 -45.18 90.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 109.89 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.8 m -66.9 -43.26 83.84 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.076 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.35 -44.45 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.403 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.91 -48.6 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.4 96.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.441 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.27 -47.6 83.62 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.421 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.95 -44.34 96.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.783 HG23 ' HG3' ' A' ' 83' ' ' ARG . 86.3 m -64.93 -45.28 86.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.495 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -69.51 -50.95 40.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.56 -44.86 96.25 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.08 -41.44 86.36 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.145 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.4 mt -63.56 -43.79 98.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 0.0 110.703 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' A' ' 40' ' ' TYR . 83.5 mt -70.5 -27.76 64.44 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 98.9 mt-10 -86.12 -12.8 49.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.99 -61.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 111.372 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 77.6 mm-40 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.569 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.12 30.64 6.73 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.33 126.68 27.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.57 -0.3 89.38 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.528 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.8 -43.03 6.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 117.421 0.61 . . . . 0.0 111.408 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.653 ' HB2' HD22 ' A' ' 32' ' ' LEU . 39.9 m-85 -115.9 144.66 43.73 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.396 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.63 124.27 49.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -95.58 129.2 42.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.276 0.56 . . . . 0.0 112.042 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.1 mptm? -126.35 109.73 12.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.336 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.4 t -98.27 128.54 49.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.617 0.722 . . . . 0.0 110.987 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.65 116.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.77 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -86.63 103.44 15.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.2 m -67.29 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.3 mt -70.17 -39.41 75.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.88 -37.35 73.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.388 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -128.82 86.31 57.84 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.067 0.46 . . . . 0.0 110.302 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.96 -27.96 80.3 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.017 2.478 . . . . 0.0 112.464 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.9 mt-30 -63.25 -42.04 99.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.02 -36.98 75.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.014 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.02 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.09 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.26 -38.9 85.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.44 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.5 mm-40 -60.95 -40.78 94.62 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.49 9.66 41.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.035 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 49.88 52.05 15.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.52 106.31 16.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.467 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.08 -5.97 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.819 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.47 141.19 30.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.1 p -134.43 151.13 75.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.953 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.19 149.13 93.69 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.1 -1.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.04 119.65 34.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -105.66 116.87 32.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.67 139.44 34.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.536 0.684 . . . . 0.0 112.005 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -96.57 104.72 16.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.6 m -81.38 -28.72 10.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.951 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.73 135.02 19.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.933 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.65 152.21 89.66 Favored 'Cis proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.66 -1.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 60.0 Cg_endo -71.46 159.09 52.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.834 2.356 . . . . 0.0 111.869 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 24.5 Cg_exo -65.9 158.21 77.93 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 124.886 -0.881 . . . . 0.0 113.665 -0.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' VAL . 90.7 t -70.04 127.13 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.771 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -108.24 119.03 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 95.3 mtm-85 -101.3 121.81 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.244 0.545 . . . . 0.0 110.594 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 93' ' ' LEU . 68.3 mt -105.11 115.24 46.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.702 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.74 126.97 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -161.84 35.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.677 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -81.83 99.37 8.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.3 mt -89.36 -3.17 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.143 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.7 m -70.33 -20.24 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.447 0.641 . . . . 0.0 109.787 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.3 t-20 -86.02 117.28 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.375 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.783 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -59.72 -37.18 78.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.206 -178.21 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 42.9 mt-10 -60.17 -44.86 94.71 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.82 97.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.09 -47.16 93.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.836 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD13 ' HG3' ' A' ' 35' ' ' GLU . 58.6 tp -64.27 -47.7 78.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.808 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.7 mt -63.61 -45.74 96.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.69 99.4 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.029 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.2 mt -66.45 -36.07 81.87 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -61.62 -46.08 91.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.829 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.47 -39.7 92.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD11 HD11 ' A' ' 76' ' ' ILE . 88.6 mt -64.9 -41.09 95.89 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.32 90.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.38 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.56 -37.84 85.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.091 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.53 -40.95 98.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.441 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 8' ' ' ALA . 83.3 mt -69.82 -44.06 79.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.57 -35.31 91.63 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.844 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.38 -39.51 90.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -70.76 125.41 26.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.332 0.587 . . . . 0.0 110.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -111.39 145.14 39.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -91.16 109.27 20.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.5 -28.99 70.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.661 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -87.55 100.61 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.549 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.86 110.37 62.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.031 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -60.15 146.11 96.98 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.968 2.445 . . . . 0.0 112.76 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.14 136.78 48.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.08 164.23 31.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.601 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -65.91 -38.16 87.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 110.872 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.55 122.25 28.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.218 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.63 152.43 22.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.89 121.9 64.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.281 0.562 . . . . 0.0 109.995 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.779 HD11 ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -112.55 127.08 55.97 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.682 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -110.13 129.09 55.76 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.302 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.81 123.8 49.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.71 119.58 38.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 47' ' ' VAL . 25.1 m -126.46 160.7 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.75 96.46 5.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -153.35 52.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.033 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -113.58 39.12 2.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 111.186 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -69.13 157.98 87.81 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.918 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.3 -36.74 79.46 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.419 2.08 . . . . 0.0 113.649 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.407 HD22 ' HD3' ' A' ' 63' ' ' PRO . 8.9 p-10 -69.23 -46.0 68.41 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.364 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.6 m -65.06 -43.92 90.68 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.53 -45.73 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.713 0.292 . . . . 0.0 111.045 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 64.4 ttt180 -61.93 -46.25 90.14 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.57 -42.8 98.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.154 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.71 -47.03 87.14 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.752 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.758 0.313 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.759 HG23 ' HG2' ' A' ' 83' ' ' ARG . 87.1 m -66.08 -45.08 82.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.363 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.76 -51.02 29.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.51 -45.08 95.71 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.55 -42.24 92.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.191 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 70.9 mt -63.66 -46.07 95.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.163 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 40' ' ' TYR . 76.6 mt -68.03 -37.35 81.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.33 -36.39 76.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.47 -55.31 2.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -64.48 -39.99 94.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.6 m-85 -117.84 29.41 7.84 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.9 ttmt -51.36 123.43 9.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 112.091 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.91 -0.61 88.24 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.465 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.77 -42.77 5.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.024 0.912 . . . . 0.0 111.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HB2' HD22 ' A' ' 32' ' ' LEU . 28.9 m-85 -115.43 143.92 44.58 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.102 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.78 123.49 48.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.06 127.63 39.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.4 104.89 8.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.09 127.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.657 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.1 mm -109.96 115.7 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.756 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -85.94 103.08 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.6 m -66.56 -32.29 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.4 -40.51 73.87 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -71.21 -37.45 72.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.315 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -125.54 82.37 63.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.67 -31.53 92.17 Favored 'Trans proline' 0 C--O 1.23 0.083 0 C-N-CA 123.22 2.613 . . . . 0.0 112.337 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.73 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.1 mp0 -63.17 -42.11 99.35 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.568 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.37 -37.08 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.02 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.66 97.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.742 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.17 -38.1 84.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.477 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.73 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.3 mt-10 -60.68 -40.75 93.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.325 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 9.54 41.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.982 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 50.47 51.78 16.14 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.811 0.694 . . . . 0.0 112.708 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.0 106.24 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.58 0.59 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.626 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.49 149.64 36.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.399 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.6 p -147.15 143.94 18.97 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.9 Cg_endo -79.67 151.61 85.28 Favored 'Cis proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.931 -1.696 . . . . 0.0 112.652 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.4 m -126.04 130.09 50.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.387 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.779 ' HG ' HD11 ' A' ' 10' ' ' LEU . 6.3 tt -103.79 119.58 39.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.29 137.69 34.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.431 0.634 . . . . 0.0 111.77 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -99.99 104.67 16.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 ' HE3' ' A' ' 11' ' ' LYS . 16.0 m -81.99 -28.73 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.42 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 68' ' ' VAL . 2.1 mm? -135.34 136.85 25.11 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.461 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -75.14 156.27 99.76 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.49 -1.046 . . . . 0.0 112.388 -2.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.49 156.61 61.09 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.701 2.268 . . . . 0.0 111.861 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.65 164.61 86.9 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.234 0.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 68' ' ' VAL . 98.6 t -70.28 125.84 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.962 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -106.82 117.09 33.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.682 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -103.37 124.47 48.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.122 0.486 . . . . 0.0 110.03 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.555 HD12 HD22 ' A' ' 65' ' ' LEU . 50.8 mt -111.18 119.99 60.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.308 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.31 125.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.65 -165.96 38.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.845 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -82.53 102.77 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.71 -3.28 58.28 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.448 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 49.5 m -69.49 -21.54 63.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.169 0.509 . . . . 0.0 110.344 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -86.66 120.07 27.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.166 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.759 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.16 -36.35 77.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.79 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.77 -44.03 97.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.67 -40.39 95.32 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.468 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.42 -43.95 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.29 -47.92 66.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.796 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.9 mt -60.91 -46.85 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 122.938 0.149 . . . . 0.0 111.364 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.71 97.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.687 0.279 . . . . 0.0 111.162 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.1 mp -68.26 -40.41 81.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.162 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.78 -41.74 95.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.281 0.086 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.14 -39.71 94.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 76' ' ' ILE . 88.5 mt -67.16 -39.9 86.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.388 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.18 90.14 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.634 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.34 -38.11 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.187 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.3 -40.85 97.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.399 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' ALA . 83.4 mt -70.0 -42.54 79.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.43 -35.5 91.13 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.501 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.08 -40.29 95.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.714 0.293 . . . . 0.0 111.412 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -92.12 110.33 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.96 135.43 51.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -111.32 107.36 16.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.437 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -155.94 153.19 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.38 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.39 -30.01 67.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.972 0.415 . . . . 0.0 111.179 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -91.27 106.03 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.481 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.935 0.398 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 122.87 88.45 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.54 141.9 98.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.817 2.345 . . . . 0.0 112.875 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.2 mt -115.48 150.77 35.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -103.61 135.14 45.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.453 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mttp 69.99 -67.65 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.864 0.727 . . . . 0.0 112.002 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -77.26 127.25 32.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.435 0.636 . . . . 0.0 111.385 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -116.8 153.66 32.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.753 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.63 123.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.231 0.539 . . . . 0.0 110.337 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 129.95 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.2 mttt -115.25 131.53 56.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.7 125.23 51.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.44 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.38 117.32 34.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.537 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 30.6 m -125.95 160.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 0.0 111.891 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.35 97.95 5.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.29 -149.71 51.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.138 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -114.55 43.49 1.91 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -69.88 157.76 88.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.401 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 13.0 Cg_endo -57.13 -33.82 96.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.001 1.801 . . . . 0.0 112.414 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -68.75 -43.85 74.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.284 0.564 . . . . 0.0 109.566 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.537 ' OG ' ' HB ' ' A' ' 14' ' ' VAL . 43.5 t -64.54 -47.96 76.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.014 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.88 96.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpt180 -62.41 -48.96 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.59 99.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.438 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.44 -47.54 85.24 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.475 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.09 -40.32 95.97 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.773 0.32 . . . . 0.0 111.089 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 83' ' ' ARG . 86.5 m -65.39 -45.45 83.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.591 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -70.66 -49.0 51.99 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.28 -45.25 95.25 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.7 -39.87 91.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.675 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.7 mt -64.57 -45.21 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.321 0.582 . . . . 0.0 110.824 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 40' ' ' TYR . 81.0 mt -71.33 -29.49 65.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.2 mt-10 -90.29 -1.77 57.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -131.2 -61.96 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.621 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HG3' HD21 ' A' ' 87' ' ' LEU . 78.5 mm-40 -64.45 -42.43 95.96 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 90' ' ' LEU . 98.0 m-85 -124.45 30.67 5.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttpt -60.14 129.63 42.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.085 0.469 . . . . 0.0 111.255 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.98 78.84 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' THR . 52.4 t -105.32 -40.97 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 110.95 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' HB2' HD22 ' A' ' 32' ' ' LEU . 49.6 m-85 -117.08 144.95 44.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.394 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.07 123.15 47.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 tp -95.2 127.65 41.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.367 0.603 . . . . 0.0 112.429 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.0 mptp? -122.84 137.28 54.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.045 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.45 130.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.686 0.755 . . . . 0.0 110.662 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -113.26 103.73 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.409 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.72 104.75 7.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.5 m -68.33 -32.04 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.08 -39.78 75.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.92 -37.63 72.92 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -129.7 85.86 57.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.072 0.463 . . . . 0.0 110.454 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.09 -28.07 79.66 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.028 2.485 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.74 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.4 tt0 -62.53 -42.95 99.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.13 -36.14 74.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.18 97.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.38 -38.15 84.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.559 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.57 -40.41 91.56 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.76 9.67 42.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.007 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 50.89 51.77 16.34 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.721 0.638 . . . . 0.0 112.668 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.3 mm -86.21 106.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.8 mt -107.73 1.33 22.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.502 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.24 147.82 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 111.321 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -148.07 139.15 13.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.474 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 76.8 Cg_endo -79.93 152.32 85.12 Favored 'Cis proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.061 -1.641 . . . . 0.0 112.76 -1.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.2 m -127.02 130.26 49.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.341 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -104.86 117.79 34.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.777 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 135.22 35.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 74' ' ' ARG . 17.0 ttpp -96.11 104.53 16.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG21 ' HE3' ' A' ' 11' ' ' LYS . 29.4 m -80.52 -28.65 11.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.754 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -136.91 138.09 25.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.419 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.89 152.69 96.95 Favored 'Cis proline' 0 C--N 1.35 0.61 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.454 -1.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.46 157.12 59.98 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.57 2.18 . . . . 0.0 111.746 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.11 166.17 82.3 Favored 'Cis proline' 0 C--N 1.352 0.716 0 C-N-CA 124.313 -1.12 . . . . 0.0 113.4 0.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 68' ' ' VAL . 87.6 t -70.12 126.08 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.345 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 52.0 tpt85 -102.3 113.93 27.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.494 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -101.19 122.75 44.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.71 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 93' ' ' LEU . 66.2 mt -106.37 118.59 54.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.198 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.59 125.8 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.664 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.45 -166.95 39.63 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.774 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -82.86 102.73 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.42 -2.42 58.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.155 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.0 m -68.53 -21.72 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.493 . . . . 0.0 110.161 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.1 118.82 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.259 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.96 -36.22 76.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.635 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.73 -44.11 97.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.64 -40.75 96.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.509 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.598 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 74.0 t -64.92 -42.29 94.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.32 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD21 ' HG3' ' A' ' 35' ' ' GLU . 1.2 mt -69.01 -46.64 67.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.52 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.65 -46.45 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.553 0.216 . . . . 0.0 110.816 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.9 95.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -66.7 -41.9 87.29 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.384 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.44 -45.8 89.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.279 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.53 -39.65 94.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.614 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 76' ' ' ILE . 86.1 mt -65.28 -40.8 94.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 110.704 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.56 91.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.965 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.6 -38.65 88.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 110.184 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.96 -41.47 99.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.53 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.2 mt -71.0 -44.1 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.215 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.45 -35.62 91.98 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.781 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.88 -40.16 94.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 111.454 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -83.54 111.1 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.21 0.529 . . . . 0.0 110.543 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -111.73 145.8 38.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.732 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -88.36 99.57 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -125.26 112.3 16.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.181 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.37 -29.27 69.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.414 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.78 105.57 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.437 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 71' ' ' PRO . . . -73.09 128.81 87.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.123 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 2' ' ' ALA . 53.1 Cg_exo -58.81 143.66 98.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.979 2.453 . . . . 0.0 112.895 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 70' ' ' PRO . 1.7 mp -108.1 139.95 42.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -127.96 160.37 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.22 -39.34 92.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.342 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.51 117.6 21.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.253 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.23 152.6 19.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.075 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.78 125.18 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.73 128.27 56.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.3 mttt -112.83 128.52 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.362 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -105.9 123.25 47.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.9 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.5 m-85 -101.0 119.34 38.6 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . 20.3 m -125.8 160.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.558 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.27 98.96 6.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.83 -152.77 52.57 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.764 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -115.03 43.45 1.99 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.966 0.412 . . . . 0.0 110.601 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -71.47 158.24 88.34 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.789 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.53 -37.36 82.65 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.152 1.901 . . . . 0.0 112.714 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.5 -46.04 81.22 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.274 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.8 m -66.24 -44.07 84.76 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.272 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.07 -45.88 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.871 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -62.26 -46.97 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.56 97.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.76 -46.3 90.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.502 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.54 -41.31 98.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 0.0 110.754 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.757 HG23 ' HG3' ' A' ' 83' ' ' ARG . 87.3 m -64.46 -44.65 90.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -72.39 -50.0 29.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.44 97.36 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 28.3 t-20 -64.74 -43.31 93.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.082 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -63.87 -45.41 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.009 0.433 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 40' ' ' TYR . 76.5 mt -69.4 -35.82 76.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 30' ' ' ASN . 15.6 pt-20 -74.27 -18.64 60.7 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' A' ' 33' ' ' GLU . 75.5 mmtt -120.06 -61.76 1.56 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 111.818 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.18 -39.24 93.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.439 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -114.02 22.49 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.29 126.32 26.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.047 0.451 . . . . 0.0 112.016 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.23 -9.23 78.09 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.968 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 36' ' ' PHE . 21.5 t -112.26 -44.62 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.672 0.736 . . . . 0.0 112.352 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.39 141.09 45.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.779 -178.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.97 125.62 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 32' ' ' LEU . 65.7 tp -97.12 129.86 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.481 0.657 . . . . 0.0 112.741 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.58 133.0 51.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.221 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.8 t -120.37 129.34 75.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -112.32 116.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.923 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -86.59 102.08 13.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 14' ' ' VAL . 23.0 m -66.2 -34.71 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.53 -36.67 73.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.069 0.395 . . . . 0.0 111.826 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.92 -40.47 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.76 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -129.76 86.51 55.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 109.977 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.27 -29.07 85.63 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.036 2.49 . . . . 0.0 112.676 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 24.4 mp0 -62.8 -42.09 99.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.754 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.08 -36.94 75.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.03 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.17 97.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.197 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.41 -38.41 84.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.406 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.7 -40.77 93.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -99.4 14.09 30.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.838 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 47.45 54.41 9.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.666 0.786 . . . . 0.0 113.058 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 47' ' ' VAL . 46.9 mm -88.94 108.43 18.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.56 -8.9 16.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.88 139.69 36.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.603 0.24 . . . . 0.0 111.335 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.0 p -135.36 148.61 66.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.5 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 58.8 Cg_endo -75.13 151.49 96.81 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.729 -1.779 . . . . 0.0 112.649 -1.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -116.11 124.28 49.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.543 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 80' ' ' LEU . 20.6 tp -102.7 115.17 30.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.75 138.61 30.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 112.299 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.4 ttpp -99.55 104.32 16.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.837 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.1 m -81.15 -28.72 10.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.229 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -137.3 142.09 36.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 4' ' ' LEU . 92.1 Cg_endo -78.44 156.61 93.38 Favored 'Cis proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.418 -1.493 . . . . 0.0 112.239 -1.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' ALA . 44.6 Cg_exo -60.41 150.37 81.17 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.956 2.438 . . . . 0.0 112.181 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.6 167.62 78.53 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.172 -1.178 . . . . 0.0 113.501 0.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 94.9 t -73.08 127.12 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.817 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -110.75 118.97 37.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.074 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.7 mtm105 -103.13 121.61 42.98 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.435 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.561 ' HB ' HD23 ' A' ' 65' ' ' LEU . 64.9 mt -106.14 117.74 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.544 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.35 125.23 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.162 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.86 -170.41 43.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.29 107.59 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.0 mt -90.15 -0.71 57.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.93 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -67.85 -18.8 64.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -92.6 120.48 33.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.757 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.77 -36.53 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.567 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.62 -44.11 96.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.7 -40.59 95.63 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.49 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -63.72 -44.13 98.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.337 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -47.96 64.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.93 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.67 -45.82 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 123.016 0.197 . . . . 0.0 111.3 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.4 99.13 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.16 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 86.6 mt -66.32 -39.82 89.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.329 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.42 -41.28 93.72 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.36 -37.16 86.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.24 -38.57 91.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 36' ' ' PHE . . . -62.1 -38.91 90.69 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.999 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -38.79 89.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.42 -40.9 96.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.497 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -69.29 -43.32 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.3 -32.65 81.55 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.147 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.42 -39.09 82.36 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.377 0.271 . . . . 0.0 111.623 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -70.6 122.44 19.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -110.92 139.59 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -102.77 -52.07 3.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.753 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -94.09 107.63 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -66.88 -29.54 69.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t0 64.59 -170.11 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.419 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.33 179.759 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.993 0.425 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.28 121.74 78.76 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 150.71 61.94 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.599 2.2 . . . . 0.0 112.791 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -97.81 -0.63 44.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.155 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.99 138.84 35.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -19.41 62.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.455 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 p -87.9 123.93 33.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.495 0.664 . . . . 0.0 112.316 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.63 154.18 19.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.914 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -107.36 123.18 62.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.326 0.584 . . . . 0.0 110.92 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.47 126.7 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -110.63 130.53 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.515 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.82 122.27 47.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.4 m-85 -99.65 119.87 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 47' ' ' VAL . 18.8 m -126.18 161.21 32.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.408 . . . . 0.0 111.803 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.03 101.32 8.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.59 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.69 -134.59 51.29 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.0 36.45 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 111.035 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p -63.89 151.74 88.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.758 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 15.2 Cg_endo -57.25 -31.79 91.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.404 2.069 . . . . 0.0 112.788 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.3 p-10 -70.63 -42.47 70.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 73.9 m -70.17 -42.83 71.96 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.58 -44.21 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.738 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -61.45 -47.9 83.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.224 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.576 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.72 -47.47 85.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -63.82 -42.47 97.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.889 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.763 HG23 ' HG2' ' A' ' 83' ' ' ARG . 86.1 m -65.34 -44.87 86.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.396 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -70.56 -50.74 34.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.59 -45.33 94.57 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -66.48 -39.75 88.92 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.394 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -65.17 -43.86 95.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.665 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.93 -28.33 64.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.9 mt-10 -89.45 -1.47 58.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -132.05 -62.31 0.85 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.19 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 87' ' ' LEU . 78.8 mm-40 -65.19 -41.15 94.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.5 29.94 6.44 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.1 ttpt -61.92 129.43 40.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.45 . . . . 0.0 111.246 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.47 -8.91 78.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.029 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.87 -44.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.206 0.503 . . . . 0.0 111.375 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.4 m-85 -113.02 141.43 46.86 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.057 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.54 124.85 50.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -97.21 128.27 43.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 112.281 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptp? -125.55 110.37 13.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.026 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.15 128.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.538 0.685 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -111.36 116.55 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.738 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -86.4 103.37 14.9 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.4 m -67.33 -32.44 57.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.13 -39.2 75.56 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.87 -37.25 73.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.409 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -129.2 86.42 56.84 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.349 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.88 -28.42 81.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.985 2.457 . . . . 0.0 112.619 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 64.4 tt0 -62.72 -42.25 99.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.388 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.02 -36.68 75.26 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.671 -0.411 . . . . 0.0 109.926 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.17 97.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.038 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.56 -38.62 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.694 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.8 mm-40 -60.86 -40.68 93.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.497 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.37 9.7 41.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.076 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.11 52.39 14.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.93 108.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.571 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.33 -11.52 15.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.839 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.46 139.6 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.552 0.215 . . . . 0.0 111.168 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.9 p -132.78 148.55 69.96 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 63.0 Cg_endo -75.47 151.95 96.86 Favored 'Cis proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.893 -1.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -117.91 122.78 44.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.228 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 80' ' ' LEU . 24.5 tp -104.86 114.33 28.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -139.59 137.24 35.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 112.201 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 17.2 ttpp -96.64 104.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 73' ' ' VAL . 27.5 m -81.14 -28.59 10.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.531 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.33 137.39 22.31 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.56 152.66 96.44 Favored 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.254 -1.144 . . . . 0.0 112.461 -1.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.35 156.61 61.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.716 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 167.63 79.24 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.317 -1.118 . . . . 0.0 113.387 0.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 68' ' ' VAL . 87.5 t -70.67 126.38 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -106.85 117.88 35.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.52 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 95.8 mtm-85 -101.72 123.07 45.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.91 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 93' ' ' LEU . 69.5 mt -105.51 117.08 50.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.597 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -117.23 126.13 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.48 -166.95 40.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.771 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.93 101.77 11.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.9 mt -89.76 -0.69 57.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.09 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -68.37 -24.17 64.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.514 . . . . 0.0 110.0 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -84.0 119.13 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.443 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.23 -36.15 77.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.577 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.24 -46.51 88.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.8 -40.23 96.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.7 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.6 t -62.6 -43.81 98.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mt -67.14 -44.89 78.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.402 0.144 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.8 97.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.248 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.42 -38.46 81.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.803 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.02 -46.52 88.83 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.46 -39.69 94.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 76' ' ' ILE . 87.3 mt -65.29 -40.98 94.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.21 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.82 92.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.6 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.96 -38.15 87.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.1 -40.06 94.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.5 mt -67.77 -44.37 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.14 -35.62 91.77 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.777 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -96.16 17.47 15.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 111.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -92.71 118.6 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.319 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.32 142.54 43.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.687 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.69 -43.38 98.97 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.23 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -91.47 103.97 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.16 -29.22 68.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.157 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t0 66.77 -175.23 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.312 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.522 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.138 0.495 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.18 110.88 64.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.04 143.18 99.58 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.859 2.372 . . . . 0.0 112.771 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.22 149.27 37.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -62.61 -38.04 88.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.446 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -62.24 -38.73 90.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.893 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -79.37 123.54 27.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.29 151.92 23.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.24 126.6 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 67' ' ' LYS . 25.6 mt -115.67 134.95 54.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.072 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.59 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -115.0 126.36 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.82 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 122.72 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.7 m-85 -99.65 118.47 36.25 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 47' ' ' VAL . 28.3 m -126.5 160.82 33.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.002 0.43 . . . . 0.0 111.503 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.17 104.4 11.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 60.8 -130.78 48.4 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.415 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -131.66 50.27 2.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.23 0.538 . . . . 0.0 110.289 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 52.1 p -73.15 156.0 89.72 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.818 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.6 Cg_endo -57.77 -34.64 98.5 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.103 1.869 . . . . 0.0 112.353 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.29 -42.79 87.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.0 m -70.05 -42.38 72.96 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.809 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.68 -44.29 96.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.66 -49.31 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.644 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.75 97.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.473 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.84 -47.68 83.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -62.45 -44.76 95.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.741 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' HG3' ' A' ' 83' ' ' ARG . 93.1 m -63.05 -49.45 74.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.983 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HA ' HG11 ' A' ' 86' ' ' VAL . 62.9 tp -67.96 -46.18 72.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.86 99.71 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.95 -42.07 97.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.69 -44.29 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.537 . . . . 0.0 110.493 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 42' ' ' LEU . 72.9 mt -66.8 -35.6 80.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 77.7 mm-40 -87.88 -1.27 57.87 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -129.91 -64.09 0.88 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.593 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.55 -42.11 95.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.42 30.05 6.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 64.7 tttp -60.39 129.52 42.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 111.247 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.25 -8.33 79.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.769 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.15 -41.59 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.886 0.343 . . . . 0.0 111.036 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -115.18 143.79 44.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.171 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.82 126.38 51.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HB2' HD13 ' A' ' 32' ' ' LEU . 64.7 tp -97.51 129.5 44.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.622 0.725 . . . . 0.0 112.922 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -126.02 132.4 52.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.114 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -120.65 129.96 75.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.383 0.611 . . . . 0.0 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -112.4 116.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.932 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.12 103.6 14.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 14' ' ' VAL . 23.8 m -66.71 -33.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 16' ' ' GLY . 81.6 mt -70.24 -39.68 74.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.76 -37.57 73.41 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.382 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -129.04 86.55 56.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.097 0.475 . . . . 0.0 110.321 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.82 -28.44 81.59 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.92 2.413 . . . . 0.0 112.466 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.731 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.21 -42.26 99.26 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.785 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.16 -36.93 75.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.034 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.73 98.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.693 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.23 -38.3 85.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.322 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.5 mt-10 -60.73 -40.81 93.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -97.69 9.62 42.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.094 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.04 52.02 15.51 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.383 0.673 . . . . 0.0 112.707 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mm -87.48 107.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.77 1.37 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.58 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.1 148.7 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.701 0.286 . . . . 0.0 111.437 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.9 p -147.43 142.66 17.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.328 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.76 151.05 84.26 Favored 'Cis proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.927 -1.697 . . . . 0.0 112.578 -1.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -128.16 130.94 48.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.519 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.21 120.44 41.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.77 136.38 37.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 0.0 111.39 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.4 OUTLIER -93.45 103.94 16.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 ' HE3' ' A' ' 11' ' ' LYS . 28.0 m -80.97 -28.09 11.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.879 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -136.97 138.37 25.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.089 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 2.7 Cg_exo -79.74 148.31 79.45 Favored 'Cis proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.41 -1.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.405 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 32.5 Cg_exo -61.57 153.69 64.97 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.957 2.438 . . . . 0.0 111.864 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 17.5 Cg_exo -69.05 160.81 85.3 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.974 -0.844 . . . . 0.0 113.742 0.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 90.2 t -72.31 126.27 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.732 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -106.78 118.24 36.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -100.43 125.72 46.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.2 0.524 . . . . 0.0 110.4 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.936 HD11 HD11 ' A' ' 93' ' ' LEU . 66.2 mt -107.79 116.55 51.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.708 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.89 126.42 75.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.49 -164.88 38.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.635 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.66 100.06 9.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.11 -2.37 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.065 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.0 m -68.63 -20.91 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.24 0.543 . . . . 0.0 110.267 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.2 t-20 -87.9 120.46 29.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.542 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -60.37 -37.48 80.88 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 93.6 mt-10 -61.17 -43.24 99.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.59 -40.96 96.45 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 28' ' ' LEU . 74.2 t -63.62 -42.58 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.227 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.38 -49.55 54.35 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.017 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.68 -47.53 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.64 98.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 32' ' ' LEU . 56.9 tp -67.41 -40.49 85.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.869 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -62.64 -43.84 97.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.819 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.63 -38.9 92.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.712 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.936 HD11 HD11 ' A' ' 76' ' ' ILE . 92.4 mt -65.29 -40.3 93.66 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.847 0.356 . . . . 0.0 110.675 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.36 90.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.845 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.6 -38.44 87.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 110.066 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.74 -41.08 99.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.464 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 8' ' ' ALA . 85.3 mt -69.83 -43.75 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.67 91.97 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.805 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.93 -39.81 93.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.784 0.326 . . . . 0.0 111.532 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -84.68 117.35 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.81 137.14 48.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.736 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -163.01 -51.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -88.92 106.14 18.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.635 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 106' ' ' LYS . 33.6 t70 -67.15 -29.57 69.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.143 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.3 t0 56.59 46.61 20.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.862 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 104' ' ' ASP . 15.9 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.04 63.88 9.06 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 123.818 0.699 . . . . 0.0 112.388 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 143.3 99.59 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.757 2.305 . . . . 0.0 112.64 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -89.61 -10.4 46.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.876 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -79.08 143.71 35.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.524 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -87.15 -11.5 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -90.82 123.76 34.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.55 153.16 22.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.55 121.23 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.472 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 50.2 tp -113.99 126.37 55.06 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 99.4 mttt -110.95 135.25 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.324 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.57 123.77 51.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.924 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' CD2' HG13 ' A' ' 59' ' ' ILE . 97.7 m-85 -98.28 121.86 40.73 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.2 m -124.84 159.02 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.568 0.223 . . . . 0.0 110.559 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 18' ' ' THR . . . -125.72 96.56 4.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.62 88.37 Favored Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.583 -0.818 . . . . 0.0 114.883 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.01 47.44 9.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.591 0.71 . . . . 0.0 110.326 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' ALA . 68.1 p -72.26 165.48 50.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.022 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.96 -37.72 67.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.119 1.88 . . . . 0.0 112.909 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -64.48 -44.7 90.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -65.31 -43.55 90.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.15 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.96 -44.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 109.991 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -61.56 -47.69 84.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.224 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.18 99.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.244 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 44' ' ' VAL . 62.1 tp -61.83 -47.81 83.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.352 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.66 -40.18 96.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.792 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 83' ' ' ARG . 93.5 m -64.6 -46.5 82.37 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.222 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 65' ' ' LEU . 6.0 mt -70.01 -47.02 63.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.07 -42.65 98.9 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.58 -44.55 96.04 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.73 -45.83 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.621 0.724 . . . . 0.0 111.04 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 40' ' ' TYR . 91.4 mt -69.63 -32.52 71.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.313 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.7 mt-10 -84.16 -10.14 58.0 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -125.78 -62.04 1.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.223 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.66 -42.37 98.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 90' ' ' LEU . 97.8 m-85 -123.89 31.31 5.88 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.3 128.1 34.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.022 0.439 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.63 -0.22 89.65 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.655 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.96 -44.75 6.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 117.327 0.563 . . . . 0.0 111.603 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.631 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -114.02 142.13 46.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.579 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 126.0 51.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 32' ' ' LEU . 59.1 tp -96.35 125.05 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 111.279 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.2 mptp? -125.08 113.0 17.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.519 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 25' ' ' LEU . 87.9 t -98.64 128.67 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.542 0.687 . . . . 0.0 111.033 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.6 mm -111.14 116.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.897 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.54 104.13 15.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' VAL . 28.8 m -67.64 -33.64 63.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.47 -39.86 73.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.06 -36.27 72.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -124.78 81.72 61.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.811 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.56 -32.81 93.93 Favored 'Trans proline' 0 N--CA 1.466 -0.099 0 C-N-CA 123.307 2.671 . . . . 0.0 112.267 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.681 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 mp0 -63.15 -41.97 99.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.23 -37.37 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.937 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.58 97.07 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.42 -38.7 88.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.395 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -60.76 -40.55 92.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.81 9.53 42.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.009 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? 49.87 51.97 15.54 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 13' ' ' TYR . 43.3 mm -91.45 108.2 19.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.696 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -110.63 2.94 18.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.729 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.58 36.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.812 0.339 . . . . 0.0 111.516 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -147.6 148.8 32.02 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.0 Cg_exo -77.74 146.26 81.32 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.518 -1.451 . . . . 0.0 111.571 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -128.41 130.08 47.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.163 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 28' ' ' LEU . 7.8 mt -102.52 125.26 49.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -143.17 127.36 17.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.014 0.435 . . . . 0.0 110.767 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.5 OUTLIER -98.6 101.35 12.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.852 ' HA ' HG22 ' A' ' 73' ' ' VAL . 74.3 t -71.81 -39.05 67.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.582 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.7 134.39 26.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 0.0 112.334 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' NZ ' ' A' ' 67' ' ' LYS . 83.6 Cg_endo -76.5 154.48 97.65 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.374 -1.511 . . . . 0.0 112.475 -1.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 155.46 66.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.58 2.187 . . . . 0.0 112.017 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.3 164.59 86.65 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.446 0.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 68' ' ' VAL . 61.0 t -70.6 125.7 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.871 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.3 mmm180 -94.37 114.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -101.29 120.69 40.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.323 0.582 . . . . 0.0 110.55 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 72.5 mt -111.38 118.74 58.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.169 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.61 127.37 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.865 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.81 -162.53 35.98 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -81.33 100.53 9.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.71 -4.08 57.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.2 m -70.27 -22.35 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.093 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.2 t-20 -81.63 117.99 22.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 27' ' ' THR . 90.6 mtm180 -60.41 -36.74 78.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.082 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 41.3 mt-10 -60.63 -44.87 95.85 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.31 -41.64 96.74 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.959 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 69.8 t -63.79 -45.68 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.548 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -65.04 -46.87 79.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.297 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -62.57 -47.09 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.49 0.186 . . . . 0.0 111.229 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.98 97.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -67.28 -40.04 86.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.196 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.28 -44.54 94.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.02 -39.75 95.68 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.855 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 76' ' ' ILE . 87.3 mt -65.09 -41.22 95.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.681 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' A' ' 97' ' ' ILE . . . -63.55 -38.8 92.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.34 -38.61 90.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.884 0.373 . . . . 0.0 110.319 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.52 -40.42 96.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.95 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 94' ' ' ALA . 82.0 mt -64.57 -45.02 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.665 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.56 91.92 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.514 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.53 -40.59 97.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.047 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.37 125.87 28.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.911 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.39 135.65 47.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.943 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -110.94 -51.52 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.65 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -91.97 109.92 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -95.51 14.62 22.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.86 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -138.74 163.18 32.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.77 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 3' ' ' PRO . . . -62.18 -50.39 80.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 2' ' ' ALA . 67.8 Cg_endo -71.54 154.72 60.09 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.971 1.781 . . . . 0.0 112.82 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.9 -11.47 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 57.55 -131.12 1.47 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.842 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.05 0.7 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.677 0.275 . . . . 0.0 111.244 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.4 130.51 36.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.611 0.719 . . . . 0.0 111.987 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -107.5 153.47 22.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.626 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -108.31 124.53 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.207 0.527 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.79 127.35 56.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.589 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.5 mttt -115.03 132.21 56.67 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.773 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.7 124.75 50.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.005 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -98.41 118.94 36.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.2 m -125.58 160.3 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.368 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.35 104.19 10.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.556 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.77 -129.9 44.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.088 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -134.22 53.06 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.5 . . . . 0.0 110.3 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -74.34 157.56 86.35 Favored Pre-proline 0 CA--C 1.515 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.859 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.89 -33.72 97.39 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -67.24 -43.57 81.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -67.76 -43.02 80.82 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.7 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.95 -44.0 96.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.905 0.383 . . . . 0.0 110.438 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 tpt180 -63.42 -49.67 72.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.507 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.45 98.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.0 -46.56 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.294 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -64.69 -42.31 95.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.725 0.298 . . . . 0.0 110.97 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' HG3' ' A' ' 83' ' ' ARG . 94.2 m -63.04 -49.12 75.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 86' ' ' VAL . 62.2 tp -67.58 -45.1 76.53 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.18 -42.87 99.69 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.48 -44.64 96.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 110.797 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 78.0 mt -63.54 -45.54 97.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.029 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 42' ' ' LEU . 70.9 mt -66.48 -37.34 84.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.8 mt-10 -65.09 -36.31 83.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -114.13 -53.12 2.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.8 mm-40 -65.78 -41.6 91.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.66 29.56 6.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 13.8 tmtt? -60.01 127.21 30.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.023 0.439 . . . . 0.0 111.324 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.61 -8.04 80.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.675 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.76 -46.06 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.511 0.656 . . . . 0.0 111.561 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.03 141.86 46.9 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.46 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.81 128.38 49.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.548 ' HB2' HD13 ' A' ' 32' ' ' LEU . 56.8 tp -98.52 126.36 44.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptm? -124.67 139.2 54.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.854 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.69 132.79 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.583 0.706 . . . . 0.0 110.925 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.11 104.73 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.72 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -77.52 102.02 6.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 14' ' ' VAL . 25.5 m -66.71 -34.18 68.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.49 -37.36 74.21 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.776 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -70.42 -40.58 73.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.571 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -126.14 83.09 64.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 -33.04 95.56 Favored 'Trans proline' 0 CA--C 1.527 0.132 0 C-N-CA 123.218 2.612 . . . . 0.0 112.576 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.693 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 53.4 tt0 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.72 -37.12 76.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.04 -42.01 97.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.125 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.76 -38.21 86.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.532 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.1 mm-40 -60.6 -40.36 91.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.03 8.96 43.36 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.884 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 51.35 50.92 17.93 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.75 104.93 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.48 2.82 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.639 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.38 149.66 38.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.444 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -148.0 145.55 21.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.046 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.75 148.68 83.71 Favored 'Cis proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.464 -1.473 . . . . 0.0 111.622 -2.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -123.78 128.57 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 80' ' ' LEU . 20.1 tp -102.59 119.18 38.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.472 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.83 139.31 30.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.527 0.679 . . . . 0.0 112.258 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HE3' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -100.3 105.01 16.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.589 HG21 ' HE3' ' A' ' 11' ' ' LYS . 28.6 m -81.42 -28.85 10.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.907 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -135.83 139.07 29.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.394 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 92.6 Cg_endo -81.44 152.18 78.85 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.432 -1.487 . . . . 0.0 112.596 -1.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 36.3 Cg_exo -61.17 153.11 67.15 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.987 2.458 . . . . 0.0 112.03 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 18.4 Cg_exo -68.87 158.99 87.62 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.915 -0.869 . . . . 0.0 113.727 0.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.3 t -74.21 126.6 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.58 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.725 ' HG2' HD11 ' A' ' 93' ' ' LEU . 22.3 tpp180 -105.82 120.12 40.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.014 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -103.82 126.11 50.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.21 0.528 . . . . 0.0 110.082 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.53 117.97 56.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.847 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.0 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.022 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.95 -166.36 39.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.801 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -82.26 101.91 10.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 65' ' ' LEU . 88.5 mt -89.9 -1.29 57.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.327 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.6 m -68.86 -21.59 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -87.2 120.29 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.253 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -59.93 -36.06 76.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.643 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.68 -44.32 96.66 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.23 -41.33 94.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.204 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 28' ' ' LEU . 72.9 t -63.18 -45.92 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.239 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.29 -48.76 72.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.003 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.85 -47.69 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.35 -41.91 96.51 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.675 0.274 . . . . 0.0 111.471 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 32' ' ' LEU . 53.1 tp -65.6 -39.98 92.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.347 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.8 -43.96 97.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.689 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp -61.62 -41.73 97.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.684 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.725 HD11 ' HG2' ' A' ' 74' ' ' ARG . 3.9 mm? -65.94 -41.79 90.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.618 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.57 91.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.563 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.74 -38.94 89.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.809 0.338 . . . . 0.0 110.459 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.58 -40.35 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 8' ' ' ALA . 91.8 mt -66.04 -44.65 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.867 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.16 -35.79 92.04 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.603 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.48 -39.73 94.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.303 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -85.28 114.01 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -87.09 134.74 33.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.619 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.1 110.39 6.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.928 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t0 55.8 51.3 12.55 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.61 0.568 . . . . 0.0 111.652 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.6 -29.91 70.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.674 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -91.46 100.98 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.603 179.672 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.51 117.16 65.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.974 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.21 152.89 62.15 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.716 2.278 . . . . 0.0 112.797 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -110.79 133.76 53.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -125.14 -68.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.535 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -93.52 -4.76 50.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -90.32 124.55 35.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.25 152.48 22.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.675 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.6 t -108.88 121.38 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.188 0.518 . . . . 0.0 109.951 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 65' ' ' LEU . 43.5 tp -113.5 126.8 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.8 mttt -111.43 133.33 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.786 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.31 124.72 53.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.6 m-85 -100.17 119.41 38.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 25' ' ' LEU . 15.7 m -125.61 160.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.891 0.377 . . . . 0.0 111.167 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.24 102.93 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.558 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.02 -133.19 50.99 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -125.83 38.08 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -67.76 154.35 93.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.34 -37.76 81.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.048 1.832 . . . . 0.0 112.872 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -65.18 -44.5 88.25 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.262 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 75.6 m -68.46 -43.9 76.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.289 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.3 -45.81 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 110.614 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -62.34 -46.18 89.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.72 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.07 98.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.811 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD23 HD13 ' A' ' 12' ' ' LEU . 74.2 mt -63.03 -41.88 99.64 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.62 -40.0 95.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.0 110.291 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 83' ' ' ARG . 85.9 m -66.57 -45.22 80.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.468 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -51.55 21.59 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.57 -43.77 98.25 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.01 -43.43 95.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.232 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.2 mt -64.14 -45.15 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.951 0.405 . . . . 0.0 111.148 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 40' ' ' TYR . 79.1 mt -68.79 -35.64 77.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.9 mt-10 -71.66 -24.63 61.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -114.48 -59.75 1.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.315 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.87 -40.94 95.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB2' HD23 ' A' ' 32' ' ' LEU . 98.7 m-85 -122.32 29.58 6.91 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 59.5 tttp -62.12 127.73 32.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 111.318 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.42 79.84 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.139 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.49 -43.28 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 117.168 0.484 . . . . 0.0 111.37 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 32.3 m-85 -114.53 143.63 44.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.004 -0.679 . . . . 0.0 112.107 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 123.86 48.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.76 127.73 40.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.347 0.594 . . . . 0.0 112.039 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.25 108.83 12.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.214 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.87 127.86 47.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.764 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -110.95 115.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.871 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -86.15 101.19 12.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.0 m -64.31 -34.79 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -71.33 -37.89 71.7 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.32 -41.24 73.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.94 0.4 . . . . 0.0 110.627 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.17 79.1 62.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.32 -20.05 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.418 2.079 . . . . 0.0 112.777 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.746 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.2 mt-30 -63.28 -41.75 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 99.9 mt -70.97 -36.38 72.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.782 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 -42.04 98.55 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.2 85.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.162 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.2 mt-10 -60.89 -40.4 92.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.66 9.82 40.45 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.965 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.87 51.85 16.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.49 0.716 . . . . 0.0 112.925 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.6 mm -88.55 107.24 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.563 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.98 1.41 24.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.57 149.31 37.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 111.314 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -147.42 143.05 17.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.55 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.99 150.62 82.63 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.886 -1.714 . . . . 0.0 112.576 -1.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -127.47 131.22 50.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.443 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 80' ' ' LEU . 51.8 tp -105.2 120.84 42.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.112 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.44 135.96 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.419 0.628 . . . . 0.0 111.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -101.23 104.59 15.64 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.557 HG21 ' HE3' ' A' ' 11' ' ' LYS . 29.9 m -79.94 -28.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.145 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -134.72 139.02 31.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.439 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 83.1 Cg_endo -80.23 152.88 84.6 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.569 -1.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 34.5 Cg_exo -61.18 152.55 71.13 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.995 2.463 . . . . 0.0 112.038 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.1 160.29 89.28 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 124.894 -0.878 . . . . 0.0 113.668 0.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 68' ' ' VAL . 93.1 t -73.89 127.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HG2' HD21 ' A' ' 93' ' ' LEU . 21.9 tpp180 -106.05 118.88 37.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -104.43 124.38 49.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.108 0.48 . . . . 0.0 109.769 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 93' ' ' LEU . 64.1 mt -109.33 117.59 54.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.418 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.26 127.72 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.541 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.42 -158.8 31.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.19 86.38 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.3 mp -77.26 -10.01 59.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.765 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.0 p -67.94 -19.11 64.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.861 0.362 . . . . 0.0 111.007 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.09 120.71 30.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.84 -35.8 75.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.596 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.3 -44.76 95.13 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -64.42 -41.24 96.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.947 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.38 -47.2 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.686 0.279 . . . . 0.0 110.571 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.07 -47.61 76.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.749 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.68 -46.06 97.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -62.85 -41.32 99.31 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.479 0.18 . . . . 0.0 111.248 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.428 HD21 ' CD2' ' A' ' 10' ' ' LEU . 89.1 mt -66.32 -38.3 87.38 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.064 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.29 -42.41 96.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.441 0.162 . . . . 0.0 110.942 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.3 -40.03 95.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.722 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 76' ' ' ILE . 89.2 mt -66.93 -40.49 87.63 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.93 0.395 . . . . 0.0 110.59 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.31 90.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.575 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.45 -37.68 84.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.139 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.76 -40.7 98.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.1 mt -70.02 -43.67 79.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.47 -22.05 72.89 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.841 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.41 -39.65 93.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 111.016 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.66 126.15 28.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.098 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -97.86 148.35 23.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -153.82 158.11 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -88.76 104.42 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.28 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -94.89 6.94 47.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.62 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.1 t0 55.91 43.77 26.89 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.639 0.587 . . . . 0.0 111.798 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.65 179.665 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 146.71 62.3 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.59 149.99 56.37 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.738 2.292 . . . . 0.0 112.974 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.21 137.23 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -130.39 149.44 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.83 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.8 -40.13 95.9 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.199 0.523 . . . . 0.0 110.698 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.745 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.556 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -95.69 152.3 18.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.155 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.4 t -111.62 124.02 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 130.35 56.16 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.7 mttt -115.63 131.29 56.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.47 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.43 124.75 51.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.8 m-85 -100.51 119.8 39.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . 26.4 m -126.99 160.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 111.682 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.65 105.57 12.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.657 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.75 -130.29 45.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.09 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -136.56 52.22 1.96 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.38 158.02 84.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.952 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 74.5 Cg_exo -54.31 -37.16 88.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.702 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -64.79 -45.23 87.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 110.002 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -66.84 -43.12 84.51 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.6 -44.62 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.589 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.9 tpt180 -62.01 -47.66 83.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.17 -42.74 99.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.65 -47.74 83.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.514 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.7 97.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.722 HG23 ' HG2' ' A' ' 83' ' ' ARG . 87.4 m -65.42 -45.47 83.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.4 -50.0 43.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.78 -45.6 93.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.78 -43.34 93.56 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.22 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.5 mt -63.6 -44.81 98.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.004 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 40' ' ' TYR . 84.8 mt -71.2 -27.9 63.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -88.85 -4.36 58.5 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.94 -62.13 1.02 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.268 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.298 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.27 30.2 6.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.53 126.29 26.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.44 83.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.335 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.88 -41.38 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.19 0.495 . . . . 0.0 111.486 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.607 ' HB2' HD22 ' A' ' 32' ' ' LEU . 37.8 m-85 -116.1 144.31 44.31 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.481 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.65 124.57 49.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -97.04 129.82 44.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.464 0.649 . . . . 0.0 112.533 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -125.8 134.33 51.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.442 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -120.48 129.56 75.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.412 0.625 . . . . 0.0 110.774 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -112.49 116.21 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.806 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -86.34 104.62 16.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 14' ' ' VAL . 17.5 m -68.22 -21.16 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.53 -38.42 17.23 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.387 0.54 . . . . 0.0 111.873 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.86 -37.37 73.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.412 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -132.9 77.01 69.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.63 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.53 -19.3 67.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.604 2.202 . . . . 0.0 112.718 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.687 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.7 mt-30 -63.13 -41.04 99.24 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.75 -36.16 73.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.8 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.45 97.68 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.132 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.63 86.62 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.172 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.88 -40.32 92.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.344 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.47 10.27 40.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.994 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 50.18 52.68 14.26 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 48.8 mm -88.84 109.23 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.34 -7.2 17.82 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.11 142.99 30.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.495 0.188 . . . . 0.0 111.22 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.0 p -135.25 149.91 71.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.8 Cg_endo -75.84 151.36 95.58 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.608 -1.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.02 123.63 44.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.426 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -104.23 116.84 32.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -141.27 136.63 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.196 0.522 . . . . 0.0 111.605 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.3 ttpp -99.37 101.29 12.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' VAL . 78.1 t -71.5 -39.24 70.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.257 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -128.71 140.66 39.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.856 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 72.6 Cg_endo -75.37 153.5 98.63 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.391 -1.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 39.8 Cg_exo -60.62 149.9 84.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.959 2.44 . . . . 0.0 112.246 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.67 169.13 73.41 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.417 0.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 68' ' ' VAL . 70.9 t -72.95 124.92 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.416 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.6 mmm180 -100.54 114.01 27.28 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 87.5 mtm180 -98.06 118.63 35.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 93' ' ' LEU . 63.1 mt -106.6 116.48 50.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.508 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.48 127.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 111.305 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.79 -165.4 38.68 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.613 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -80.51 101.73 9.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.96 -3.5 58.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -68.12 -21.37 64.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.309 0.576 . . . . 0.0 110.0 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -84.18 116.76 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.34 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.0 mtm-85 -60.47 -37.24 80.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.5 -44.2 96.23 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -63.75 -40.81 97.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.419 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.48 -44.3 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.452 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -46.67 72.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.536 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.1 mt -61.73 -46.11 97.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.345 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.24 98.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.258 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.76 -38.24 86.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.722 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -62.18 -46.3 89.53 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.803 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.3 -39.47 92.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.373 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 76' ' ' ILE . 89.8 mt -64.44 -41.07 96.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.895 0.378 . . . . 0.0 110.336 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.52 91.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.512 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -38.27 88.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.996 0.427 . . . . 0.0 110.039 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.74 -40.65 97.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 8' ' ' ALA . 86.3 mt -68.38 -44.27 83.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.881 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.07 -24.94 70.64 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.11 -38.63 89.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 111.131 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -85.89 107.98 17.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -84.49 143.36 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.99 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -159.6 161.18 35.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -87.23 106.16 17.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.26 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.81 -29.26 69.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.68 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.79 102.91 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 110.632 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.755 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.36 63.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.74 155.52 58.38 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.752 2.302 . . . . 0.0 112.647 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.0 mt -107.84 138.55 43.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.664 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -95.47 151.96 18.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -65.8 -38.52 89.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.677 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.77 122.07 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.989 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -88.57 152.33 21.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.137 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.78 121.78 63.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.16 127.59 55.63 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -113.59 132.94 55.54 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.883 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.9 124.05 51.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.975 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -98.96 118.91 36.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.5 m -125.63 160.22 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.441 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.49 103.94 10.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.72 -129.53 44.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.264 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.22 52.68 1.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.802 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -74.91 158.36 84.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.704 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.09 -37.01 86.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.9 -45.79 80.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.8 0.333 . . . . 0.0 110.117 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.0 m -65.75 -44.25 86.49 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG12 ' HE2' ' A' ' 26' ' ' LYS . 55.1 t -65.15 -45.81 92.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.749 0.309 . . . . 0.0 110.877 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -62.63 -46.81 86.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.89 98.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.56 -47.42 85.61 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.726 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HE2' HG12 ' A' ' 22' ' ' VAL . 57.2 mtmt -63.04 -41.16 99.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 110.761 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 83' ' ' ARG . 90.6 m -65.16 -49.51 69.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.073 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' HA ' HG11 ' A' ' 86' ' ' VAL . 56.6 tp -68.67 -46.5 68.9 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.8 -44.6 95.73 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.15 -41.07 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.873 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 76.7 mt -64.01 -44.38 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.62 HD22 ' HB2' ' A' ' 40' ' ' TYR . 80.4 mt -69.13 -34.45 75.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 48.7 mt-10 -81.88 -11.86 58.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -122.26 -61.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.4 mm-40 -64.69 -40.56 95.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.37 29.82 7.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -56.79 128.07 34.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 111.719 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 -1.89 88.36 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.559 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.61 -41.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.486 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 32' ' ' LEU . 38.0 m-85 -115.55 144.44 43.87 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.294 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.93 124.78 50.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -95.39 129.95 42.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.372 0.606 . . . . 0.0 112.455 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.6 mptp? -127.87 114.55 17.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.207 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -102.47 128.05 55.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.518 0.675 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -109.96 115.88 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -86.99 102.04 14.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.4 m -65.27 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.3 -39.38 74.85 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.81 -37.81 73.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.646 0.26 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -129.01 86.33 57.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.48 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -61.52 -29.0 83.99 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.891 2.394 . . . . 0.0 112.579 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.735 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.9 tt0 -62.42 -43.8 97.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.63 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.16 -36.58 74.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.177 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.87 -41.85 97.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.615 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.17 -38.51 85.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.408 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.84 -40.65 93.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.303 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -97.15 9.84 41.06 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.907 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm 50.56 51.39 16.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.694 . . . . 0.0 112.843 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.02 105.51 15.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.11 1.45 24.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.18 150.54 36.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -146.21 146.88 29.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.981 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.12 148.25 81.66 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.404 -1.498 . . . . 0.0 111.791 -1.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -123.49 128.74 50.22 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 80' ' ' LEU . 26.7 tp -102.6 120.36 40.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.895 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.65 136.05 28.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.43 0.633 . . . . 0.0 111.881 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.4 ttpp -99.83 104.66 16.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.2 m -80.31 -28.73 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.675 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.7 mt -136.93 138.29 25.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.66 157.4 97.69 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.481 -1.466 . . . . 0.0 112.305 -1.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.92 154.69 70.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.662 2.241 . . . . 0.0 111.927 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.86 164.99 86.13 Favored 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 124.138 -1.192 . . . . 0.0 113.412 0.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 68' ' ' VAL . 96.5 t -71.29 127.49 33.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.058 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 mmm180 -102.01 114.03 27.78 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -101.2 121.81 42.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 109.655 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 93' ' ' LEU . 52.0 mt -111.87 118.18 56.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.041 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.06 125.24 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.55 -165.32 38.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.715 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.26 101.64 11.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.6 mt -89.84 -0.26 57.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.955 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 m -71.0 -15.96 62.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.202 0.525 . . . . 0.0 110.135 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -91.66 119.18 31.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.202 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -59.79 -36.56 76.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.617 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.74 -46.08 90.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.28 -40.21 95.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' LEU . 73.4 t -62.71 -43.13 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 35' ' ' GLU . 1.5 mt -67.54 -45.48 75.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.682 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.58 -47.36 93.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.549 0.214 . . . . 0.0 111.361 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -64.06 -41.36 97.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.557 0.218 . . . . 0.0 111.276 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.8 -39.66 83.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.885 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.89 -45.8 90.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.89 -40.18 94.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.354 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' ILE . 91.9 mt -64.93 -41.0 95.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.954 0.407 . . . . 0.0 110.297 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.18 90.15 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.483 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.72 -38.32 87.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.049 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.15 -40.77 98.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.358 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 8' ' ' ALA . 86.2 mt -69.41 -43.73 80.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.92 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.51 -22.9 71.76 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.748 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.46 -39.2 92.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -69.21 123.88 22.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -89.75 147.18 23.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.54 -42.5 99.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.252 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.38 158.13 36.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.093 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.26 -30.53 70.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.383 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.96 -75.77 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.673 0.608 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.797 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.015 0.436 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.68 110.72 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.92 145.25 98.78 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.949 2.433 . . . . 0.0 112.557 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.7 mt -106.29 142.48 35.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -104.98 157.04 17.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.69 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -63.05 -38.71 92.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -77.86 123.29 26.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.259 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.15 152.4 22.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.929 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 69' ' ' LEU . 63.2 t -112.04 124.44 68.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.089 0.471 . . . . 0.0 110.32 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -113.14 132.68 55.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.677 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.0 mttt -115.69 129.08 56.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.329 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.29 123.88 49.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.5 m-85 -100.71 119.51 38.7 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.57 161.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.946 0.403 . . . . 0.0 111.635 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.72 103.53 10.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.889 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.45 48.35 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.713 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.55 50.19 2.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.62 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.6 p -72.99 154.02 90.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.736 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.62 -32.68 95.13 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.8 p-10 -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.9 m -67.81 -42.74 81.06 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.19 -45.72 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 63.6 ttt180 -62.39 -46.75 87.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.28 94.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.533 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.2 tp -61.94 -46.05 91.01 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.22 -41.3 99.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 110.543 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 83' ' ' ARG . 89.9 m -63.92 -45.71 88.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.132 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -68.56 -50.31 52.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.89 -43.97 97.76 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.46 85.62 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.219 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.21 -43.94 97.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.789 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 40' ' ' TYR . 78.9 mt -71.25 -26.63 62.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.0 mt-10 -89.2 -3.51 58.55 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -130.25 -61.88 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 111.084 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.1 mm-40 -65.04 -41.17 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.524 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.58 30.06 6.37 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.0 ttpt -61.81 127.95 33.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.13 80.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.905 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.58 -40.55 5.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.951 0.376 . . . . 0.0 111.403 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 32' ' ' LEU . 40.7 m-85 -115.84 144.88 43.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.21 125.1 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.7 tp -97.58 127.88 43.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.4 mptt -122.6 136.97 55.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.953 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.9 132.37 70.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.734 0.778 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.79 105.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.173 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -77.25 103.14 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' CB ' ' A' ' 54' ' ' ALA . 55.3 t -61.29 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.113 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.64 -37.39 79.65 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.0 -41.12 74.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.896 0.379 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -126.92 82.78 67.22 Favored Pre-proline 0 CA--C 1.517 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 110.867 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.85 -32.82 95.93 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.253 2.635 . . . . 0.0 112.632 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.744 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.14 -42.23 99.43 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.5 -37.53 74.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.081 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.659 ' CB ' HG13 ' A' ' 47' ' ' VAL . . . -64.1 -41.6 97.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.985 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.57 -36.37 80.78 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.663 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 96.2 mt-10 -59.58 -39.28 83.6 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -98.29 7.83 45.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.578 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 49.72 53.34 12.92 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.81 107.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.586 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -104.98 -10.86 16.96 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.905 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.04 137.39 39.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 0.0 111.023 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.6 p -134.41 148.48 67.78 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.0 Cg_endo -76.27 152.4 96.16 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.777 -1.759 . . . . 0.0 112.717 -1.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.62 123.95 45.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.275 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 10' ' ' LEU . 53.7 tp -105.01 117.75 34.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.19 137.18 34.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.564 0.697 . . . . 0.0 111.816 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.3 ttpp -93.23 103.35 15.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.73 HG13 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -79.24 -30.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.73 ' HG ' HG13 ' A' ' 68' ' ' VAL . 91.1 mt -138.04 143.0 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.02 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 98.7 Cg_endo -77.74 156.4 95.37 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.476 -1.468 . . . . 0.0 112.353 -1.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 43.7 Cg_exo -60.4 150.48 80.57 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.398 . . . . 0.0 112.146 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.85 166.82 80.17 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.507 0.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 86.5 t -73.17 125.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -108.54 117.42 34.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.6 mtm105 -99.89 121.65 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.686 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 93' ' ' LEU . 67.9 mt -104.26 116.03 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.623 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.99 125.7 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.864 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.17 -162.47 36.25 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.609 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.39 99.12 9.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.88 -5.8 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.792 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.457 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 48.7 m -68.56 -19.88 64.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.479 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.36 120.07 30.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.702 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.929 -178.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.4 -44.47 95.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.42 -41.25 96.71 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.08 -46.14 94.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.677 0.275 . . . . 0.0 110.559 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.01 -47.63 76.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.717 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.31 -46.85 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.04 98.83 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.538 0.209 . . . . 0.0 111.4 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.92 -39.0 87.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.588 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -64.07 -45.25 89.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -39.66 95.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 76' ' ' ILE . 88.4 mt -65.42 -40.33 93.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 110.549 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.56 91.64 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.851 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.93 -39.18 91.17 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.92 -40.82 97.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.466 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.575 HD13 ' HB2' ' A' ' 8' ' ' ALA . 94.8 mt -66.47 -45.57 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.736 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -36.2 93.04 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.86 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -106.61 35.82 2.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -88.7 118.6 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.29 142.84 42.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.29 103.35 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.539 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.11 103.21 15.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.799 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -96.16 7.71 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 t70 69.79 -65.85 0.29 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.417 0.687 . . . . 0.0 111.911 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.75 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 120.84 79.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.691 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.53 142.6 99.15 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.833 2.355 . . . . 0.0 112.777 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.99 152.65 19.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -77.95 125.99 30.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.652 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm 69.63 -49.03 0.62 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.655 0.782 . . . . 0.0 112.999 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -82.71 127.01 33.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.381 0.61 . . . . 0.0 111.972 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.39 153.84 20.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.345 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.0 t -108.15 123.67 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.273 0.558 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD21 HD11 ' A' ' 90' ' ' LEU . 33.6 tp -114.91 126.1 54.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.7 mttt -114.07 138.37 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.382 0.61 . . . . 0.0 111.635 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.18 124.43 52.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.399 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.8 m-85 -99.32 119.93 38.73 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 47' ' ' VAL . 23.1 m -127.17 161.48 34.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.95 0.405 . . . . 0.0 111.792 -178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.41 104.1 10.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.78 -131.82 49.13 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.755 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -129.68 48.28 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.368 0.604 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.509 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.8 p -71.95 153.63 92.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.72 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 16.1 Cg_endo -57.86 -32.1 94.14 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.396 2.064 . . . . 0.0 112.679 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.3 p-10 -69.8 -42.86 73.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.5 m -69.13 -42.15 76.39 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.69 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 55.7 t -64.51 -45.05 96.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.338 . . . . 0.0 110.545 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.5 tpt180 -61.39 -47.62 84.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.69 98.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.277 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.74 -46.39 89.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.254 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 22' ' ' VAL . 75.8 mmtt -64.13 -40.76 96.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.575 HG23 ' HG2' ' A' ' 83' ' ' ARG . 89.1 m -65.02 -45.29 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.255 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.1 mm? -68.94 -50.2 51.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.86 -44.03 97.65 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -62.33 -45.43 93.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.769 0.318 . . . . 0.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.6 mt -64.1 -45.74 95.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.804 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 42' ' ' LEU . 77.7 mt -68.38 -35.04 77.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.0 mt-10 -67.82 -34.13 76.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.61 -55.83 2.45 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.655 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.3 mp0 -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.7 m-85 -122.13 29.03 7.21 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 65.4 tttm -58.6 124.85 21.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 -7.48 81.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.8 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.41 -44.65 7.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.535 0.668 . . . . 0.0 111.762 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -113.7 142.09 46.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.763 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.17 124.61 48.92 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HD13 ' A' ' 32' ' ' LEU . 66.2 tp -96.01 125.67 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CB ' ' HG2' ' A' ' 11' ' ' LYS . 1.4 mptp? -123.07 138.64 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.027 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.5 131.56 72.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.673 0.749 . . . . 0.0 110.992 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.36 103.85 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.343 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -76.59 103.89 6.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.5 m -67.48 -33.1 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.37 -38.27 71.58 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.948 -0.47 . . . . 0.0 111.623 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -70.38 -41.53 72.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -129.29 73.94 81.33 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.68 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.29 -22.76 75.53 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.812 2.342 . . . . 0.0 112.715 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.37 -40.73 98.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.15 -36.27 71.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.802 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.46 97.7 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.13 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.89 -38.36 86.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.97 -40.17 92.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -96.83 8.68 43.8 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.957 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.59 53.06 13.4 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.8 mm -89.07 109.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.6 mt -106.98 -5.64 18.02 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.39 143.23 30.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.562 0.22 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.4 p -136.44 148.84 65.61 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.5 Cg_endo -76.4 152.19 95.72 Favored 'Cis proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.801 -1.749 . . . . 0.0 112.698 -1.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.89 124.67 45.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.466 178.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.0 tp -104.52 118.73 37.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.35 138.63 31.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.494 0.664 . . . . 0.0 111.973 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 3.3 ttpp -99.68 104.28 16.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 73' ' ' VAL . 29.7 m -78.7 -29.06 14.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.812 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.65 136.11 24.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.028 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 3.0 Cg_exo -79.83 147.37 77.45 Favored 'Cis proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.454 -1.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 32.3 Cg_exo -61.84 154.62 59.9 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.052 2.502 . . . . 0.0 111.74 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 19.2 Cg_exo -68.71 159.84 85.65 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.997 -0.835 . . . . 0.0 113.747 0.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' VAL . 99.5 t -72.72 126.97 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.62 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -105.88 118.88 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.077 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 98.5 mtt180 -104.73 124.2 48.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 93' ' ' LEU . 71.3 mt -105.74 117.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.013 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.94 127.64 75.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.751 0.31 . . . . 0.0 110.879 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.48 -158.91 32.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -82.76 97.09 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.04 -5.95 59.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.1 m -69.16 -21.46 63.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.235 0.54 . . . . 0.0 110.11 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.3 t-20 -85.14 118.63 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.602 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.575 ' HG2' HG23 ' A' ' 27' ' ' THR . 81.1 mtp180 -60.36 -37.08 79.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.272 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 41.8 mt-10 -60.49 -43.79 96.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.15 97.34 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.17 -43.54 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.816 0.341 . . . . 0.0 110.517 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 ' HG2' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -67.91 -48.5 65.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.373 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.31 -46.19 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.26 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.34 -40.87 98.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.038 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.7 mp -67.58 -38.35 83.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.23 -42.18 96.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.43 -39.7 94.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.282 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD11 HD11 ' A' ' 76' ' ' ILE . 86.7 mt -65.49 -40.75 93.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.747 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 97' ' ' ILE . . . -63.56 -39.1 93.54 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.717 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.77 -37.99 88.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.31 -39.6 93.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.35 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 94' ' ' ALA . 76.0 mt -62.56 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.023 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.71 93.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.415 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.72 -40.57 92.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.775 0.322 . . . . 0.0 111.404 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.79 109.56 17.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -111.05 127.98 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.523 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.59 106.77 4.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.607 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -89.49 105.23 17.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.75 13.19 31.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -90.45 103.64 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.608 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.412 179.807 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.87 71.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.59 156.88 57.12 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.742 2.295 . . . . 0.0 112.776 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.8 mt -104.22 137.59 41.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.67 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -76.45 151.91 36.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.52 -39.13 93.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.77 123.6 30.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -96.31 153.73 17.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.076 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.19 122.34 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.55 . . . . 0.0 110.408 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 32' ' ' LEU . 44.7 tp -114.13 126.56 55.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.7 mttt -113.3 136.02 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.503 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.37 124.92 53.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.917 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 92.0 m-85 -100.94 120.35 40.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 25' ' ' LEU . 15.8 m -125.18 159.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.85 0.357 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.66 -151.17 50.35 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -115.41 42.4 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 0.0 111.112 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.4 p -70.93 156.92 91.38 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -53.85 -37.11 84.89 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.172 1.915 . . . . 0.0 112.667 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -65.37 -45.56 83.63 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.234 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -67.13 -43.64 81.88 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.185 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.42 -44.47 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.692 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.4 tpt180 -62.06 -47.06 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.95 94.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.97 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 14' ' ' VAL . 58.6 mt -63.49 -43.28 97.74 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.85 -40.74 97.29 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.606 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 83' ' ' ARG . 85.1 m -66.68 -44.79 80.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.222 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -69.99 -50.79 38.08 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.82 -44.88 95.97 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.86 -44.32 93.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.339 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.9 mt -63.28 -45.29 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.368 . . . . 0.0 111.251 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 40' ' ' TYR . 77.0 mt -68.46 -35.74 77.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.1 mt-10 -69.82 -29.66 66.98 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -114.2 -55.3 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -65.36 -40.82 94.07 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.36 28.18 7.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 24.3 tptm -58.62 126.91 29.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 111.631 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -9.22 78.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.735 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.01 -45.08 6.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 117.5 0.65 . . . . 0.0 111.724 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -114.44 141.7 47.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.685 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.18 126.87 51.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HB2' HD13 ' A' ' 32' ' ' LEU . 67.9 tp -97.65 127.41 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.392 0.615 . . . . 0.0 112.545 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -122.98 137.85 54.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.881 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.37 131.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.816 0.817 . . . . 0.0 110.953 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.94 104.75 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.869 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -77.05 104.65 7.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.596 HG13 ' CB ' ' A' ' 54' ' ' ALA . 53.5 t -61.42 -43.18 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.23 -40.47 77.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.46 -38.15 71.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.177 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -128.92 72.32 81.77 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.73 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.74 -23.98 76.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.689 2.259 . . . . 0.0 112.808 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.755 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.5 -41.78 98.54 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.11 -37.08 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.596 ' CB ' HG13 ' A' ' 47' ' ' VAL . . . -63.57 -42.27 98.32 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.82 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.02 -37.59 84.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.376 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.6 mt-10 -60.2 -39.62 87.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.003 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.05 10.21 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.809 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.55 52.09 15.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.15 108.01 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -104.85 -11.0 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.912 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.93 138.68 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.628 0.251 . . . . 0.0 111.057 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -133.55 148.71 69.8 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 59.5 Cg_endo -75.03 151.87 97.43 Favored 'Cis proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.79 -1.754 . . . . 0.0 112.665 -1.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.07 124.28 45.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.609 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.49 118.3 36.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.36 138.85 31.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -100.8 105.01 16.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 73' ' ' VAL . 28.3 m -80.18 -29.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -135.62 137.18 25.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.202 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.65 156.1 95.59 Favored 'Cis proline' 0 C--N 1.347 0.481 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.538 -1.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.99 156.21 66.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.783 2.322 . . . . 0.0 112.13 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.8 163.11 89.75 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.193 -1.169 . . . . 0.0 113.585 0.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 68' ' ' VAL . 98.3 t -70.51 127.54 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HG2' HD21 ' A' ' 93' ' ' LEU . 17.1 tpt180 -107.04 118.55 37.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 88.9 mtm180 -104.4 122.16 44.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.363 0.602 . . . . 0.0 110.395 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 93' ' ' LEU . 70.0 mt -104.83 117.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.851 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.2 mm -116.96 126.29 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.71 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.24 -162.95 36.74 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.868 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -82.28 99.91 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.36 -5.41 59.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.187 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.57 -20.0 63.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 110.089 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -87.17 118.26 26.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.339 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.66 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.91 -35.87 75.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.707 -178.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.14 -44.75 94.7 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -41.2 96.31 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.8 -46.26 94.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.95 -47.6 77.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.671 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.89 -46.8 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.58 -40.93 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.11 -36.88 82.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.09 -45.83 91.76 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.03 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.4 -39.42 93.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.174 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD11 HD11 ' A' ' 76' ' ' ILE . 86.6 mt -66.47 -40.78 89.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.934 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.45 79.14 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.541 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.53 -41.77 97.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.521 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -62.75 -40.37 97.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.277 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 8' ' ' ALA . 88.5 mt -66.01 -45.56 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.824 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.8 92.48 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.61 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.17 -39.65 93.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.688 0.28 . . . . 0.0 111.455 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -80.96 115.42 20.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.186 0.517 . . . . 0.0 110.691 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.65 141.99 44.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.672 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -81.16 120.0 24.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.348 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 59.3 52.23 6.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.649 0.593 . . . . 0.0 111.904 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.64 13.35 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.4 103.05 15.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.441 179.867 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.87 121.48 77.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.36 152.43 60.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.62 2.213 . . . . 0.0 112.941 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.09 150.64 35.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -62.35 -38.83 91.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.391 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -63.24 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.982 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -76.3 124.56 27.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.359 0.599 . . . . 0.0 111.709 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.26 19.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.619 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.65 127.25 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 111.75 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.446 HD22 HD11 ' A' ' 65' ' ' LEU . 11.1 mt -112.82 133.74 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.737 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.0 mttt -113.73 127.36 56.0 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.111 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.08 121.72 44.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.254 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.0 m-85 -98.98 117.34 33.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 47' ' ' VAL . 31.2 m -126.79 160.57 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.063 0.459 . . . . 0.0 111.563 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.47 104.48 11.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.688 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.5 -129.24 44.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.204 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.9 52.45 1.99 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.016 0.436 . . . . 0.0 110.89 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -74.11 157.53 86.73 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.479 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -54.22 -36.84 87.31 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.132 1.888 . . . . 0.0 112.608 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.45 -46.23 80.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 110.209 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -66.26 -43.75 85.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.227 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 26' ' ' LYS . 55.2 t -64.89 -44.36 96.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.833 0.349 . . . . 0.0 110.636 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -62.1 -48.25 81.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.634 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.23 99.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.248 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.52 -47.32 86.14 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.228 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 22' ' ' VAL . 57.1 mtmt -64.36 -40.39 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.821 0.343 . . . . 0.0 110.95 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.726 HG23 ' HG2' ' A' ' 83' ' ' ARG . 91.2 m -65.22 -45.59 84.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.042 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -73.6 -45.7 51.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.35 -43.46 98.83 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -64.12 -43.03 96.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.034 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.641 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 64.2 mt -62.88 -45.96 97.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 111.312 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CB ' ' A' ' 40' ' ' TYR . 87.2 mt -67.87 -37.36 81.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.215 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.13 -37.41 78.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -106.2 -57.47 2.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.641 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 21.1 mp0 -62.84 -40.54 97.73 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD1' HD12 ' A' ' 90' ' ' LEU . 98.4 m-85 -122.8 31.27 6.11 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttmt -50.22 123.9 9.3 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.392 0.433 . . . . 0.0 112.143 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.78 0.85 89.89 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.358 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -106.9 -44.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.964 0.882 . . . . 0.0 111.7 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.544 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.1 m-85 -116.51 144.73 43.97 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.02 125.58 51.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.021 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -98.41 124.54 43.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.503 . . . . 0.0 111.602 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -121.78 118.81 29.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.34 130.56 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.768 0.794 . . . . 0.0 111.174 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -112.91 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.177 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.24 105.07 8.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 14' ' ' VAL . 25.4 m -69.53 -31.64 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.19 -39.79 75.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.01 -37.2 72.64 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.273 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -129.09 85.97 58.39 Favored Pre-proline 0 CA--C 1.515 -0.37 0 CA-C-O 121.108 0.48 . . . . 0.0 110.434 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.28 -28.39 78.91 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.999 2.466 . . . . 0.0 112.489 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.26 -41.75 99.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.46 -36.26 73.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.888 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.11 96.86 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.084 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.28 -38.3 84.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.612 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.31 -40.16 89.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.355 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -98.39 9.12 43.81 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.842 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp 49.03 53.55 12.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.38 0.672 . . . . 0.0 112.81 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.0 mm -87.78 108.22 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.07 1.51 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.69 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.41 148.81 36.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.402 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.0 p -147.31 142.21 16.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.79 151.12 84.23 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.092 -1.628 . . . . 0.0 112.467 -1.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -128.75 131.64 47.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.345 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 28' ' ' LEU . 63.1 tp -106.27 120.28 41.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -137.77 134.64 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 111.184 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 22.0 ttpp -91.83 104.14 16.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 ' HE3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -82.19 -24.11 9.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.245 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 70' ' ' PRO . 29.6 tp -139.41 131.89 15.29 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.816 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.788 ' HA ' HD12 ' A' ' 69' ' ' LEU . 6.0 Cg_exo -81.44 152.02 78.65 Favored 'Cis proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.485 -1.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 59.2 Cg_endo -71.06 159.49 52.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.714 2.276 . . . . 0.0 111.629 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 36.9 Cg_exo -63.69 155.21 71.92 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 125.097 -0.793 . . . . 0.0 113.611 0.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 92.9 t -69.25 124.9 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -102.15 116.15 32.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -99.62 124.97 45.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.272 0.558 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.677 HD11 HD11 ' A' ' 93' ' ' LEU . 69.0 mt -108.56 117.48 54.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.837 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.83 126.71 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -163.19 36.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.811 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -82.16 98.81 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.64 -7.68 58.11 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.4 p -68.21 -19.61 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.233 0.539 . . . . 0.0 110.385 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.82 116.8 23.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.112 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.49 -36.91 79.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.091 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -60.07 -44.61 94.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.83 -41.31 97.87 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.093 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 79.5 t -64.52 -44.76 96.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.256 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.0 tp -66.01 -45.49 81.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -62.12 -46.44 96.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.586 0.231 . . . . 0.0 110.755 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.04 96.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.588 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.44 -45.84 91.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.025 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.79 -39.96 95.49 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.217 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 76' ' ' ILE . 89.5 mt -65.53 -41.07 93.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.101 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.49 91.19 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.628 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.06 -36.53 81.93 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 110.324 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.27 -40.22 93.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.233 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.59 -43.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.6 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.92 89.81 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.781 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.81 -40.26 92.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.01 107.68 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.809 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.54 142.15 44.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -151.97 173.05 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -101.67 101.92 12.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -104.14 13.22 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.299 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -89.14 103.89 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.69 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.913 0.387 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . . . -61.74 -50.3 82.4 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 2' ' ' ALA . 44.2 Cg_exo -60.42 143.04 99.45 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.171 1.914 . . . . 0.0 112.729 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.2 145.19 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -126.47 154.08 44.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -64.05 -38.8 92.4 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.108 0.48 . . . . 0.0 110.805 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.96 121.52 27.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.997 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -87.48 151.9 22.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.077 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.4 t -111.82 124.14 68.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.83 128.06 56.25 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.574 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.2 mttt -112.92 130.3 56.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.45 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -107.48 124.32 49.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.486 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 97.3 m-85 -99.66 117.4 33.94 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.2 m -125.36 161.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.076 0.465 . . . . 0.0 111.628 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.13 100.89 8.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.01 -135.51 50.41 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.839 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -123.72 44.67 2.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -70.62 155.2 93.75 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.8 -38.27 85.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.009 1.806 . . . . 0.0 112.805 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.85 -43.8 91.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.342 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -68.41 -43.55 76.96 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.146 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.41 -46.04 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.796 0.331 . . . . 0.0 110.812 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NE ' ' HB2' ' A' ' 81' ' ' SER . 69.8 ttt180 -61.94 -47.24 85.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.711 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.84 97.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.079 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.27 -45.45 94.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -63.84 -40.64 97.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.331 . . . . 0.0 110.403 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.732 HG23 ' HG2' ' A' ' 83' ' ' ARG . 88.7 m -66.0 -45.58 81.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.03 -50.2 36.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.37 -43.95 98.0 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.97 -42.63 94.41 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.22 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 -45.04 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD13 ' HB2' ' A' ' 42' ' ' LEU . 54.7 mt -68.19 -35.17 77.58 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt-10 -85.78 -5.53 59.24 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -62.21 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.043 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.02 -41.04 97.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.34 30.25 6.37 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.79 128.56 37.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.75 -8.44 79.79 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.178 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.81 -42.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.153 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -115.02 143.61 44.91 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.977 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 125.57 50.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 32' ' ' LEU . 65.7 tp -97.52 126.4 42.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.435 0.636 . . . . 0.0 112.657 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -121.74 137.76 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.783 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.37 131.3 72.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.681 0.753 . . . . 0.0 110.998 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.65 104.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.401 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -77.04 103.72 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.0 m -67.94 -33.75 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.53 -37.09 74.05 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.516 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.22 -40.82 74.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -126.97 83.81 64.98 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 -31.67 93.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.363 2.709 . . . . 0.0 112.595 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.738 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -62.98 -41.54 99.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.517 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.5 mt -70.39 -36.63 74.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.85 97.47 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.813 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.22 -38.13 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.382 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.1 mt-10 -60.57 -40.56 92.15 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.455 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.59 8.93 43.75 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.027 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 50.97 52.01 15.88 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.442 0.697 . . . . 0.0 112.759 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.22 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.03 -6.34 18.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.102 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.16 142.26 30.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.535 0.207 . . . . 0.0 111.191 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.0 p -137.33 147.69 59.07 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.384 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 66.5 Cg_endo -76.85 152.99 95.92 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.819 -1.742 . . . . 0.0 112.646 -1.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -121.52 129.74 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.131 179.044 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 12' ' ' LEU . 75.9 mt -103.62 118.53 36.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -141.93 132.0 24.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.63 0.729 . . . . 0.0 111.518 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.5 ttmt -94.8 104.54 16.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.8 m -80.42 -28.44 11.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.117 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -138.31 140.41 28.34 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 10.1 Cg_exo -74.78 151.42 96.91 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.289 -1.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 38.1 Cg_exo -60.87 151.6 76.3 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.944 2.429 . . . . 0.0 112.001 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.79 169.34 73.79 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.583 0.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 93.0 t -72.75 126.49 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -109.62 119.76 40.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.3 mtm105 -102.68 122.39 44.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.961 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 93' ' ' LEU . 74.9 mt -103.57 115.37 45.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.675 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.18 127.68 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.85 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.34 32.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.737 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -81.41 96.03 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -4.57 57.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.394 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.497 ' HB2' ' NE ' ' A' ' 23' ' ' ARG . 97.2 p -68.28 -20.68 64.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -86.72 121.42 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.44 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.0 mtm-85 -60.26 -36.37 77.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.538 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.64 -44.31 96.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.06 -40.21 94.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.552 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.1 -43.73 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.42 -48.49 64.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.91 -47.52 92.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.668 0.27 . . . . 0.0 111.308 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.43 -39.76 85.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -61.83 -44.38 96.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.581 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.79 -39.1 93.18 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 76' ' ' ILE . 87.6 mt -65.64 -40.42 92.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 110.56 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.52 -37.98 89.39 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.704 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.32 -37.71 84.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 110.025 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.14 -41.36 98.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.312 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.1 mt -70.52 -43.42 77.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.719 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.09 -35.12 91.01 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.89 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.09 -39.61 90.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.697 0.284 . . . . 0.0 111.484 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.81 117.59 23.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 110.557 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -111.03 138.6 47.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.516 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -139.05 109.08 6.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -156.67 160.19 39.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.0 -29.7 69.6 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -154.36 162.12 41.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.833 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.77 120.78 75.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.134 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.98 154.83 57.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.771 2.314 . . . . 0.0 112.912 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.95 134.48 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 169.91 19.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.655 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -63.39 -39.02 93.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.28 122.2 28.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.358 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.54 18.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.543 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.7 t -108.15 122.07 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.185 0.517 . . . . 0.0 110.559 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 32' ' ' LEU . 42.0 tp -114.24 125.16 53.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.8 mttt -112.29 137.43 50.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.362 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.54 123.8 50.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.11 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.9 m-85 -98.86 120.92 40.12 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 25' ' ' LEU . 17.0 m -126.38 160.57 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.36 106.56 13.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.226 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.23 -130.96 47.64 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.536 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -134.86 48.39 2.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -74.37 158.46 85.26 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.779 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -54.11 -37.51 87.08 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.089 1.859 . . . . 0.0 112.658 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -65.01 -45.26 86.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.886 0.374 . . . . 0.0 110.02 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.3 m -66.75 -43.69 83.44 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.058 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.08 -46.4 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 0.0 110.486 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -62.4 -46.72 87.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -63.49 -44.39 94.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.081 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD23 HD13 ' A' ' 12' ' ' LEU . 66.8 mt -63.53 -41.75 98.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.59 -40.46 96.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.291 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 83' ' ' ARG . 85.5 m -66.24 -45.1 81.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.48 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -50.9 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.69 -45.23 94.86 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.39 -43.36 94.72 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.213 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.3 mt -63.05 -45.1 99.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.824 0.345 . . . . 0.0 111.071 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.471 HD11 HD23 ' A' ' 10' ' ' LEU . 77.6 mt -68.94 -36.22 77.69 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.3 mt-10 -70.85 -27.31 63.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -114.27 -58.92 2.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.08 -40.93 97.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.83 28.7 7.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 88.2 tttt -58.63 127.65 33.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 111.541 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.13 -8.51 79.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.506 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.5 -44.91 6.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 117.455 0.627 . . . . 0.0 111.611 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.0 m-85 -115.04 143.26 45.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.091 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.97 125.1 50.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 tp -96.89 126.72 42.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.274 0.559 . . . . 0.0 112.023 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 mptp? -123.46 118.13 26.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.951 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.07 129.23 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.761 . . . . 0.0 110.704 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mm -113.45 105.25 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.3 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -77.78 102.76 7.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.67 -33.77 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.57 -38.38 70.95 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.01 -0.431 . . . . 0.0 111.603 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.76 -40.68 72.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.46 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.06 73.67 81.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.612 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.45 -22.91 75.76 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.769 2.313 . . . . 0.0 112.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.36 -41.04 98.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.18 -36.42 71.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.847 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.32 97.74 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.275 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.97 -38.48 86.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.177 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -61.09 -40.03 92.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -96.68 9.17 42.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.88 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 51.08 52.13 15.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.5 mm -88.23 108.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.28 -6.53 18.34 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.063 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.61 140.3 31.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.522 0.201 . . . . 0.0 111.149 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.6 p -134.9 149.1 69.58 Favored Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.594 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.9 Cg_endo -75.68 151.29 95.72 Favored 'Cis proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.744 -1.773 . . . . 0.0 112.698 -1.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.89 125.31 48.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.73 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.98 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.31 139.65 31.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.514 0.673 . . . . 0.0 112.079 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.68 104.73 15.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.7 m -80.02 -28.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -136.1 139.22 29.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.381 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.04 153.11 96.01 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.483 -1.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.69 156.24 64.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 111.795 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.64 166.45 82.01 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.301 -1.124 . . . . 0.0 113.449 0.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 68' ' ' VAL . 92.9 t -70.3 126.99 31.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -105.59 114.99 29.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 89.0 mtm180 -102.87 122.03 43.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.256 0.551 . . . . 0.0 110.863 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 93' ' ' LEU . 66.0 mt -101.91 115.74 44.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.346 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.67 122.84 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.98 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.81 -166.15 38.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.48 96.22 10.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.457 . . . . 0.0 109.856 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -89.89 11.11 21.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.823 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.6 m -72.66 -21.61 61.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 110.008 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -85.76 124.25 32.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.948 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.761 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.74 -37.32 81.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.727 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -59.58 -47.59 84.97 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.97 -39.35 93.95 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.749 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG21 HG22 ' A' ' 27' ' ' THR . 60.8 t -62.13 -44.2 98.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 35' ' ' GLU . 3.8 mt -66.13 -44.33 84.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.318 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.03 -47.9 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.508 0.194 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -64.54 -42.44 95.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.458 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.43 -38.23 80.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.77 -46.57 88.99 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 86.4 mt -64.67 -39.74 94.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 76' ' ' ILE . 86.8 mt -66.25 -39.73 89.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.258 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.57 79.1 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.51 -39.39 90.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.41 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 79.3 mm-40 -61.22 -40.29 93.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.708 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.94 -46.54 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.742 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.92 -36.22 93.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.518 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.06 -40.38 96.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -69.84 126.94 31.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.306 0.574 . . . . 0.0 110.637 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -111.28 143.94 41.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.684 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.13 -42.02 99.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -155.26 160.75 41.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.98 -29.82 69.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.416 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -154.89 162.5 41.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.205 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.844 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.0 mtp . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.003 0.43 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.47 122.4 85.89 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -59.3 141.58 97.94 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.813 2.342 . . . . 0.0 112.692 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 66.8 mt -109.01 143.1 38.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.418 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.7 mpt_? -95.94 138.52 33.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.597 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.6 -70.75 0.14 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.876 0.735 . . . . 0.0 111.819 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -79.29 126.75 31.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.0 111.499 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -116.11 153.93 30.88 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.598 179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.61 123.68 63.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.228 0.537 . . . . 0.0 110.312 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.53 129.74 56.25 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.677 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.4 mttt -116.2 133.3 56.18 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.733 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.16 126.89 55.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.369 178.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 98.6 m-85 -99.86 118.78 37.05 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 21' ' ' SER . 19.5 m -125.99 160.34 33.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.29 102.85 9.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.061 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.16 -132.7 48.69 Favored Glycine 0 C--N 1.332 0.321 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.699 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -129.96 45.84 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.692 0.282 . . . . 0.0 111.403 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -71.27 155.89 92.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.7 Cg_exo -54.47 -37.21 89.82 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 121.997 1.798 . . . . 0.0 112.703 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -64.97 -44.95 87.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.943 -0.303 . . . . 0.0 110.584 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 14' ' ' VAL . 78.8 p -70.52 -40.48 73.45 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.503 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 53.5 t -64.42 -44.54 97.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.052 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.0 tpt180 -61.86 -47.21 86.05 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.411 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -44.7 95.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.869 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 12' ' ' LEU . 66.1 mt -63.63 -42.93 98.1 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 22' ' ' VAL . 75.8 mmtt -64.85 -40.9 95.91 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.246 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.751 HG23 ' HG2' ' A' ' 83' ' ' ARG . 91.4 m -65.9 -49.68 67.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.317 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' HA ' HG11 ' A' ' 86' ' ' VAL . 59.4 tp -68.99 -46.62 67.58 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.83 -43.81 97.82 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -41.59 92.2 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.876 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.504 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 75.9 mt -63.94 -44.99 98.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.0 110.751 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.691 HD22 ' HB2' ' A' ' 40' ' ' TYR . 84.7 mt -67.96 -36.01 79.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.0 mt-10 -70.2 -27.4 64.46 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -115.51 -56.01 2.39 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -65.55 -40.85 93.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -121.9 29.9 6.89 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -57.57 125.96 25.21 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.487 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.34 -7.16 82.61 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.439 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 7' ' ' THR . 46.1 t -106.09 -42.19 6.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 117.374 0.587 . . . . 0.0 111.535 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.691 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.1 m-85 -116.25 144.17 44.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.746 -0.782 . . . . 0.0 112.37 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.13 124.99 50.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.59 130.64 43.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.681 0.753 . . . . 0.0 113.029 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.26 133.03 51.57 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.22 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.8 t -119.96 128.96 75.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.424 0.63 . . . . 0.0 110.663 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -111.38 114.81 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.901 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -86.09 101.52 13.03 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.3 m -64.35 -34.79 71.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.4 mt -71.36 -39.37 71.31 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.069 -0.394 . . . . 0.0 111.792 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -70.95 -40.87 71.75 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.032 0.444 . . . . 0.0 110.743 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -128.65 73.63 80.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.653 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.46 -23.05 76.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.735 2.29 . . . . 0.0 112.701 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.25 -41.3 99.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.01 -36.69 72.52 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.734 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.31 98.1 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.201 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.92 -38.73 86.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.239 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.3 mm-40 -60.94 -40.25 92.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.4 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.28 9.2 41.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.945 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.91 51.9 16.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -88.23 107.87 18.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -107.98 2.45 23.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.743 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.69 149.33 38.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.747 0.308 . . . . 0.0 111.34 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.0 p -148.26 140.16 14.3 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.635 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.5 Cg_endo -80.07 151.95 84.11 Favored 'Cis proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.888 -1.713 . . . . 0.0 112.674 -1.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HD23 ' A' ' 12' ' ' LEU . 94.5 m -125.32 129.87 50.84 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.398 178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.6 tp -99.94 120.31 39.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.108 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.67 134.06 26.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 111.904 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 29.0 ttpt -95.17 103.7 15.56 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.755 HG13 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -77.36 -30.31 17.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.671 -177.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.755 ' HG ' HG13 ' A' ' 68' ' ' VAL . 86.7 mt -137.44 139.59 27.96 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.931 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 85.0 Cg_endo -79.58 150.84 84.61 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.576 -1.427 . . . . 0.0 112.784 -1.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 33.5 Cg_exo -61.7 152.42 74.19 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.984 2.456 . . . . 0.0 111.939 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.89 160.79 87.81 Favored 'Cis proline' 0 C--N 1.35 0.653 0 C-N-CA 124.765 -0.931 . . . . 0.0 113.558 0.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 97.0 t -71.65 125.93 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 38.3 mmt180 -97.37 113.81 25.53 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.651 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -100.49 120.45 40.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 93' ' ' LEU . 55.7 mt -110.42 118.24 56.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.013 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.87 126.82 75.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.981 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.21 -163.07 36.78 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -81.76 99.9 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -85.68 -7.18 58.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.189 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.0 m -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.0 110.158 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -83.8 117.87 23.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.311 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.751 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.05 -35.44 75.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.657 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.25 -44.45 95.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -41.43 96.04 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 28' ' ' LEU . 74.6 t -63.69 -46.54 94.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.424 178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.88 -47.43 77.88 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.96 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.8 mt -61.87 -46.27 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.19 -41.81 99.25 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.324 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.447 HD11 HD12 ' A' ' 28' ' ' LEU . 87.3 mt -65.33 -38.96 91.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.569 0.223 . . . . 0.0 110.775 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.24 -46.37 87.24 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.64 -40.03 95.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.116 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 76' ' ' ILE . 89.7 mt -65.63 -40.28 92.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.906 0.384 . . . . 0.0 110.609 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.38 -38.67 92.05 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.72 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.75 -38.68 88.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.015 0.436 . . . . 0.0 110.207 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.87 -41.05 99.24 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.288 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB2' ' A' ' 8' ' ' ALA . 92.7 mt -65.86 -45.41 91.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.839 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.87 -35.68 92.34 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.589 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.19 -39.54 93.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.739 0.304 . . . . 0.0 111.519 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -78.93 113.61 17.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.124 0.488 . . . . 0.0 110.735 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -111.92 141.53 45.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.36 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -63.22 -42.84 99.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -156.67 155.71 32.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.286 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -69.1 -29.66 67.79 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.166 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.0 t0 57.56 43.08 23.19 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.923 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.577 179.576 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.998 0.428 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.45 113.11 66.04 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.861 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -60.07 147.2 94.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.973 2.448 . . . . 0.0 112.674 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.95 2.66 56.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.827 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.25 161.48 34.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.819 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -91.31 -3.02 57.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p -87.71 126.88 35.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.201 0.524 . . . . 0.0 111.624 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.527 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.07 152.37 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.432 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.4 t -113.45 124.53 70.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.136 0.493 . . . . 0.0 111.082 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.3 mt -112.52 132.0 55.31 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.644 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -112.67 126.56 55.52 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.724 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.36 123.16 47.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.199 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.449 ' CD2' HG13 ' A' ' 59' ' ' ILE . 93.2 m-85 -99.51 119.68 38.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.1 m -124.79 159.57 31.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.981 0.42 . . . . 0.0 111.587 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.65 102.89 9.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.247 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -135.49 49.14 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.579 -0.737 . . . . 0.0 113.004 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -124.2 44.63 2.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.016 0.436 . . . . 0.0 110.669 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.0 p -70.94 154.99 93.96 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.696 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.38 -34.34 97.77 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.139 1.893 . . . . 0.0 112.259 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -65.92 -43.09 89.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.1 m -70.02 -42.72 72.59 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.065 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.76 -43.96 96.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.866 0.365 . . . . 0.0 110.457 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.6 tpt180 -62.29 -47.76 82.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.374 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.73 99.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.59 -47.8 83.83 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.534 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.77 97.5 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.723 HG23 ' HG2' ' A' ' 83' ' ' ARG . 85.6 m -66.0 -45.43 81.59 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.539 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -69.72 -50.44 43.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.1 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.91 -44.6 96.46 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -65.24 -42.8 93.02 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.247 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.27 -44.56 97.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.004 0.43 . . . . 0.0 111.095 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.671 HD22 ' HB2' ' A' ' 40' ' ' TYR . 78.8 mt -71.47 -26.31 62.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -89.66 -2.71 58.37 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.042 -0.411 . . . . 0.0 112.01 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -131.15 -62.09 0.9 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.916 0.389 . . . . 0.0 111.314 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.98 -41.42 95.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.606 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -123.76 30.2 6.27 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 29.8 ttpp -61.06 127.5 31.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.037 0.446 . . . . 0.0 111.309 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.25 -8.01 80.54 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.957 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.43 -41.98 6.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 117.051 0.425 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.671 ' HB2' HD22 ' A' ' 32' ' ' LEU . 35.4 m-85 -116.24 144.99 43.49 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.275 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.45 125.06 50.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.0 tp -96.19 128.35 43.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.346 0.593 . . . . 0.0 112.13 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -126.3 112.21 15.44 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.189 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.4 t -99.57 128.7 51.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.591 0.71 . . . . 0.0 111.028 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.8 mm -111.43 116.74 53.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.752 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -86.1 104.98 16.19 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 14' ' ' VAL . 19.4 m -68.26 -18.86 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.5 mt -90.63 -38.66 12.97 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.875 -0.516 . . . . 0.0 112.244 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.74 -37.29 73.43 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.917 0.389 . . . . 0.0 110.201 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -132.32 76.66 72.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.691 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -63.3 -20.29 70.12 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.541 2.16 . . . . 0.0 112.599 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.74 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 24.3 mp0 -62.84 -41.76 99.47 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.6 -36.6 73.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.85 98.29 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.815 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.63 -37.24 82.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.4 mt-10 -60.34 -39.92 88.85 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.57 7.84 45.72 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.994 -0.283 . . . . 0.0 110.73 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm 49.04 53.46 12.55 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.842 0.714 . . . . 0.0 112.852 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.449 HG13 ' CD2' ' A' ' 13' ' ' TYR . 47.1 mm -87.27 108.64 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.602 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -109.31 4.19 22.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.64 148.49 40.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 111.493 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 p -148.49 141.92 15.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.047 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.37 149.11 85.66 Favored 'Cis proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.661 -1.391 . . . . 0.0 111.826 -2.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.7 m -127.45 129.49 47.57 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.78 118.5 36.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.538 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.56 132.73 35.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.323 0.582 . . . . 0.0 111.02 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' HD2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -95.01 104.0 15.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 178.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.644 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.1 m -80.61 -27.62 11.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.457 -178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -136.62 138.8 27.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.484 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.461 ' HD2' ' HE2' ' A' ' 67' ' ' LYS . 16.7 Cg_exo -71.6 153.13 96.88 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.362 -2.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.11 156.81 61.58 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.655 2.237 . . . . 0.0 111.892 178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.12 165.78 83.36 Favored 'Cis proline' 0 C--N 1.351 0.681 0 C-N-CA 124.201 -1.166 . . . . 0.0 113.43 0.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.581 HG22 ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -69.46 126.2 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.145 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -105.93 115.14 29.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -96.81 125.09 41.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.184 0.516 . . . . 0.0 110.118 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 72.3 mt -109.7 117.13 53.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.872 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.8 mm -117.77 127.06 75.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.829 0.347 . . . . 0.0 110.799 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.62 -166.37 39.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.817 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -82.46 99.86 9.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.5 mt -86.28 -5.13 59.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.278 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.1 m -68.6 -23.98 64.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.243 0.544 . . . . 0.0 109.899 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -84.34 118.61 24.33 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.191 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.1 -35.68 75.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.664 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -60.74 -43.73 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.69 -40.61 95.67 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.73 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 73.3 t -64.14 -42.59 96.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.841 0.353 . . . . 0.0 110.27 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -48.46 63.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.475 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.58 -46.75 95.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.538 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -63.62 -41.25 98.3 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.531 0.205 . . . . 0.0 111.185 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.77 -37.98 82.81 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 110.586 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.08 -46.87 82.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.08 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.29 -39.57 94.2 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.44 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 89' ' ' ALA . 3.8 mm? -67.4 -39.55 85.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.602 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.36 89.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.398 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.36 -38.41 86.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.51 -40.87 98.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.359 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' A' ' 8' ' ' ALA . 94.7 mt -65.88 -45.33 91.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.79 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.14 -36.09 92.97 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.465 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.16 -39.79 95.67 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.727 0.299 . . . . 0.0 111.426 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -80.07 114.83 19.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.262 0.553 . . . . 0.0 110.795 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -111.5 144.59 40.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.585 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -89.54 103.25 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.533 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -90.97 107.66 19.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.159 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.25 -29.09 69.84 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.725 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -85.42 104.96 15.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.507 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.013 -179.933 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.9 tpp . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.633 0.254 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.28 63.18 10.04 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.333 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -70.55 150.86 64.08 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.381 2.054 . . . . 0.0 112.677 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.41 143.03 45.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.755 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -106.07 -70.14 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.445 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -91.08 -12.78 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.659 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.72 127.69 36.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.338 0.589 . . . . 0.0 111.102 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.545 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -113.26 152.89 29.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.783 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -109.62 124.25 66.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.16 0.505 . . . . 0.0 110.25 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.96 130.08 56.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.3 mttt -115.76 130.76 56.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.638 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.78 124.57 50.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.309 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.0 m-85 -100.9 119.84 39.29 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 47' ' ' VAL . 26.9 m -126.55 160.33 34.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.001 0.429 . . . . 0.0 111.628 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 104.48 11.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.413 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 62.29 -129.79 43.4 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.075 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -136.61 53.23 1.92 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.175 0.512 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -75.88 158.11 82.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.995 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.49 -37.46 89.95 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.129 1.886 . . . . 0.0 112.647 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -64.66 -44.96 88.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.941 0.401 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -66.69 -43.77 83.53 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.925 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.97 -45.72 93.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -62.3 -46.25 89.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.398 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.74 99.19 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.173 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.86 -46.87 87.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.303 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.47 -40.04 96.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.662 0.268 . . . . 0.0 110.704 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.769 HG23 ' HG3' ' A' ' 83' ' ' ARG . 90.5 m -63.89 -45.89 87.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -50.46 54.55 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.17 -43.91 97.78 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.48 -46.43 90.04 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.847 0.356 . . . . 0.0 111.128 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.617 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 70.6 mt -64.13 -44.99 97.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.665 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' HB2' ' A' ' 40' ' ' TYR . 82.1 mt -68.16 -34.59 76.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 98.5 mt-10 -66.41 -35.84 81.33 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -110.62 -56.63 2.33 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.617 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.2 mp0 -63.38 -42.0 98.82 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HD23 ' A' ' 32' ' ' LEU . 99.3 m-85 -124.09 29.96 6.26 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 30.1 ttpp -60.96 127.75 33.08 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.116 0.484 . . . . 0.0 111.464 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.12 -7.88 80.82 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.151 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.1 -42.84 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 117.219 0.51 . . . . 0.0 111.469 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.682 ' HB2' HD22 ' A' ' 32' ' ' LEU . 57.0 m-85 -116.4 145.13 43.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.66 -0.816 . . . . 0.0 112.487 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.86 125.36 50.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -96.23 129.05 43.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.347 0.594 . . . . 0.0 112.42 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -127.26 135.54 50.75 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.809 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.7 t -121.15 129.75 75.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.383 0.611 . . . . 0.0 110.983 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.67 116.26 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.651 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.57 103.51 15.14 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.6 m -66.68 -32.43 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.7 mt -70.24 -38.77 75.26 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.69 -37.53 73.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.725 0.298 . . . . 0.0 111.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -129.73 85.51 58.01 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.124 0.488 . . . . 0.0 110.339 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.85 -27.84 80.76 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 123.033 2.488 . . . . 0.0 112.579 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.735 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 70.4 tp60 -63.05 -42.24 99.67 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.348 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -70.54 -36.57 73.76 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.033 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.7 98.12 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.623 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.28 -38.11 84.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.337 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.0 mt-10 -60.42 -40.86 92.54 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.596 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -99.82 13.23 34.47 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.928 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 48.8 52.27 14.39 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.9 mm -86.75 106.17 15.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.2 mt -105.8 -6.24 19.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.939 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.45 140.98 32.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.552 0.215 . . . . 0.0 111.182 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.8 p -136.19 148.7 65.56 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.417 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.0 Cg_endo -75.16 151.77 97.11 Favored 'Cis proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.855 -1.727 . . . . 0.0 112.628 -1.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.85 124.68 45.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.499 178.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.0 tp -104.95 116.96 32.85 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.534 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.14 138.43 35.23 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.484 0.659 . . . . 0.0 111.916 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.0 ttpp -96.37 104.47 16.44 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.605 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.2 m -81.04 -28.3 11.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.253 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.95 139.11 29.47 Favored Pre-proline 0 C--N 1.331 -0.233 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.049 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 86.2 Cg_endo -78.97 155.1 91.53 Favored 'Cis proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.512 -1.453 . . . . 0.0 112.466 -1.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 42.5 Cg_exo -60.77 151.35 77.42 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.997 2.464 . . . . 0.0 112.132 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -77.43 166.75 81.06 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.144 -1.19 . . . . 0.0 113.531 0.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 68' ' ' VAL . 99.2 t -71.93 127.04 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.758 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -110.51 117.76 34.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.553 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 89.9 mtm180 -101.02 119.68 39.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.18 0.514 . . . . 0.0 110.803 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD11 HD11 ' A' ' 93' ' ' LEU . 71.4 mt -102.49 115.55 44.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.834 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.01 127.74 75.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.863 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.74 -158.86 31.75 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.07 86.64 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.31 -14.87 61.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.097 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 61.5 m -67.9 -20.57 65.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 110.402 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -84.87 117.6 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.769 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.8 OUTLIER -59.96 -35.34 74.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.686 -178.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -59.98 -44.41 94.51 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.66 -41.38 96.14 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.028 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.1 t -64.11 -46.53 93.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.641 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.463 HD13 ' HG2' ' A' ' 35' ' ' GLU . 53.2 tp -64.59 -47.5 78.44 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.67 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.51 -46.02 97.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.427 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.49 -42.63 98.54 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -66.06 -38.54 88.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.603 0.24 . . . . 0.0 110.587 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -64.76 -44.79 88.95 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.81 -40.07 94.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.918 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 76' ' ' ILE . 88.8 mt -65.08 -40.2 94.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.018 0.437 . . . . 0.0 109.976 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.09 89.8 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.618 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.31 -39.57 90.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.93 0.395 . . . . 0.0 109.946 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.487 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.545 HD13 ' HB2' ' A' ' 8' ' ' ALA . 88.9 mt -68.69 -44.41 82.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.034 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.33 -35.3 91.44 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.77 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -61.83 -39.27 91.24 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 122.443 0.297 . . . . 0.0 111.593 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -69.62 125.01 25.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.304 0.573 . . . . 0.0 110.606 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -111.45 145.39 39.06 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.551 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.62 -43.92 97.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.131 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -93.65 108.58 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.898 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.97 -29.44 70.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.747 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -87.55 102.13 14.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.784 0.326 . . . . 0.0 110.379 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.7 pttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.926 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.8 mtt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 121.016 0.436 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.2 111.91 64.18 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.941 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.62 144.13 99.5 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.898 2.398 . . . . 0.0 112.587 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.0 mt -106.53 136.19 46.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.582 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -128.84 161.34 30.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.579 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -62.0 -39.14 91.23 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.44 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.89 123.21 28.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.191 0.52 . . . . 0.0 110.916 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -98.01 152.53 19.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -111.27 124.04 67.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.315 0.579 . . . . 0.0 110.327 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.75 131.18 55.79 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.623 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -113.8 129.37 56.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.401 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.25 121.87 46.1 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.113 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB2' ' OG1' ' A' ' 64' ' ' THR . 94.6 m-85 -99.22 120.97 40.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.483 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.8 m -125.93 160.24 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 120.974 0.416 . . . . 0.0 111.365 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.34 104.93 12.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.521 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 61.76 -131.4 46.33 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.296 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -135.39 50.74 2.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.206 0.527 . . . . 0.0 110.083 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.2 p -75.12 158.69 83.91 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.972 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.4 Cg_exo -54.2 -37.47 87.74 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.035 1.823 . . . . 0.0 112.626 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.0 -45.18 90.14 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 109.89 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.8 m -66.9 -43.26 83.84 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.076 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.35 -44.45 97.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.949 0.404 . . . . 0.0 110.403 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.91 -48.6 78.25 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.542 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -44.4 96.28 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.441 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -62.27 -47.6 83.62 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.421 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -61.95 -44.34 96.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.783 HG23 ' HG3' ' A' ' 83' ' ' ARG . 86.3 m -64.93 -45.28 86.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.495 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -69.51 -50.95 40.33 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.56 -44.86 96.25 Favored 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -67.08 -41.44 86.36 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.145 -178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.4 mt -63.56 -43.79 98.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 0.0 110.703 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.653 HD22 ' HB2' ' A' ' 40' ' ' TYR . 83.5 mt -70.5 -27.76 64.44 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 98.9 mt-10 -86.12 -12.8 49.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -120.99 -61.48 1.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.009 0.433 . . . . 0.0 111.372 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 77.6 mm-40 -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.569 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -121.12 30.64 6.73 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -56.33 126.68 27.36 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.091 0.472 . . . . 0.0 111.76 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.57 -0.3 89.38 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.528 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.8 -43.03 6.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 117.421 0.61 . . . . 0.0 111.408 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.653 ' HB2' HD22 ' A' ' 32' ' ' LEU . 39.9 m-85 -115.9 144.66 43.73 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.396 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.63 124.27 49.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.2 tp -95.58 129.2 42.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.276 0.56 . . . . 0.0 112.042 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.1 mptm? -126.35 109.73 12.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.336 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.4 t -98.27 128.54 49.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.617 0.722 . . . . 0.0 110.987 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 35.9 mm -111.65 116.8 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.77 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -86.63 103.44 15.11 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.2 m -67.29 -32.94 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 16' ' ' GLY . 80.3 mt -70.17 -39.41 75.29 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -70.88 -37.35 73.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.388 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -128.82 86.31 57.84 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.067 0.46 . . . . 0.0 110.302 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.96 -27.96 80.3 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.017 2.478 . . . . 0.0 112.464 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.9 mt-30 -63.25 -42.04 99.14 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.731 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.02 -36.98 75.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.014 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.02 97.57 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.09 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.26 -38.9 85.89 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.44 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.5 mm-40 -60.95 -40.78 94.62 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.652 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.49 9.66 41.82 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.035 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 49.88 52.05 15.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.52 106.31 16.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.467 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -107.08 -5.97 17.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.819 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.47 141.19 30.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.61 0.243 . . . . 0.0 111.344 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.1 p -134.43 151.13 75.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.953 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -73.19 149.13 93.69 Favored 'Cis proline' 0 C--N 1.343 0.282 0 C-N-CA 123.493 -1.461 . . . . 0.0 112.1 -1.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.04 119.65 34.87 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -105.66 116.87 32.67 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.67 139.44 34.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.536 0.684 . . . . 0.0 112.005 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -96.57 104.72 16.72 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.6 m -81.38 -28.72 10.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.951 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.9 mt -136.73 135.02 19.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.933 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -78.65 152.21 89.66 Favored 'Cis proline' 0 CA--C 1.533 0.473 0 C-N-CA 123.589 -1.421 . . . . 0.0 112.66 -1.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.439 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 60.0 Cg_endo -71.46 159.09 52.43 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.834 2.356 . . . . 0.0 111.869 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 24.5 Cg_exo -65.9 158.21 77.93 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 124.886 -0.881 . . . . 0.0 113.665 -0.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 68' ' ' VAL . 90.7 t -70.04 127.13 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.771 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -108.24 119.03 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.146 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 95.3 mtm-85 -101.3 121.81 42.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.244 0.545 . . . . 0.0 110.594 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.728 HD11 HD11 ' A' ' 93' ' ' LEU . 68.3 mt -105.11 115.24 46.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.702 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -118.74 126.97 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -161.84 35.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.677 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -81.83 99.37 8.98 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.3 mt -89.36 -3.17 58.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 112.143 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.7 m -70.33 -20.24 63.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.447 0.641 . . . . 0.0 109.787 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.3 t-20 -86.02 117.28 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.375 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.783 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.9 OUTLIER -59.72 -37.18 78.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.206 -178.21 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 42.9 mt-10 -60.17 -44.86 94.71 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.82 97.08 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.818 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.09 -47.16 93.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.836 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD13 ' HG3' ' A' ' 35' ' ' GLU . 58.6 tp -64.27 -47.7 78.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.808 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.7 mt -63.61 -45.74 96.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.81 -41.69 99.4 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.029 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.2 mt -66.45 -36.07 81.87 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -61.62 -46.08 91.34 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.829 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.47 -39.7 92.29 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD11 HD11 ' A' ' 76' ' ' ILE . 88.6 mt -64.9 -41.09 95.89 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.32 90.66 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.38 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.56 -37.84 85.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.9 0.381 . . . . 0.0 110.091 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.53 -40.95 98.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.441 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 8' ' ' ALA . 83.3 mt -69.82 -44.06 79.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.763 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.57 -35.31 91.63 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.844 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.38 -39.51 90.93 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -70.76 125.41 26.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.332 0.587 . . . . 0.0 110.536 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -111.39 145.14 39.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.523 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.048 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -91.16 109.27 20.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.5 -28.99 70.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.661 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -87.55 100.61 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 0.0 110.448 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.549 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.081 0.467 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.86 110.37 62.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.031 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -60.15 146.11 96.98 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.968 2.445 . . . . 0.0 112.76 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.6 mt -110.14 136.78 48.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.08 164.23 31.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.601 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -65.91 -38.16 87.96 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.076 0.465 . . . . 0.0 110.872 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.55 122.25 28.3 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.218 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.63 152.43 22.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.98 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -110.89 121.9 64.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.281 0.562 . . . . 0.0 109.995 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.779 HD11 ' HG ' ' A' ' 65' ' ' LEU . 0.7 OUTLIER -112.55 127.08 55.97 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.682 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -110.13 129.09 55.76 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.302 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.81 123.8 49.6 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.609 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.71 119.58 38.82 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 47' ' ' VAL . 25.1 m -126.46 160.7 33.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.75 96.46 5.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.671 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.75 -153.35 52.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.033 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -113.58 39.12 2.72 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 111.186 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -69.13 157.98 87.81 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.918 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.3 -36.74 79.46 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.419 2.08 . . . . 0.0 113.649 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.407 HD22 ' HD3' ' A' ' 63' ' ' PRO . 8.9 p-10 -69.23 -46.0 68.41 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.364 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.6 m -65.06 -43.92 90.68 Favored 'General case' 0 CA--C 1.523 -0.074 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.53 -45.73 91.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.713 0.292 . . . . 0.0 111.045 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 64.4 ttt180 -61.93 -46.25 90.14 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.57 -42.8 98.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.154 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.71 -47.03 87.14 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.752 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.22 -40.42 97.41 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.758 0.313 . . . . 0.0 110.825 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.759 HG23 ' HG2' ' A' ' 83' ' ' ARG . 87.1 m -66.08 -45.08 82.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.363 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -70.76 -51.02 29.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.477 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.51 -45.08 95.71 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -65.55 -42.24 92.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.191 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 70.9 mt -63.66 -46.07 95.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.163 179.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD22 ' HB2' ' A' ' 40' ' ' TYR . 76.6 mt -68.03 -37.35 81.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.33 -36.39 76.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -106.47 -55.31 2.35 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -64.48 -39.99 94.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.6 m-85 -117.84 29.41 7.84 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.9 ttmt -51.36 123.43 9.67 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.021 0.439 . . . . 0.0 112.091 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.91 -0.61 88.24 Favored Glycine 0 CA--C 1.519 0.301 0 CA-C-N 115.733 -0.667 . . . . 0.0 114.465 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.8 t -108.77 -42.77 5.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.024 0.912 . . . . 0.0 111.643 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.495 ' HB2' HD22 ' A' ' 32' ' ' LEU . 28.9 m-85 -115.43 143.92 44.58 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 119.998 -0.681 . . . . 0.0 112.102 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.78 123.49 48.03 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.06 127.63 39.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 111.898 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.4 104.89 8.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.259 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.09 127.72 45.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.657 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.1 mm -109.96 115.7 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.756 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -85.94 103.08 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.6 m -66.56 -32.29 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.3 mt -70.4 -40.51 73.87 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -71.21 -37.45 72.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.692 0.282 . . . . 0.0 111.315 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -125.54 82.37 63.36 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.67 -31.53 92.17 Favored 'Trans proline' 0 C--O 1.23 0.083 0 C-N-CA 123.22 2.613 . . . . 0.0 112.337 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.73 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.1 mp0 -63.17 -42.11 99.35 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.568 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.7 mt -70.37 -37.08 74.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.02 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -41.66 97.88 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.742 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -67.17 -38.1 84.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.477 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.73 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.3 mt-10 -60.68 -40.75 93.33 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.325 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.19 9.54 41.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.982 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 50.47 51.78 16.14 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 123.811 0.694 . . . . 0.0 112.708 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mm -88.0 106.24 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.609 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.58 0.59 24.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.626 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.49 149.64 36.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 0.0 111.399 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.6 p -147.15 143.94 18.97 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 71.9 Cg_endo -79.67 151.61 85.28 Favored 'Cis proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.931 -1.696 . . . . 0.0 112.652 -2.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.4 m -126.04 130.09 50.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.387 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.779 ' HG ' HD11 ' A' ' 10' ' ' LEU . 6.3 tt -103.79 119.58 39.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.274 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.29 137.69 34.39 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.431 0.634 . . . . 0.0 111.77 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 13.0 ttmt -99.99 104.67 16.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.682 HG21 ' HE3' ' A' ' 11' ' ' LYS . 16.0 m -81.99 -28.73 9.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.42 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD22 HG23 ' A' ' 68' ' ' VAL . 2.1 mm? -135.34 136.85 25.11 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.461 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -75.14 156.27 99.76 Favored 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.49 -1.046 . . . . 0.0 112.388 -2.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.49 156.61 61.09 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.701 2.268 . . . . 0.0 111.861 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.65 164.61 86.9 Favored 'Cis proline' 0 C--N 1.351 0.684 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.234 0.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 68' ' ' VAL . 98.6 t -70.28 125.84 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.962 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -106.82 117.09 33.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.682 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -103.37 124.47 48.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.122 0.486 . . . . 0.0 110.03 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.555 HD12 HD22 ' A' ' 65' ' ' LEU . 50.8 mt -111.18 119.99 60.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.308 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.31 125.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.65 -165.96 38.9 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.845 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -82.53 102.77 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.71 -3.28 58.28 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.448 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 49.5 m -69.49 -21.54 63.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.169 0.509 . . . . 0.0 110.344 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -86.66 120.07 27.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.166 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.759 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.16 -36.35 77.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.79 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.77 -44.03 97.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.67 -40.39 95.32 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.468 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.0 t -63.42 -43.95 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.29 -47.92 66.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.796 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.9 mt -60.91 -46.85 95.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 122.938 0.149 . . . . 0.0 111.364 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.71 97.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.687 0.279 . . . . 0.0 111.162 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.1 mp -68.26 -40.41 81.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.162 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.78 -41.74 95.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.281 0.086 . . . . 0.0 111.122 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.14 -39.71 94.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.569 0.223 . . . . 0.0 110.892 179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD11 HD11 ' A' ' 76' ' ' ILE . 88.5 mt -67.16 -39.9 86.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.388 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.18 90.14 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.634 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.34 -38.11 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.987 0.422 . . . . 0.0 110.187 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.3 -40.85 97.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.399 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' ALA . 83.4 mt -70.0 -42.54 79.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.852 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.43 -35.5 91.13 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.501 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.08 -40.29 95.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.714 0.293 . . . . 0.0 111.412 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -92.12 110.33 21.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.083 0.468 . . . . 0.0 110.688 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -110.96 135.43 51.48 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.789 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -111.32 107.36 16.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.437 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -155.94 153.19 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.38 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -69.39 -30.01 67.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.972 0.415 . . . . 0.0 111.179 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -91.27 106.03 18.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.379 -0.819 . . . . 0.0 111.481 179.661 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.935 0.398 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 122.87 88.45 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.967 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.54 141.9 98.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.817 2.345 . . . . 0.0 112.875 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 67.2 mt -115.48 150.77 35.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -103.61 135.14 45.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.453 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 mttp 69.99 -67.65 0.23 Allowed 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.864 0.727 . . . . 0.0 112.002 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 0.7 OUTLIER -77.26 127.25 32.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.435 0.636 . . . . 0.0 111.385 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.558 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -116.8 153.66 32.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.753 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.8 t -108.63 123.55 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 121.231 0.539 . . . . 0.0 110.337 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.75 129.95 56.24 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.604 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.2 mttt -115.25 131.53 56.9 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.7 125.23 51.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.44 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.1 m-85 -100.38 117.32 34.32 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.537 ' HB ' ' OG ' ' A' ' 21' ' ' SER . 30.6 m -125.95 160.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.022 0.439 . . . . 0.0 111.891 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -120.35 97.95 5.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.646 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.29 -149.71 51.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.138 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -114.55 43.49 1.91 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.967 0.413 . . . . 0.0 111.005 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.9 p -69.88 157.76 88.91 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.401 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.619 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 13.0 Cg_endo -57.13 -33.82 96.55 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.001 1.801 . . . . 0.0 112.414 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -68.75 -43.85 74.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.284 0.564 . . . . 0.0 109.566 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.537 ' OG ' ' HB ' ' A' ' 14' ' ' VAL . 43.5 t -64.54 -47.96 76.86 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.014 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.73 -43.88 96.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.619 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpt180 -62.41 -48.96 77.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.646 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.59 99.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.438 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.44 -47.54 85.24 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.475 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.09 -40.32 95.97 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.773 0.32 . . . . 0.0 111.089 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 83' ' ' ARG . 86.5 m -65.39 -45.45 83.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.591 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -70.66 -49.0 51.99 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.28 -45.25 95.25 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -65.7 -39.87 91.68 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.675 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.7 mt -64.57 -45.21 96.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.321 0.582 . . . . 0.0 110.824 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 40' ' ' TYR . 81.0 mt -71.33 -29.49 65.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.2 mt-10 -90.29 -1.77 57.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -131.2 -61.96 0.9 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.621 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HG3' HD21 ' A' ' 87' ' ' LEU . 78.5 mm-40 -64.45 -42.43 95.96 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.597 ' CD1' HD12 ' A' ' 90' ' ' LEU . 98.0 m-85 -124.45 30.67 5.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttpt -60.14 129.63 42.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.085 0.469 . . . . 0.0 111.255 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.14 -8.98 78.84 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.773 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' THR . 52.4 t -105.32 -40.97 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.862 0.331 . . . . 0.0 110.95 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' HB2' HD22 ' A' ' 32' ' ' LEU . 49.6 m-85 -117.08 144.95 44.07 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.394 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.07 123.15 47.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.3 tp -95.2 127.65 41.42 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.367 0.603 . . . . 0.0 112.429 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 2.0 mptp? -122.84 137.28 54.98 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.045 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.45 130.95 73.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.686 0.755 . . . . 0.0 110.662 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -113.26 103.73 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.409 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.72 104.75 7.39 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.5 m -68.33 -32.04 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.08 -39.78 75.39 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.92 -37.63 72.92 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.996 -0.282 . . . . 0.0 111.336 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -129.7 85.86 57.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 121.072 0.463 . . . . 0.0 110.454 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.09 -28.07 79.66 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.028 2.485 . . . . 0.0 112.546 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.74 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.4 tt0 -62.53 -42.95 99.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.585 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.13 -36.14 74.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.166 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.06 -42.18 97.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.38 -38.15 84.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.559 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.74 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.57 -40.41 91.56 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.425 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.76 9.67 42.03 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.007 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 50.89 51.77 16.34 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 123.721 0.638 . . . . 0.0 112.668 178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.3 mm -86.21 106.85 15.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.8 mt -107.73 1.33 22.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.502 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.24 147.82 40.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.756 0.312 . . . . 0.0 111.321 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.7 p -148.07 139.15 13.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.474 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 76.8 Cg_endo -79.93 152.32 85.12 Favored 'Cis proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.061 -1.641 . . . . 0.0 112.76 -1.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.2 m -127.02 130.26 49.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.341 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.8 tp -104.86 117.79 34.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.777 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.18 135.22 35.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.426 0.631 . . . . 0.0 111.582 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 74' ' ' ARG . 17.0 ttpp -96.11 104.53 16.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.604 HG21 ' HE3' ' A' ' 11' ' ' LYS . 29.4 m -80.52 -28.65 11.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.754 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.1 mt -136.91 138.09 25.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.419 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.89 152.69 96.95 Favored 'Cis proline' 0 C--N 1.35 0.61 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.454 -1.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.46 157.12 59.98 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.57 2.18 . . . . 0.0 111.746 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.11 166.17 82.3 Favored 'Cis proline' 0 C--N 1.352 0.716 0 C-N-CA 124.313 -1.12 . . . . 0.0 113.4 0.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 68' ' ' VAL . 87.6 t -70.12 126.08 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.345 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 67' ' ' LYS . 52.0 tpt85 -102.3 113.93 27.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.494 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -101.19 122.75 44.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.249 0.547 . . . . 0.0 110.71 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 93' ' ' LEU . 66.2 mt -106.37 118.59 54.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.198 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.6 mm -116.59 125.8 73.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.664 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.45 -166.95 39.63 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.774 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -82.86 102.73 11.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.7 mt -88.42 -2.42 58.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.155 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.0 m -68.53 -21.72 64.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.493 . . . . 0.0 110.161 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -87.1 118.82 26.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.259 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.625 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.96 -36.22 76.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.635 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.73 -44.11 97.04 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.64 -40.75 96.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.509 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.598 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 74.0 t -64.92 -42.29 94.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.32 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD21 ' HG3' ' A' ' 35' ' ' GLU . 1.2 mt -69.01 -46.64 67.48 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.52 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.5 mt -61.65 -46.45 96.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.553 0.216 . . . . 0.0 110.816 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.0 -39.9 95.17 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.818 0.342 . . . . 0.0 110.712 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 86' ' ' VAL . 0.2 OUTLIER -66.7 -41.9 87.29 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.384 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -63.44 -45.8 89.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.279 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.53 -39.65 94.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.614 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 76' ' ' ILE . 86.1 mt -65.28 -40.8 94.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.893 0.377 . . . . 0.0 110.704 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.56 91.58 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.965 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.6 -38.65 88.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.953 0.406 . . . . 0.0 110.184 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.96 -41.47 99.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.53 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.2 mt -71.0 -44.1 75.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.215 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.45 -35.62 91.98 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.781 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.88 -40.16 94.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.637 0.256 . . . . 0.0 111.454 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -83.54 111.1 18.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.21 0.529 . . . . 0.0 110.543 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -111.73 145.8 38.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.732 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -88.36 99.57 12.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.559 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -125.26 112.3 16.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.181 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.37 -29.27 69.98 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.414 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.78 105.57 17.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.57 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.437 179.636 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.004 0.431 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.497 ' HB3' ' HG2' ' A' ' 71' ' ' PRO . . . -73.09 128.81 87.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.123 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 2' ' ' ALA . 53.1 Cg_exo -58.81 143.66 98.97 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.979 2.453 . . . . 0.0 112.895 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 70' ' ' PRO . 1.7 mp -108.1 139.95 42.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.439 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.0 mtt85 -127.96 160.37 32.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.121 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -62.22 -39.34 92.45 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.342 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.51 117.6 21.37 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.093 0.473 . . . . 0.0 110.253 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -98.23 152.6 19.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.075 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.3 t -111.78 125.18 69.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.122 0.487 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.73 128.27 56.35 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.3 mttt -112.83 128.52 56.47 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.362 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.454 ' HG ' HD12 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -105.9 123.25 47.68 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.9 179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.5 m-85 -101.0 119.34 38.6 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . 20.3 m -125.8 160.78 32.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.92 0.391 . . . . 0.0 111.558 -178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.27 98.96 6.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.336 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.83 -152.77 52.57 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.764 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -115.03 43.45 1.99 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.966 0.412 . . . . 0.0 110.601 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -71.47 158.24 88.34 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.789 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.53 -37.36 82.65 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.152 1.901 . . . . 0.0 112.714 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.5 -46.04 81.22 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.801 0.334 . . . . 0.0 110.274 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.8 m -66.24 -44.07 84.76 Favored 'General case' 0 CA--C 1.523 -0.09 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.272 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.7 t -65.07 -45.88 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.934 0.397 . . . . 0.0 110.871 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -62.26 -46.97 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.56 97.53 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.175 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.7 tp -61.76 -46.3 90.2 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.502 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.54 -41.31 98.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.801 0.334 . . . . 0.0 110.754 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.757 HG23 ' HG3' ' A' ' 83' ' ' ARG . 87.3 m -64.46 -44.65 90.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.37 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -72.39 -50.0 29.71 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.44 97.36 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.464 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 28.3 t-20 -64.74 -43.31 93.75 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.082 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.465 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -63.87 -45.41 97.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.009 0.433 . . . . 0.0 110.764 178.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 40' ' ' TYR . 76.5 mt -69.4 -35.82 76.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.464 ' HG2' ' HA ' ' A' ' 30' ' ' ASN . 15.6 pt-20 -74.27 -18.64 60.7 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HG2' ' HG3' ' A' ' 33' ' ' GLU . 75.5 mmtt -120.06 -61.76 1.56 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.972 0.415 . . . . 0.0 111.818 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.18 -39.24 93.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.439 -178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.917 ' HZ ' ' HB2' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -114.02 22.49 13.84 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -61.29 126.32 26.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.047 0.451 . . . . 0.0 112.016 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.23 -9.23 78.09 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 115.782 -0.645 . . . . 0.0 113.968 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.41 ' HB ' ' CD2' ' A' ' 36' ' ' PHE . 21.5 t -112.26 -44.62 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.672 0.736 . . . . 0.0 112.352 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -111.39 141.09 45.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.796 -0.762 . . . . 0.0 111.779 -178.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.97 125.62 50.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 32' ' ' LEU . 65.7 tp -97.12 129.86 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.481 0.657 . . . . 0.0 112.741 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -126.58 133.0 51.17 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.221 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.8 t -120.37 129.34 75.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.362 0.601 . . . . 0.0 110.72 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.6 mm -112.32 116.26 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.923 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -86.59 102.08 13.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 14' ' ' VAL . 23.0 m -66.2 -34.71 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.53 -36.67 73.84 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.069 0.395 . . . . 0.0 111.826 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.92 -40.47 75.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 110.76 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -129.76 86.51 55.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 109.977 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.27 -29.07 85.63 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.036 2.49 . . . . 0.0 112.676 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.684 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 24.4 mp0 -62.8 -42.09 99.57 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.754 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.08 -36.94 75.29 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.03 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.17 97.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.197 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.41 -38.41 84.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.406 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.7 -40.77 93.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.768 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -99.4 14.09 30.96 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.838 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 47.45 54.41 9.67 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.666 0.786 . . . . 0.0 113.058 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG21 HG11 ' A' ' 47' ' ' VAL . 46.9 mm -88.94 108.43 18.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -107.56 -8.9 16.04 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.88 139.69 36.31 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.603 0.24 . . . . 0.0 111.335 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.0 p -135.36 148.61 66.86 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.5 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 58.8 Cg_endo -75.13 151.49 96.81 Favored 'Cis proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.729 -1.779 . . . . 0.0 112.649 -1.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.3 OUTLIER -116.11 124.28 49.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.543 178.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 80' ' ' LEU . 20.6 tp -102.7 115.17 30.06 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.75 138.61 30.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.604 0.716 . . . . 0.0 112.299 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 5.4 ttpp -99.55 104.32 16.11 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.604 -1.18 . . . . 0.0 107.837 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.1 m -81.15 -28.72 10.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.229 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.9 mt -137.3 142.09 36.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.043 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.61 ' HB2' HD23 ' A' ' 4' ' ' LEU . 92.1 Cg_endo -78.44 156.61 93.38 Favored 'Cis proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.418 -1.493 . . . . 0.0 112.239 -1.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.497 ' HG2' ' HB3' ' A' ' 2' ' ' ALA . 44.6 Cg_exo -60.41 150.37 81.17 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.956 2.438 . . . . 0.0 112.181 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.6 167.62 78.53 Favored 'Cis proline' 0 C--N 1.35 0.641 0 C-N-CA 124.172 -1.178 . . . . 0.0 113.501 0.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 94.9 t -73.08 127.12 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.817 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -110.75 118.97 37.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.074 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.7 mtm105 -103.13 121.61 42.98 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.306 0.574 . . . . 0.0 110.435 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.561 ' HB ' HD23 ' A' ' 65' ' ' LEU . 64.9 mt -106.14 117.74 52.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.544 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.35 125.23 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 0.0 111.162 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 170.86 -170.41 43.16 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.29 107.59 13.22 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.0 mt -90.15 -0.71 57.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.93 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 80.3 p -67.85 -18.8 64.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.17 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -92.6 120.48 33.08 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.757 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.77 -36.53 76.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.567 -178.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.62 -44.11 96.71 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.7 -40.59 95.63 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.49 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.2 t -63.72 -44.13 98.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.337 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.88 -47.96 64.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.93 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.67 -45.82 96.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 123.016 0.197 . . . . 0.0 111.3 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.21 -41.4 99.13 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 121.174 -0.21 . . . . 0.0 111.16 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 86.6 mt -66.32 -39.82 89.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.329 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -65.42 -41.28 93.72 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.36 -37.16 86.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.614 0.245 . . . . 0.0 110.961 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.9 mt -64.24 -38.57 91.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.118 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.917 ' HB2' ' HZ ' ' A' ' 36' ' ' PHE . . . -62.1 -38.91 90.69 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.999 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -61.78 -38.79 89.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 110.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.42 -40.9 96.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.497 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -69.29 -43.32 81.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.81 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.3 -32.65 81.55 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.147 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.42 -39.09 82.36 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.377 0.271 . . . . 0.0 111.623 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -70.6 122.44 19.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.263 0.554 . . . . 0.0 110.359 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -110.92 139.59 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.725 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -102.77 -52.07 3.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.753 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -94.09 107.63 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.597 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -66.88 -29.54 69.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.198 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 t0 64.59 -170.11 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.419 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.33 179.759 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.993 0.425 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.28 121.74 78.76 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.019 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.86 150.71 61.94 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.599 2.2 . . . . 0.0 112.791 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 78.5 mt -97.81 -0.63 44.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.155 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.99 138.84 35.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -19.41 62.39 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.455 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 p -87.9 123.93 33.16 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.495 0.664 . . . . 0.0 112.316 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.63 154.18 19.77 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.914 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -107.36 123.18 62.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.326 0.584 . . . . 0.0 110.92 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.435 HD23 ' CE2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.47 126.7 55.61 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.579 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -110.63 130.53 55.54 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.515 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.82 122.27 47.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.125 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.4 m-85 -99.65 119.87 38.78 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 47' ' ' VAL . 18.8 m -126.18 161.21 32.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.408 . . . . 0.0 111.803 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.03 101.32 8.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.59 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.69 -134.59 51.29 Favored Glycine 0 C--N 1.333 0.411 0 CA-C-N 115.68 -0.691 . . . . 0.0 113.492 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.0 36.45 4.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.071 0.462 . . . . 0.0 111.035 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 10.1 p -63.89 151.74 88.64 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.758 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 15.2 Cg_endo -57.25 -31.79 91.77 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.404 2.069 . . . . 0.0 112.788 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 5.3 p-10 -70.63 -42.47 70.85 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.431 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 73.9 m -70.17 -42.83 71.96 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.043 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.0 t -64.58 -44.21 96.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.988 0.423 . . . . 0.0 110.738 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -61.45 -47.9 83.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.224 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.76 -43.36 96.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.576 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.72 -47.47 85.11 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.641 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -63.82 -42.47 97.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.889 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.763 HG23 ' HG2' ' A' ' 83' ' ' ARG . 86.1 m -65.34 -44.87 86.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.396 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -70.56 -50.74 34.26 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.59 -45.33 94.57 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -66.48 -39.75 88.92 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.394 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.1 mt -65.17 -43.86 95.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.866 0.365 . . . . 0.0 110.665 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.93 -28.33 64.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.9 mt-10 -89.45 -1.47 58.06 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -132.05 -62.31 0.85 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.19 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 87' ' ' LEU . 78.8 mm-40 -65.19 -41.15 94.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.5 29.94 6.44 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.1 ttpt -61.92 129.43 40.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.044 0.45 . . . . 0.0 111.246 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.47 -8.91 78.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.029 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.87 -44.51 6.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 117.206 0.503 . . . . 0.0 111.375 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.569 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.4 m-85 -113.02 141.43 46.86 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.057 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.54 124.85 50.03 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -97.21 128.27 43.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.389 0.614 . . . . 0.0 112.281 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptp? -125.55 110.37 13.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.026 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -98.15 128.67 49.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.538 0.685 . . . . 0.0 111.126 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.5 mm -111.36 116.55 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.738 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -86.4 103.37 14.9 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.4 m -67.33 -32.44 57.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.13 -39.2 75.56 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.87 -37.25 73.04 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.409 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -129.2 86.42 56.84 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 121.04 0.448 . . . . 0.0 110.349 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.88 -28.42 81.24 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.985 2.457 . . . . 0.0 112.619 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 64.4 tt0 -62.72 -42.25 99.57 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.388 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.02 -36.68 75.26 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.671 -0.411 . . . . 0.0 109.926 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.17 97.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.038 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.56 -38.62 84.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.456 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.694 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.8 mm-40 -60.86 -40.68 93.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.497 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.37 9.7 41.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.076 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.11 52.39 14.81 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.93 108.37 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.571 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.33 -11.52 15.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.839 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.46 139.6 37.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.552 0.215 . . . . 0.0 111.168 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.9 p -132.78 148.55 69.96 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.64 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 63.0 Cg_endo -75.47 151.95 96.86 Favored 'Cis proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.668 -1.805 . . . . 0.0 112.893 -1.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -117.91 122.78 44.18 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.228 178.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HB2' HD11 ' A' ' 80' ' ' LEU . 24.5 tp -104.86 114.33 28.47 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -139.59 137.24 35.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.586 0.708 . . . . 0.0 112.201 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 17.2 ttpp -96.64 104.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 73' ' ' VAL . 27.5 m -81.14 -28.59 10.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.531 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.33 137.39 22.31 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -71.56 152.66 96.44 Favored 'Cis proline' 0 C--N 1.35 0.607 0 C-N-CA 124.254 -1.144 . . . . 0.0 112.461 -1.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.35 156.61 61.42 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.639 2.226 . . . . 0.0 111.716 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.28 167.63 79.24 Favored 'Cis proline' 0 C--N 1.352 0.712 0 C-N-CA 124.317 -1.118 . . . . 0.0 113.387 0.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 68' ' ' VAL . 87.5 t -70.67 126.38 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.248 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -106.85 117.88 35.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.52 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 95.8 mtm-85 -101.72 123.07 45.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.91 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.596 HD11 HD11 ' A' ' 93' ' ' LEU . 69.5 mt -105.51 117.08 50.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.597 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.3 mm -117.23 126.13 74.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.816 0.341 . . . . 0.0 110.833 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.48 -166.95 40.11 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.771 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -82.93 101.77 11.25 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.417 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.9 mt -89.76 -0.69 57.7 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.09 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -68.37 -24.17 64.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.178 0.514 . . . . 0.0 110.0 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -84.0 119.13 24.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.443 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.23 -36.15 77.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.577 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.24 -46.51 88.28 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.8 -40.23 96.16 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.7 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 68.6 t -62.6 -43.81 98.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mt -67.14 -44.89 78.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.94 -47.48 93.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.402 0.144 . . . . 0.0 111.274 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.94 -41.8 97.52 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.248 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mp -68.42 -38.46 81.23 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.803 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -62.02 -46.52 88.83 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.524 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.46 -39.69 94.29 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.596 HD11 HD11 ' A' ' 76' ' ' ILE . 87.3 mt -65.29 -40.98 94.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.21 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.82 92.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.6 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.96 -38.15 87.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.439 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.1 -40.06 94.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.588 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.5 mt -67.77 -44.37 85.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.14 -35.62 91.77 Favored Glycine 0 C--N 1.332 0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.777 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -96.16 17.47 15.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.759 0.314 . . . . 0.0 111.188 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -92.71 118.6 31.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.319 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -111.32 142.54 43.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.687 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -62.69 -43.38 98.97 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.23 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -91.47 103.97 16.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -68.16 -29.22 68.05 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.157 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 t0 66.77 -175.23 0.19 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.312 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.373 -0.822 . . . . 0.0 110.522 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.138 0.495 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.18 110.88 64.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -60.04 143.18 99.58 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.859 2.372 . . . . 0.0 112.771 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -115.22 149.27 37.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -62.61 -38.04 88.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.446 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -62.24 -38.73 90.36 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.893 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.8 p -79.37 123.54 27.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.29 151.92 23.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.838 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.2 t -114.24 126.6 71.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 110.78 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 67' ' ' LYS . 25.6 mt -115.67 134.95 54.53 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.072 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.59 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.1 mttt -115.0 126.36 54.66 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.82 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 122.72 45.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.7 m-85 -99.65 118.47 36.25 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 47' ' ' VAL . 28.3 m -126.5 160.82 33.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.002 0.43 . . . . 0.0 111.503 -178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.17 104.4 11.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 48' ' ' LEU . . . 60.8 -130.78 48.4 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.415 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -131.66 50.27 2.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.23 0.538 . . . . 0.0 110.289 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 52.1 p -73.15 156.0 89.72 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.818 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.6 Cg_endo -57.77 -34.64 98.5 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.103 1.869 . . . . 0.0 112.353 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.29 -42.79 87.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.0 m -70.05 -42.38 72.96 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.809 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.68 -44.29 96.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.1 tpm_? -62.66 -49.31 75.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.644 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -43.75 97.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.473 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.84 -47.68 83.97 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.238 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -62.45 -44.76 95.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.865 0.364 . . . . 0.0 110.741 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' HG3' ' A' ' 83' ' ' ARG . 93.1 m -63.05 -49.45 74.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.983 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HA ' HG11 ' A' ' 86' ' ' VAL . 62.9 tp -67.96 -46.18 72.12 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.86 99.71 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -63.95 -42.07 97.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.793 0.33 . . . . 0.0 110.84 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.69 -44.29 96.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.227 0.537 . . . . 0.0 110.493 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 42' ' ' LEU . 72.9 mt -66.8 -35.6 80.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.643 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.412 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 77.7 mm-40 -87.88 -1.27 57.87 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -129.91 -64.09 0.88 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.593 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -64.55 -42.11 95.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -124.42 30.05 6.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.412 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 64.7 tttp -60.39 129.52 42.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 111.247 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.25 -8.33 79.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.769 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.15 -41.59 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.886 0.343 . . . . 0.0 111.036 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -115.18 143.79 44.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.171 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.82 126.38 51.84 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HB2' HD13 ' A' ' 32' ' ' LEU . 64.7 tp -97.51 129.5 44.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.622 0.725 . . . . 0.0 112.922 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -126.02 132.4 52.0 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.114 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.9 t -120.65 129.96 75.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 121.383 0.611 . . . . 0.0 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 39.8 mm -112.4 116.21 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.932 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.12 103.6 14.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 14' ' ' VAL . 23.8 m -66.71 -33.07 61.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 16' ' ' GLY . 81.6 mt -70.24 -39.68 74.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -70.76 -37.57 73.41 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.382 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -129.04 86.55 56.92 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.097 0.475 . . . . 0.0 110.321 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.82 -28.44 81.59 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.92 2.413 . . . . 0.0 112.466 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.731 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.21 -42.26 99.26 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.785 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.16 -36.93 75.04 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.034 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.73 98.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.693 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.23 -38.3 85.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.322 178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.5 mt-10 -60.73 -40.81 93.76 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.421 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -97.69 9.62 42.09 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.094 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 50.04 52.02 15.51 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.383 0.673 . . . . 0.0 112.707 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mm -87.48 107.17 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.651 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.77 1.37 22.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.58 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.1 148.7 37.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.701 0.286 . . . . 0.0 111.437 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.9 p -147.43 142.66 17.06 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.328 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.76 151.05 84.26 Favored 'Cis proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.927 -1.697 . . . . 0.0 112.578 -1.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -128.16 130.94 48.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.519 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.21 120.44 41.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.346 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.77 136.38 37.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 0.0 111.39 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.4 OUTLIER -93.45 103.94 16.11 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.59 HG21 ' HE3' ' A' ' 11' ' ' LYS . 28.0 m -80.97 -28.09 11.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.879 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -136.97 138.37 25.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.089 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 2.7 Cg_exo -79.74 148.31 79.45 Favored 'Cis proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.118 -1.201 . . . . 0.0 112.41 -1.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.405 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 32.5 Cg_exo -61.57 153.69 64.97 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.957 2.438 . . . . 0.0 111.864 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 17.5 Cg_exo -69.05 160.81 85.3 Favored 'Cis proline' 0 C--N 1.352 0.762 0 C-N-CA 124.974 -0.844 . . . . 0.0 113.742 0.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 90.2 t -72.31 126.27 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.732 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -106.78 118.24 36.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -100.43 125.72 46.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.2 0.524 . . . . 0.0 110.4 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.936 HD11 HD11 ' A' ' 93' ' ' LEU . 66.2 mt -107.79 116.55 51.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.708 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.89 126.42 75.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.49 -164.88 38.26 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.635 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.66 100.06 9.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.9 mt -88.11 -2.37 58.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.065 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.0 m -68.63 -20.91 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.24 0.543 . . . . 0.0 110.267 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.402 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.2 t-20 -87.9 120.46 29.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.542 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -60.37 -37.48 80.88 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 93.6 mt-10 -61.17 -43.24 99.19 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.59 -40.96 96.45 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.713 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 28' ' ' LEU . 74.2 t -63.62 -42.58 96.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.227 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.38 -49.55 54.35 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.088 -0.506 . . . . 0.0 112.017 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.68 -47.53 92.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.44 -41.64 98.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.695 0.283 . . . . 0.0 111.274 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.43 HD21 HD23 ' A' ' 32' ' ' LEU . 56.9 tp -67.41 -40.49 85.58 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.869 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -62.64 -43.84 97.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.819 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.63 -38.9 92.06 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.712 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.936 HD11 HD11 ' A' ' 76' ' ' ILE . 92.4 mt -65.29 -40.3 93.66 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.847 0.356 . . . . 0.0 110.675 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.36 90.78 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.845 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.6 -38.44 87.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 110.066 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -62.74 -41.08 99.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.464 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.565 HD13 ' HB2' ' A' ' 8' ' ' ALA . 85.3 mt -69.83 -43.75 79.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.911 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.67 91.97 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.805 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -61.93 -39.81 93.34 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.784 0.326 . . . . 0.0 111.532 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -84.68 117.35 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.224 0.535 . . . . 0.0 110.597 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.81 137.14 48.84 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.736 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -163.01 -51.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.606 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -88.92 106.14 18.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.635 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 106' ' ' LYS . 33.6 t70 -67.15 -29.57 69.32 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.143 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.3 t0 56.59 46.61 20.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.862 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 104' ' ' ASP . 15.9 mmtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.566 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 110.704 -0.11 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.04 63.88 9.06 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 123.818 0.699 . . . . 0.0 112.388 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 143.3 99.59 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.757 2.305 . . . . 0.0 112.64 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -89.61 -10.4 46.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.876 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -79.08 143.71 35.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.524 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -87.15 -11.5 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.911 0.386 . . . . 0.0 110.821 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -90.82 123.76 34.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.137 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.55 153.16 22.03 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.939 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.0 t -110.55 121.23 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.472 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 40' ' ' TYR . 50.2 tp -113.99 126.37 55.06 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 99.4 mttt -110.95 135.25 51.75 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.324 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.57 123.77 51.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.924 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' CD2' HG13 ' A' ' 59' ' ' ILE . 97.7 m-85 -98.28 121.86 40.73 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.422 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.2 m -124.84 159.02 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.568 0.223 . . . . 0.0 110.559 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 18' ' ' THR . . . -125.72 96.56 4.82 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.3 7.62 88.37 Favored Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.583 -0.818 . . . . 0.0 114.883 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.01 47.44 9.75 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.591 0.71 . . . . 0.0 110.326 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' ALA . 68.1 p -72.26 165.48 50.4 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.022 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.96 -37.72 67.83 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.119 1.88 . . . . 0.0 112.909 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -64.48 -44.7 90.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.4 m -65.31 -43.55 90.72 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.15 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.0 t -63.96 -44.97 98.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.952 0.406 . . . . 0.0 109.991 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -61.56 -47.69 84.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.224 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.18 99.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.244 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 44' ' ' VAL . 62.1 tp -61.83 -47.81 83.41 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.352 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -63.66 -40.18 96.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.792 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.598 HG23 ' HG2' ' A' ' 83' ' ' ARG . 93.5 m -64.6 -46.5 82.37 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.222 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 65' ' ' LEU . 6.0 mt -70.01 -47.02 63.83 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.613 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.07 -42.65 98.9 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -62.58 -44.55 96.04 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.944 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.6 mt -63.73 -45.83 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.621 0.724 . . . . 0.0 111.04 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 40' ' ' TYR . 91.4 mt -69.63 -32.52 71.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.313 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 45.7 mt-10 -84.16 -10.14 58.0 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -125.78 -62.04 1.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.223 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.66 -42.37 98.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' CD1' HD12 ' A' ' 90' ' ' LEU . 97.8 m-85 -123.89 31.31 5.88 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.3 128.1 34.13 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.022 0.439 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.63 -0.22 89.65 Favored Glycine 0 CA--C 1.52 0.351 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.655 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.6 t -109.96 -44.75 6.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 117.327 0.563 . . . . 0.0 111.603 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.631 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -114.02 142.13 46.56 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.579 -178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 126.0 51.68 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 32' ' ' LEU . 59.1 tp -96.35 125.05 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 111.279 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.2 mptp? -125.08 113.0 17.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.519 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG21 HD13 ' A' ' 25' ' ' LEU . 87.9 t -98.64 128.67 49.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.542 0.687 . . . . 0.0 111.033 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.6 mm -111.14 116.56 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.897 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.54 104.13 15.7 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 14' ' ' VAL . 28.8 m -67.64 -33.64 63.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.0 mt -70.47 -39.86 73.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.06 -36.27 72.23 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.768 0.318 . . . . 0.0 111.071 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -124.78 81.72 61.04 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.026 0.441 . . . . 0.0 110.811 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.56 -32.81 93.93 Favored 'Trans proline' 0 N--CA 1.466 -0.099 0 C-N-CA 123.307 2.671 . . . . 0.0 112.267 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.681 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 1.7 mp0 -63.15 -41.97 99.38 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.1 mt -70.23 -37.37 74.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.663 -0.415 . . . . 0.0 109.937 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -41.58 97.07 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.153 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.42 -38.7 88.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.395 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -60.76 -40.55 92.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.496 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.81 9.53 42.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.009 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? 49.87 51.97 15.54 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 13' ' ' TYR . 43.3 mm -91.45 108.2 19.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.696 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.7 mt -110.63 2.94 18.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.729 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.66 150.58 36.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.812 0.339 . . . . 0.0 111.516 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -147.6 148.8 32.02 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.094 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 6.0 Cg_exo -77.74 146.26 81.32 Favored 'Cis proline' 0 C--N 1.345 0.35 0 C-N-CA 123.518 -1.451 . . . . 0.0 111.571 -2.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.0 m -128.41 130.08 47.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.163 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 28' ' ' LEU . 7.8 mt -102.52 125.26 49.18 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.846 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -143.17 127.36 17.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.014 0.435 . . . . 0.0 110.767 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.699 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.5 OUTLIER -98.6 101.35 12.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.852 ' HA ' HG22 ' A' ' 73' ' ' VAL . 74.3 t -71.81 -39.05 67.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.582 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.0 mt -126.7 134.39 26.01 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.351 -0.54 . . . . 0.0 112.334 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HD2' ' NZ ' ' A' ' 67' ' ' LYS . 83.6 Cg_endo -76.5 154.48 97.65 Favored 'Cis proline' 0 C--N 1.35 0.634 0 C-N-CA 123.374 -1.511 . . . . 0.0 112.475 -1.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.53 155.46 66.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.58 2.187 . . . . 0.0 112.017 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.3 164.59 86.65 Favored 'Cis proline' 0 C--N 1.352 0.727 0 C-N-CA 124.137 -1.193 . . . . 0.0 113.446 0.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 68' ' ' VAL . 61.0 t -70.6 125.7 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.871 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.3 mmm180 -94.37 114.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 96.1 mtm-85 -101.29 120.69 40.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.323 0.582 . . . . 0.0 110.55 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 72.5 mt -111.38 118.74 58.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.169 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -122.61 127.37 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.865 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.81 -162.53 35.98 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.905 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -81.33 100.53 9.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.3 mt -89.71 -4.08 57.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.2 m -70.27 -22.35 62.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.227 0.537 . . . . 0.0 110.093 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.2 t-20 -81.63 117.99 22.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.598 ' HG2' HG23 ' A' ' 27' ' ' THR . 90.6 mtm180 -60.41 -36.74 78.86 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.082 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 41.3 mt-10 -60.63 -44.87 95.85 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.31 -41.64 96.74 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.959 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 69.8 t -63.79 -45.68 96.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.548 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 63.6 tp -65.04 -46.87 79.49 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.297 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.4 mt -62.57 -47.09 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.49 0.186 . . . . 0.0 111.229 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.98 97.96 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.745 0.307 . . . . 0.0 111.175 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -67.28 -40.04 86.11 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.196 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -63.28 -44.54 94.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.799 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.02 -39.75 95.68 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.855 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 76' ' ' ILE . 87.3 mt -65.09 -41.22 95.2 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.681 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' A' ' 97' ' ' ILE . . . -63.55 -38.8 92.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.34 -38.61 90.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.884 0.373 . . . . 0.0 110.319 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.52 -40.42 96.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.95 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 94' ' ' ALA . 82.0 mt -64.57 -45.02 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.665 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.49 -35.56 91.92 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.514 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.53 -40.59 97.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.818 0.342 . . . . 0.0 111.047 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.37 125.87 28.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.911 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.39 135.65 47.52 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.943 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -110.94 -51.52 2.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.65 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -91.97 109.92 21.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -95.51 14.62 22.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.86 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -138.74 163.18 32.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.709 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.77 179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 3' ' ' PRO . . . -62.18 -50.39 80.23 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.624 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 2' ' ' ALA . 67.8 Cg_endo -71.54 154.72 60.09 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 121.971 1.781 . . . . 0.0 112.82 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.9 mt -85.9 -11.47 53.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.213 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 57.55 -131.12 1.47 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.842 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.05 0.7 38.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.677 0.275 . . . . 0.0 111.244 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.4 130.51 36.47 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.611 0.719 . . . . 0.0 111.987 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -107.5 153.47 22.79 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.626 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 78.8 t -108.31 124.53 64.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.207 0.527 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.79 127.35 56.13 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.589 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.5 mttt -115.03 132.21 56.67 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.773 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.7 124.75 50.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.005 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -98.41 118.94 36.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.2 m -125.58 160.3 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.057 0.456 . . . . 0.0 111.368 -178.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.35 104.19 10.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.556 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.77 -129.9 44.88 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.088 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -134.22 53.06 2.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.149 0.5 . . . . 0.0 110.3 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -74.34 157.56 86.35 Favored Pre-proline 0 CA--C 1.515 -0.386 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.859 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 14.1 Cg_endo -57.89 -33.72 97.39 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.16 1.907 . . . . 0.0 112.191 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -67.24 -43.57 81.63 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -67.76 -43.02 80.82 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.7 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.95 -44.0 96.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.905 0.383 . . . . 0.0 110.438 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.1 tpt180 -63.42 -49.67 72.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.507 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.45 98.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.502 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.4 tp -62.0 -46.56 88.68 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.294 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -64.69 -42.31 95.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.725 0.298 . . . . 0.0 110.97 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' HG3' ' A' ' 83' ' ' ARG . 94.2 m -63.04 -49.12 75.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.862 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HA ' HG11 ' A' ' 86' ' ' VAL . 62.2 tp -67.58 -45.1 76.53 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.18 -42.87 99.69 Favored 'General case' 0 C--O 1.225 -0.225 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -61.48 -44.64 96.72 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.962 0.411 . . . . 0.0 110.797 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 78.0 mt -63.54 -45.54 97.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.029 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' A' ' 42' ' ' LEU . 70.9 mt -66.48 -37.34 84.9 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.8 mt-10 -65.09 -36.31 83.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -114.13 -53.12 2.7 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.8 mm-40 -65.78 -41.6 91.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.66 29.56 6.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 13.8 tmtt? -60.01 127.21 30.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.023 0.439 . . . . 0.0 111.324 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.61 -8.04 80.41 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.675 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.2 t -106.76 -46.06 8.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.511 0.656 . . . . 0.0 111.561 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.03 141.86 46.9 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.46 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.81 128.38 49.59 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.548 ' HB2' HD13 ' A' ' 32' ' ' LEU . 56.8 tp -98.52 126.36 44.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.3 mptm? -124.67 139.2 54.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.594 -1.185 . . . . 0.0 108.854 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.1 p -120.69 132.79 69.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.583 0.706 . . . . 0.0 110.925 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -115.11 104.73 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.72 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -77.52 102.02 6.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 14' ' ' VAL . 25.5 m -66.71 -34.18 68.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.5 mt -70.49 -37.36 74.21 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.776 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -70.42 -40.58 73.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.571 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -126.14 83.09 64.21 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.994 0.426 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.06 -33.04 95.56 Favored 'Trans proline' 0 CA--C 1.527 0.132 0 C-N-CA 123.218 2.612 . . . . 0.0 112.576 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.693 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 53.4 tt0 -62.69 -42.38 99.6 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.507 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -69.72 -37.12 76.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.04 -42.01 97.2 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.125 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.76 -38.21 86.15 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.532 178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.1 mm-40 -60.6 -40.36 91.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.542 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.03 8.96 43.36 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.884 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 51.35 50.92 17.93 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mm -87.75 104.93 14.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.459 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.48 2.82 24.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.639 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.38 149.66 38.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.444 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.2 p -148.0 145.55 21.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.046 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.75 148.68 83.71 Favored 'Cis proline' 0 N--CA 1.462 -0.362 0 C-N-CA 123.464 -1.473 . . . . 0.0 111.622 -2.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -123.78 128.57 49.75 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 80' ' ' LEU . 20.1 tp -102.59 119.18 38.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.472 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.83 139.31 30.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.527 0.679 . . . . 0.0 112.258 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.47 ' HE3' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -100.3 105.01 16.51 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.589 HG21 ' HE3' ' A' ' 11' ' ' LYS . 28.6 m -81.42 -28.85 10.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.907 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.8 mt -135.83 139.07 29.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.394 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 92.6 Cg_endo -81.44 152.18 78.85 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.432 -1.487 . . . . 0.0 112.596 -1.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 36.3 Cg_exo -61.17 153.11 67.15 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.987 2.458 . . . . 0.0 112.03 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 18.4 Cg_exo -68.87 158.99 87.62 Favored 'Cis proline' 0 C--N 1.352 0.718 0 C-N-CA 124.915 -0.869 . . . . 0.0 113.727 0.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 89.3 t -74.21 126.6 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.58 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.725 ' HG2' HD11 ' A' ' 93' ' ' LEU . 22.3 tpp180 -105.82 120.12 40.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.014 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -103.82 126.11 50.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.21 0.528 . . . . 0.0 110.082 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.9 mt -110.53 117.97 56.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.847 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -120.0 126.44 75.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.022 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.95 -166.36 39.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.801 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -82.26 101.91 10.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 65' ' ' LEU . 88.5 mt -89.9 -1.29 57.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.327 -178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 57.6 m -68.86 -21.59 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.18 0.514 . . . . 0.0 110.344 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -87.2 120.29 28.32 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.253 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -59.93 -36.06 76.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.643 -178.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -60.68 -44.32 96.66 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -65.23 -41.33 94.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.118 -0.633 . . . . 0.0 111.204 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' A' ' 28' ' ' LEU . 72.9 t -63.18 -45.92 97.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.239 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.29 -48.76 72.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.003 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.85 -47.69 91.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.35 -41.91 96.51 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.675 0.274 . . . . 0.0 111.471 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD21 ' CD2' ' A' ' 32' ' ' LEU . 53.1 tp -65.6 -39.98 92.17 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.347 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -61.8 -43.96 97.81 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.689 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp -61.62 -41.73 97.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.684 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.725 HD11 ' HG2' ' A' ' 74' ' ' ARG . 3.9 mm? -65.94 -41.79 90.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.618 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.57 91.52 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.563 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.74 -38.94 89.79 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.809 0.338 . . . . 0.0 110.459 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.58 -40.35 96.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.107 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.408 HD13 ' HB2' ' A' ' 8' ' ' ALA . 91.8 mt -66.04 -44.65 91.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.867 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.16 -35.79 92.04 Favored Glycine 0 C--N 1.333 0.381 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.603 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.48 -39.73 94.37 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 111.303 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -85.28 114.01 22.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.135 0.493 . . . . 0.0 110.512 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -87.09 134.74 33.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.619 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -141.1 110.39 6.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.928 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.9 t0 55.8 51.3 12.55 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.61 0.568 . . . . 0.0 111.652 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -66.6 -29.91 70.08 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.674 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -91.46 100.98 13.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.603 179.672 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.969 0.414 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.51 117.16 65.73 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.974 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.21 152.89 62.15 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.716 2.278 . . . . 0.0 112.797 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -110.79 133.76 53.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.54 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -125.14 -68.12 0.86 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.802 0.334 . . . . 0.0 111.535 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.5 mmtm -93.52 -4.76 50.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.583 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -90.32 124.55 35.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.103 0.478 . . . . 0.0 111.498 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.491 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.25 152.48 22.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.675 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.6 t -108.88 121.38 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.188 0.518 . . . . 0.0 109.951 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 65' ' ' LEU . 43.5 tp -113.5 126.8 55.72 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.557 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.8 mttt -111.43 133.33 53.8 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.786 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.31 124.72 53.09 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.537 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.6 m-85 -100.17 119.41 38.3 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 25' ' ' LEU . 15.7 m -125.61 160.75 31.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.891 0.377 . . . . 0.0 111.167 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.24 102.93 9.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.558 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.02 -133.19 50.99 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -125.83 38.08 4.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.99 0.424 . . . . 0.0 111.333 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -67.76 154.35 93.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -53.34 -37.76 81.56 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.048 1.832 . . . . 0.0 112.872 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -65.18 -44.5 88.25 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.262 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 14' ' ' VAL . 75.6 m -68.46 -43.9 76.02 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.289 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.3 -45.81 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.891 0.377 . . . . 0.0 110.614 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -62.34 -46.18 89.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.72 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.46 -43.07 98.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.811 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD23 HD13 ' A' ' 12' ' ' LEU . 74.2 mt -63.03 -41.88 99.64 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.62 -40.0 95.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.0 110.291 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.694 HG23 ' HG3' ' A' ' 83' ' ' ARG . 85.9 m -66.57 -45.22 80.02 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.468 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -51.55 21.59 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.57 -43.77 98.25 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.01 -43.43 95.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.232 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.2 mt -64.14 -45.15 97.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.951 0.405 . . . . 0.0 111.148 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 40' ' ' TYR . 79.1 mt -68.79 -35.64 77.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 99.9 mt-10 -71.66 -24.63 61.88 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -114.48 -59.75 1.98 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.315 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.5 mm-40 -64.87 -40.94 95.93 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB2' HD23 ' A' ' 32' ' ' LEU . 98.7 m-85 -122.32 29.58 6.91 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 33' ' ' GLU . 59.5 tttp -62.12 127.73 32.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 111.318 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.42 79.84 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 113.139 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.49 -43.28 6.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 117.168 0.484 . . . . 0.0 111.37 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 32.3 m-85 -114.53 143.63 44.66 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.004 -0.679 . . . . 0.0 112.107 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 123.86 48.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.1 tp -94.76 127.73 40.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.347 0.594 . . . . 0.0 112.039 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -125.25 108.83 12.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.214 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.87 127.86 47.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.764 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -110.95 115.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.871 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -86.15 101.19 12.77 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.0 m -64.31 -34.79 71.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.0 mt -71.33 -37.89 71.7 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -70.32 -41.24 73.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.94 0.4 . . . . 0.0 110.627 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.17 79.1 62.84 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.882 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.32 -20.05 69.56 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.418 2.079 . . . . 0.0 112.777 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.746 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 97.2 mt-30 -63.28 -41.75 99.02 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 99.9 mt -70.97 -36.38 72.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.782 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.49 -42.04 98.55 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.741 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.2 85.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.162 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.746 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 94.2 mt-10 -60.89 -40.4 92.88 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.161 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -96.66 9.82 40.45 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.965 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 50.87 51.85 16.16 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.49 0.716 . . . . 0.0 112.925 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.6 mm -88.55 107.24 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.563 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.98 1.41 24.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.57 149.31 37.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 111.314 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.1 p -147.42 143.05 17.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.55 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.99 150.62 82.63 Favored 'Cis proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.886 -1.714 . . . . 0.0 112.576 -1.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.0 m -127.47 131.22 50.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.443 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.634 ' HB2' HD21 ' A' ' 80' ' ' LEU . 51.8 tp -105.2 120.84 42.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.112 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.44 135.96 32.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.419 0.628 . . . . 0.0 111.626 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -101.23 104.59 15.64 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.557 HG21 ' HE3' ' A' ' 11' ' ' LYS . 29.9 m -79.94 -28.57 12.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.145 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.8 mt -134.72 139.02 31.15 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 120.649 -0.42 . . . . 0.0 111.439 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 83.1 Cg_endo -80.23 152.88 84.6 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.42 -1.492 . . . . 0.0 112.569 -1.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 34.5 Cg_exo -61.18 152.55 71.13 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.995 2.463 . . . . 0.0 112.038 178.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -70.1 160.29 89.28 Favored 'Cis proline' 0 C--N 1.351 0.693 0 C-N-CA 124.894 -0.878 . . . . 0.0 113.668 0.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 68' ' ' VAL . 93.1 t -73.89 127.07 35.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.642 ' HG2' HD21 ' A' ' 93' ' ' LEU . 21.9 tpp180 -106.05 118.88 37.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -104.43 124.38 49.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.108 0.48 . . . . 0.0 109.769 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 93' ' ' LEU . 64.1 mt -109.33 117.59 54.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.418 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -122.26 127.72 75.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.541 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.42 -158.8 31.71 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.831 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -81.19 86.38 6.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 65' ' ' LEU . 3.3 mp -77.26 -10.01 59.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.765 -178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 95.0 p -67.94 -19.11 64.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.861 0.362 . . . . 0.0 111.007 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.09 120.71 30.74 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.84 -35.8 75.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.596 -178.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.3 -44.76 95.13 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -64.42 -41.24 96.71 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.947 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 64.5 t -63.38 -47.2 93.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.686 0.279 . . . . 0.0 110.571 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -65.07 -47.61 76.69 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.749 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.6 mt -61.68 -46.06 97.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -62.85 -41.32 99.31 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.479 0.18 . . . . 0.0 111.248 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.428 HD21 ' CD2' ' A' ' 10' ' ' LEU . 89.1 mt -66.32 -38.3 87.38 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.064 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -64.29 -42.41 96.41 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.441 0.162 . . . . 0.0 110.942 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.3 -40.03 95.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.722 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 76' ' ' ILE . 89.2 mt -66.93 -40.49 87.63 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.93 0.395 . . . . 0.0 110.59 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -38.31 90.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.575 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.45 -37.68 84.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.877 0.37 . . . . 0.0 110.139 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.76 -40.7 98.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.52 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.491 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.1 mt -70.02 -43.67 79.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.892 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.47 -22.05 72.89 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.841 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -62.41 -39.65 93.98 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.745 0.307 . . . . 0.0 111.016 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -67.66 126.15 28.45 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.098 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -97.86 148.35 23.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.974 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -153.82 158.11 40.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -88.76 104.42 16.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.28 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -94.89 6.94 47.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.62 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.1 t0 55.91 43.77 26.89 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 123.639 0.587 . . . . 0.0 111.798 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.65 179.665 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.99 0.424 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 146.71 62.3 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.59 149.99 56.37 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.738 2.292 . . . . 0.0 112.974 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.5 mt -118.21 137.23 53.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.423 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -130.39 149.44 52.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.83 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -63.8 -40.13 95.9 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.199 0.523 . . . . 0.0 110.698 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.0 123.28 34.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.745 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.556 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -95.69 152.3 18.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.155 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.4 t -111.62 124.02 67.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 130.35 56.16 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' LYS . 98.7 mttt -115.63 131.29 56.98 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.47 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.43 124.75 51.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.8 m-85 -100.51 119.8 39.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 47' ' ' VAL . 26.4 m -126.99 160.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.959 0.409 . . . . 0.0 111.682 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.65 105.57 12.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.657 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.75 -130.29 45.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.09 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -136.56 52.22 1.96 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.126 0.489 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -75.38 158.02 84.05 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.952 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 74.5 Cg_exo -54.31 -37.16 88.58 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.702 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -64.79 -45.23 87.19 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.966 0.412 . . . . 0.0 110.002 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 66.8 m -66.84 -43.12 84.51 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.972 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.6 -44.62 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.935 0.398 . . . . 0.0 110.589 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.9 tpt180 -62.01 -47.66 83.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.394 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.17 -42.74 99.44 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 tp -61.65 -47.74 83.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.514 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.77 -40.7 97.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 110.942 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.722 HG23 ' HG2' ' A' ' 83' ' ' ARG . 87.4 m -65.42 -45.47 83.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -70.4 -50.0 43.14 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.78 -45.6 93.16 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.78 -43.34 93.56 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.22 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 74.5 mt -63.6 -44.81 98.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.959 0.409 . . . . 0.0 111.004 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 40' ' ' TYR . 84.8 mt -71.2 -27.9 63.83 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 47.1 mt-10 -88.85 -4.36 58.5 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -128.94 -62.13 1.02 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.268 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.298 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -121.27 30.2 6.91 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.53 126.29 26.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.038 0.446 . . . . 0.0 111.603 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.44 83.57 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.335 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.4 t -106.88 -41.38 5.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.19 0.495 . . . . 0.0 111.486 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.607 ' HB2' HD22 ' A' ' 32' ' ' LEU . 37.8 m-85 -116.1 144.31 44.31 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.481 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.65 124.57 49.78 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.9 tp -97.04 129.82 44.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.464 0.649 . . . . 0.0 112.533 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.6 mptt -125.8 134.33 51.72 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.442 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.1 t -120.48 129.56 75.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.412 0.625 . . . . 0.0 110.774 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -112.49 116.21 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.806 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -86.34 104.62 16.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 14' ' ' VAL . 17.5 m -68.22 -21.16 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.53 -38.42 17.23 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.387 0.54 . . . . 0.0 111.873 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -70.86 -37.37 73.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.969 0.414 . . . . 0.0 110.412 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -132.9 77.01 69.5 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.63 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.53 -19.3 67.46 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.604 2.202 . . . . 0.0 112.718 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.687 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 57.7 mt-30 -63.13 -41.04 99.24 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.75 -36.16 73.0 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.8 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.81 -42.45 97.68 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.132 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.9 -38.63 86.62 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.172 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.88 -40.32 92.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.344 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -97.47 10.27 40.2 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.994 178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 50.18 52.68 14.26 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG13 ' CD2' ' A' ' 13' ' ' TYR . 48.8 mm -88.84 109.23 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.387 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -106.34 -7.2 17.82 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.11 142.99 30.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.495 0.188 . . . . 0.0 111.22 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.0 p -135.25 149.91 71.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.637 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.501 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.8 Cg_endo -75.84 151.36 95.58 Favored 'Cis proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.702 -1.791 . . . . 0.0 112.608 -1.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.02 123.63 44.98 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.426 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.3 tp -104.23 116.84 32.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -141.27 136.63 31.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.196 0.522 . . . . 0.0 111.605 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.66 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.3 ttpp -99.37 101.29 12.51 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.843 ' HA ' HG22 ' A' ' 73' ' ' VAL . 78.1 t -71.5 -39.24 70.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.257 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -128.71 140.66 39.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.856 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 72.6 Cg_endo -75.37 153.5 98.63 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 123.326 -1.531 . . . . 0.0 112.391 -1.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 39.8 Cg_exo -60.62 149.9 84.83 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.959 2.44 . . . . 0.0 112.246 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.67 169.13 73.41 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.417 0.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 68' ' ' VAL . 70.9 t -72.95 124.92 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.416 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.6 mmm180 -100.54 114.01 27.28 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 87.5 mtm180 -98.06 118.63 35.1 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 110.443 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 93' ' ' LEU . 63.1 mt -106.6 116.48 50.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.508 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.48 127.04 74.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.968 0.413 . . . . 0.0 111.305 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 167.79 -165.4 38.68 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.613 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -80.51 101.73 9.29 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.9 mt -88.96 -3.5 58.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.321 -178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.3 m -68.12 -21.37 64.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.309 0.576 . . . . 0.0 110.0 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -84.18 116.76 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.34 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.722 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.0 mtm-85 -60.47 -37.24 80.36 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -60.5 -44.2 96.23 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -63.75 -40.81 97.62 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.419 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.2 t -63.48 -44.3 98.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.452 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.56 -46.67 72.04 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.536 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.1 mt -61.73 -46.11 97.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.345 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.68 -42.24 98.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.258 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.1 mt -66.76 -38.24 86.2 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.654 0.264 . . . . 0.0 110.722 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -62.18 -46.3 89.53 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.803 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.1 mp -65.3 -39.47 92.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.373 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 76' ' ' ILE . 89.8 mt -64.44 -41.07 96.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.895 0.378 . . . . 0.0 110.336 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.52 91.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.512 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -38.27 88.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.996 0.427 . . . . 0.0 110.039 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -62.74 -40.65 97.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.457 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 8' ' ' ALA . 86.3 mt -68.38 -44.27 83.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.881 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -65.07 -24.94 70.64 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.11 -38.63 89.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.839 0.352 . . . . 0.0 111.131 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -85.89 107.98 17.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -84.49 143.36 29.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.99 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -159.6 161.18 35.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.835 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -87.23 106.16 17.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.26 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.81 -29.26 69.16 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.68 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -86.79 102.91 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.342 . . . . 0.0 110.632 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.755 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.997 0.427 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.36 63.72 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.084 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.74 155.52 58.38 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.752 2.302 . . . . 0.0 112.647 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 74.0 mt -107.84 138.55 43.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.664 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -95.47 151.96 18.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.724 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.4 mmtm -65.8 -38.52 89.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.08 0.467 . . . . 0.0 110.677 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.77 122.07 32.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.989 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -88.57 152.33 21.91 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.137 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.78 121.78 63.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.688 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.16 127.59 55.63 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.608 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.4 mttt -113.59 132.94 55.54 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.031 -0.668 . . . . 0.0 110.883 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.9 124.05 51.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.975 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -98.96 118.91 36.81 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 47' ' ' VAL . 33.5 m -125.63 160.22 32.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.441 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.49 103.94 10.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.72 -129.53 44.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.264 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.22 52.68 1.96 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.942 0.401 . . . . 0.0 110.802 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -74.91 158.36 84.63 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.704 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.09 -37.01 86.76 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.076 1.851 . . . . 0.0 112.528 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.9 -45.79 80.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.8 0.333 . . . . 0.0 110.117 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.0 m -65.75 -44.25 86.49 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.163 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG12 ' HE2' ' A' ' 26' ' ' LYS . 55.1 t -65.15 -45.81 92.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.749 0.309 . . . . 0.0 110.877 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -62.63 -46.81 86.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.607 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.89 98.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.178 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -61.56 -47.42 85.61 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.726 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HE2' HG12 ' A' ' 22' ' ' VAL . 57.2 mtmt -63.04 -41.16 99.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.901 0.381 . . . . 0.0 110.761 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 83' ' ' ARG . 90.6 m -65.16 -49.51 69.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.073 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' HA ' HG11 ' A' ' 86' ' ' VAL . 56.6 tp -68.67 -46.5 68.9 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -62.8 -44.6 95.73 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -65.15 -41.07 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.873 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 76.7 mt -64.01 -44.38 97.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.62 HD22 ' HB2' ' A' ' 40' ' ' TYR . 80.4 mt -69.13 -34.45 75.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 48.7 mt-10 -81.88 -11.86 58.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.737 0.644 . . . . 0.0 112.737 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -122.26 -61.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.526 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.4 mm-40 -64.69 -40.56 95.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -120.37 29.82 7.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.4 tptm -56.79 128.07 34.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 111.719 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 -1.89 88.36 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.559 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.61 -41.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 117.318 0.559 . . . . 0.0 111.486 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' HB2' HD22 ' A' ' 32' ' ' LEU . 38.0 m-85 -115.55 144.44 43.87 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.294 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.93 124.78 50.13 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.1 tp -95.39 129.95 42.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.372 0.606 . . . . 0.0 112.455 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.6 mptp? -127.87 114.55 17.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.207 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.6 t -102.47 128.05 55.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.518 0.675 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.2 mm -109.96 115.88 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.899 -178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -86.99 102.04 14.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 14' ' ' VAL . 24.4 m -65.27 -32.77 59.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.3 -39.38 74.85 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.81 -37.81 73.28 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.646 0.26 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -129.01 86.33 57.59 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 110.48 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -61.52 -29.0 83.99 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.891 2.394 . . . . 0.0 112.579 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.735 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 49.9 tt0 -62.42 -43.8 97.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.63 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -70.16 -36.58 74.81 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.177 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.87 -41.85 97.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.615 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.17 -38.51 85.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.408 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.735 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 93.8 mt-10 -60.84 -40.65 93.62 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.303 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -97.15 9.84 41.06 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.907 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm 50.56 51.39 16.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.434 0.694 . . . . 0.0 112.843 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.2 mm -89.02 105.51 15.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.515 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.11 1.45 24.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.561 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.18 150.54 36.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 111.573 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.7 p -146.21 146.88 29.5 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.981 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -79.12 148.25 81.66 Favored 'Cis proline' 0 N--CA 1.461 -0.386 0 C-N-CA 123.404 -1.498 . . . . 0.0 111.791 -1.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.8 m -123.49 128.74 50.22 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.539 ' HB2' HD11 ' A' ' 80' ' ' LEU . 26.7 tp -102.6 120.36 40.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.895 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -142.65 136.05 28.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.43 0.633 . . . . 0.0 111.881 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 14.4 ttpp -99.83 104.66 16.35 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.608 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.2 m -80.31 -28.73 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.675 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.7 mt -136.93 138.29 25.51 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.346 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.66 157.4 97.69 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.481 -1.466 . . . . 0.0 112.305 -1.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.92 154.69 70.45 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.662 2.241 . . . . 0.0 111.927 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.86 164.99 86.13 Favored 'Cis proline' 0 C--N 1.35 0.65 0 C-N-CA 124.138 -1.192 . . . . 0.0 113.412 0.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 68' ' ' VAL . 96.5 t -71.29 127.49 33.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.058 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 28.1 mmm180 -102.01 114.03 27.78 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.5 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.2 mtt85 -101.2 121.81 42.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.23 0.538 . . . . 0.0 109.655 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.623 HD11 HD11 ' A' ' 93' ' ' LEU . 52.0 mt -111.87 118.18 56.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.041 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.06 125.24 74.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 169.55 -165.32 38.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.715 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.26 101.64 11.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 65' ' ' LEU . 90.6 mt -89.84 -0.26 57.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.955 -178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.8 m -71.0 -15.96 62.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.202 0.525 . . . . 0.0 110.135 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -91.66 119.18 31.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.202 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.2 OUTLIER -59.79 -36.56 76.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.617 -178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -59.74 -46.08 90.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.28 -40.21 95.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.985 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG11 ' HA ' ' A' ' 28' ' ' LEU . 73.4 t -62.71 -43.13 98.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 178.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.424 HD21 ' HG3' ' A' ' 35' ' ' GLU . 1.5 mt -67.54 -45.48 75.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.682 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.58 -47.36 93.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.549 0.214 . . . . 0.0 111.361 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.427 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -64.06 -41.36 97.4 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.557 0.218 . . . . 0.0 111.276 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.8 -39.66 83.99 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.885 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.89 -45.8 90.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.936 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.89 -40.18 94.69 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.354 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 HD11 ' A' ' 76' ' ' ILE . 91.9 mt -64.93 -41.0 95.91 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.954 0.407 . . . . 0.0 110.297 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.81 -38.18 90.15 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.483 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -61.72 -38.32 87.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 110.049 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.15 -40.77 98.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.358 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 8' ' ' ALA . 86.2 mt -69.41 -43.73 80.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.92 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.51 -22.9 71.76 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.748 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.46 -39.2 92.65 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.797 0.332 . . . . 0.0 110.988 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -69.21 123.88 22.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.236 0.541 . . . . 0.0 109.989 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -89.75 147.18 23.98 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -62.54 -42.5 99.57 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.252 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -156.38 158.13 36.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.093 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -67.26 -30.53 70.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.383 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.9 t0 67.96 -75.77 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.673 0.608 . . . . 0.0 112.021 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.797 -179.41 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.015 0.436 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.68 110.72 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.102 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.92 145.25 98.78 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.949 2.433 . . . . 0.0 112.557 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 69.7 mt -106.29 142.48 35.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.701 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -104.98 157.04 17.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.69 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -63.05 -38.71 92.25 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.083 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -77.86 123.29 26.57 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.259 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -86.15 152.4 22.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.929 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 69' ' ' LEU . 63.2 t -112.04 124.44 68.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.089 0.471 . . . . 0.0 110.32 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.445 HD12 HD11 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -113.14 132.68 55.36 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.677 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.0 mttt -115.69 129.08 56.34 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.329 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.29 123.88 49.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.238 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.5 m-85 -100.71 119.51 38.7 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.57 161.16 33.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.946 0.403 . . . . 0.0 111.635 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.72 103.53 10.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.889 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.45 48.35 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.713 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -130.55 50.19 2.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.401 0.62 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.6 p -72.99 154.02 90.86 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.736 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.62 -32.68 95.13 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.436 2.091 . . . . 0.0 112.71 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.8 p-10 -69.95 -43.34 71.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.9 m -67.81 -42.74 81.06 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.711 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.19 -45.72 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.851 0.358 . . . . 0.0 110.733 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 81' ' ' SER . 63.6 ttt180 -62.39 -46.75 87.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.353 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.55 -43.28 94.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.533 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.2 tp -61.94 -46.05 91.01 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -63.22 -41.3 99.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 110.543 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 83' ' ' ARG . 89.9 m -63.92 -45.71 88.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.132 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -68.56 -50.31 52.82 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.89 -43.97 97.76 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -41.46 85.62 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.219 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 72.6 mt -64.21 -43.94 97.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.789 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 40' ' ' TYR . 78.9 mt -71.25 -26.63 62.99 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 97.0 mt-10 -89.2 -3.51 58.55 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -130.25 -61.88 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.945 0.402 . . . . 0.0 111.084 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.1 mm-40 -65.04 -41.17 95.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.524 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.58 30.06 6.37 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 33' ' ' GLU . 40.0 ttpt -61.81 127.95 33.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.022 0.439 . . . . 0.0 111.315 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.32 -8.13 80.33 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.905 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.2 t -107.58 -40.55 5.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.951 0.376 . . . . 0.0 111.403 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 32' ' ' LEU . 40.7 m-85 -115.84 144.88 43.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.393 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.21 125.1 50.58 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.7 tp -97.58 127.88 43.87 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.4 mptt -122.6 136.97 55.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.953 177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.9 132.37 70.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.734 0.778 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.79 105.72 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.173 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -77.25 103.14 7.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' CB ' ' A' ' 54' ' ' ALA . 55.3 t -61.29 -44.52 98.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.113 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -68.64 -37.39 79.65 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -70.0 -41.12 74.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.896 0.379 . . . . 0.0 110.964 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -126.92 82.78 67.22 Favored Pre-proline 0 CA--C 1.517 -0.318 0 CA-C-O 121.1 0.476 . . . . 0.0 110.867 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.85 -32.82 95.93 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 123.253 2.635 . . . . 0.0 112.632 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.744 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.14 -42.23 99.43 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.639 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.5 -37.53 74.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.081 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.659 ' CB ' HG13 ' A' ' 47' ' ' VAL . . . -64.1 -41.6 97.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.985 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -67.57 -36.37 80.78 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.663 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.744 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 96.2 mt-10 -59.58 -39.28 83.6 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -98.29 7.83 45.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.578 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm 49.72 53.34 12.92 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -84.81 107.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.586 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -104.98 -10.86 16.96 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.905 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.04 137.39 39.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.548 0.213 . . . . 0.0 111.023 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.6 p -134.41 148.48 67.78 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.57 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.0 Cg_endo -76.27 152.4 96.16 Favored 'Cis proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.777 -1.759 . . . . 0.0 112.717 -1.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.62 123.95 45.12 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.275 178.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.445 HD11 HD12 ' A' ' 10' ' ' LEU . 53.7 tp -105.01 117.75 34.8 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -140.19 137.18 34.15 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.564 0.697 . . . . 0.0 111.816 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.3 ttpp -93.23 103.35 15.61 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.73 HG13 ' HG ' ' A' ' 69' ' ' LEU . 2.1 p -79.24 -30.38 14.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.242 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.73 ' HG ' HG13 ' A' ' 68' ' ' VAL . 91.1 mt -138.04 143.0 37.78 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.02 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 98.7 Cg_endo -77.74 156.4 95.37 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.476 -1.468 . . . . 0.0 112.353 -1.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 43.7 Cg_exo -60.4 150.48 80.57 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.896 2.398 . . . . 0.0 112.146 178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -77.85 166.82 80.17 Favored 'Cis proline' 0 C--N 1.35 0.626 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.507 0.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 86.5 t -73.17 125.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -108.54 117.42 34.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.958 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.515 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.6 mtm105 -99.89 121.65 41.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 0.0 110.686 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 93' ' ' LEU . 67.9 mt -104.26 116.03 47.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.623 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -116.99 125.7 74.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.864 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.17 -162.47 36.25 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.609 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -82.39 99.12 9.22 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.88 -5.8 58.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.792 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.457 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 48.7 m -68.56 -19.88 64.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.105 0.479 . . . . 0.0 110.501 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -89.36 120.07 30.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.702 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.4 OUTLIER -60.14 -35.48 75.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.929 -178.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.4 -44.47 95.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -64.42 -41.25 96.71 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.079 -0.649 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.5 t -64.08 -46.14 94.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.677 0.275 . . . . 0.0 110.559 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.01 -47.63 76.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.717 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.4 mt -62.31 -46.85 95.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.35 -41.04 98.83 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.538 0.209 . . . . 0.0 111.4 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.92 -39.0 87.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.588 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -64.07 -45.25 89.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.15 -39.66 95.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.992 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD11 HD11 ' A' ' 76' ' ' ILE . 88.4 mt -65.42 -40.33 93.23 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 110.549 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.32 -38.56 91.64 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.851 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -61.93 -39.18 91.17 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.92 -40.82 97.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.466 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.575 HD13 ' HB2' ' A' ' 8' ' ' ALA . 94.8 mt -66.47 -45.57 88.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.736 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.56 -36.2 93.04 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.86 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -106.61 35.82 2.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -88.7 118.6 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.046 0.45 . . . . 0.0 110.321 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.29 142.84 42.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.668 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -90.29 103.35 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.539 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -90.11 103.21 15.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.799 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -96.16 7.71 45.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.602 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.0 t70 69.79 -65.85 0.29 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.417 0.687 . . . . 0.0 111.911 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.75 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.003 0.43 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.92 120.84 79.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.691 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -59.53 142.6 99.15 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.833 2.355 . . . . 0.0 112.777 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.4 mt -99.99 152.65 19.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.359 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -77.95 125.99 30.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.652 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm 69.63 -49.03 0.62 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.655 0.782 . . . . 0.0 112.999 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -82.71 127.01 33.01 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.381 0.61 . . . . 0.0 111.972 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.39 153.84 20.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.345 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.0 t -108.15 123.67 63.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.273 0.558 . . . . 0.0 110.756 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.406 HD21 HD11 ' A' ' 90' ' ' LEU . 33.6 tp -114.91 126.1 54.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.55 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.7 mttt -114.07 138.37 50.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.382 0.61 . . . . 0.0 111.635 -177.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.18 124.43 52.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.399 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 96.8 m-85 -99.32 119.93 38.73 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 47' ' ' VAL . 23.1 m -127.17 161.48 34.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.95 0.405 . . . . 0.0 111.792 -178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.41 104.1 10.78 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.78 -131.82 49.13 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.755 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -129.68 48.28 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.368 0.604 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.509 ' HB ' ' OD1' ' A' ' 20' ' ' ASN . 2.8 p -71.95 153.63 92.82 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.72 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 16.1 Cg_endo -57.86 -32.1 94.14 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.396 2.064 . . . . 0.0 112.679 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' OD1' ' HB ' ' A' ' 18' ' ' THR . 4.3 p-10 -69.8 -42.86 73.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 72.5 m -69.13 -42.15 76.39 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.69 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 55.7 t -64.51 -45.05 96.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.338 . . . . 0.0 110.545 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 3.5 tpt180 -61.39 -47.62 84.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.66 -42.69 98.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.277 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.74 -46.39 89.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.254 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 22' ' ' VAL . 75.8 mmtt -64.13 -40.76 96.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 0.0 110.516 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.575 HG23 ' HG2' ' A' ' 83' ' ' ARG . 89.1 m -65.02 -45.29 86.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.255 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 28' ' ' LEU . 1.1 mm? -68.94 -50.2 51.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.86 -44.03 97.65 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -62.33 -45.43 93.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.769 0.318 . . . . 0.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.655 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.6 mt -64.1 -45.74 95.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.804 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD13 ' HB2' ' A' ' 42' ' ' LEU . 77.7 mt -68.38 -35.04 77.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.637 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.0 mt-10 -67.82 -34.13 76.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.61 -55.83 2.45 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.655 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 23.3 mp0 -63.82 -40.66 97.14 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 90' ' ' LEU . 98.7 m-85 -122.13 29.03 7.21 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 65.4 tttm -58.6 124.85 21.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.086 0.47 . . . . 0.0 111.571 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.35 -7.48 81.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.963 -0.637 . . . . 0.0 113.8 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -107.41 -44.65 7.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.535 0.668 . . . . 0.0 111.762 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.449 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -113.7 142.09 46.45 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.763 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.17 124.61 48.92 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' HB2' HD13 ' A' ' 32' ' ' LEU . 66.2 tp -96.01 125.67 40.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.469 0.652 . . . . 0.0 112.195 -178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' CB ' ' HG2' ' A' ' 11' ' ' LYS . 1.4 mptp? -123.07 138.64 54.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.027 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.5 131.56 72.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.673 0.749 . . . . 0.0 110.992 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -114.36 103.85 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.343 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -76.59 103.89 6.81 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.5 m -67.48 -33.1 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -177.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.8 mt -71.37 -38.27 71.58 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 121.948 -0.47 . . . . 0.0 111.623 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -70.38 -41.53 72.95 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.078 0.466 . . . . 0.0 110.508 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -129.29 73.94 81.33 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.68 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.29 -22.76 75.53 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.812 2.342 . . . . 0.0 112.715 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.689 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.37 -40.73 98.06 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.15 -36.27 71.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.802 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.46 97.7 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.13 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.89 -38.36 86.12 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.9 mm-40 -60.97 -40.17 92.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.404 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -96.83 8.68 43.8 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.957 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.59 53.06 13.4 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.8 mm -89.07 109.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.281 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.6 mt -106.98 -5.64 18.02 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.39 143.23 30.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.562 0.22 . . . . 0.0 111.214 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.4 p -136.44 148.84 65.61 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 69.5 Cg_endo -76.4 152.19 95.72 Favored 'Cis proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.801 -1.749 . . . . 0.0 112.698 -1.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.477 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.89 124.67 45.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.466 178.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.0 tp -104.52 118.73 37.3 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.606 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.35 138.63 31.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.494 0.664 . . . . 0.0 111.973 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 3.3 ttpp -99.68 104.28 16.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 73' ' ' VAL . 29.7 m -78.7 -29.06 14.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.812 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -134.65 136.11 24.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.028 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 3.0 Cg_exo -79.83 147.37 77.45 Favored 'Cis proline' 0 CA--C 1.535 0.538 0 C-N-CA 124.165 -1.181 . . . . 0.0 112.454 -1.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 32.3 Cg_exo -61.84 154.62 59.9 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.052 2.502 . . . . 0.0 111.74 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 19.2 Cg_exo -68.71 159.84 85.65 Favored 'Cis proline' 0 C--N 1.353 0.815 0 C-N-CA 124.997 -0.835 . . . . 0.0 113.747 0.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 68' ' ' VAL . 99.5 t -72.72 126.97 34.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.62 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 21.8 tpp180 -105.88 118.88 37.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.077 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 98.5 mtt180 -104.73 124.2 48.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.361 0.6 . . . . 0.0 110.69 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 93' ' ' LEU . 71.3 mt -105.74 117.7 51.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.013 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 mp -119.94 127.64 75.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.751 0.31 . . . . 0.0 110.879 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.48 -158.91 32.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.652 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -82.76 97.09 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.04 -5.95 59.12 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.1 m -69.16 -21.46 63.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.235 0.54 . . . . 0.0 110.11 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 84' ' ' GLU . 29.3 t-20 -85.14 118.63 24.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.602 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.575 ' HG2' HG23 ' A' ' 27' ' ' THR . 81.1 mtp180 -60.36 -37.08 79.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.272 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HB2' ' OD1' ' A' ' 82' ' ' ASN . 41.8 mt-10 -60.49 -43.79 96.64 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.12 -41.15 97.34 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.495 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.17 -43.54 97.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.816 0.341 . . . . 0.0 110.517 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD21 ' HG2' ' A' ' 35' ' ' GLU . 0.5 OUTLIER -67.91 -48.5 65.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.373 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.31 -46.19 97.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.26 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.34 -40.87 98.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.038 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 4.7 mp -67.58 -38.35 83.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -64.23 -42.18 96.68 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.615 0.245 . . . . 0.0 110.739 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.43 -39.7 94.34 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.282 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD11 HD11 ' A' ' 76' ' ' ILE . 86.7 mt -65.49 -40.75 93.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.747 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 97' ' ' ILE . . . -63.56 -39.1 93.54 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.717 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.77 -37.99 88.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.988 0.423 . . . . 0.0 110.542 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -62.31 -39.6 93.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.35 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 94' ' ' ALA . 76.0 mt -62.56 -45.95 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.023 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.15 -36.71 93.81 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.415 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.72 -40.57 92.34 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.775 0.322 . . . . 0.0 111.404 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -83.79 109.56 17.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.16 0.505 . . . . 0.0 110.761 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -111.05 127.98 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.523 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.59 106.77 4.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.607 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -89.49 105.23 17.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.477 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.75 13.19 31.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -90.45 103.64 16.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.608 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.416 -0.802 . . . . 0.0 111.412 179.807 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptt? . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.99 0.424 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.87 71.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.8 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.59 156.88 57.12 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.742 2.295 . . . . 0.0 112.776 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.8 mt -104.22 137.59 41.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.67 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -76.45 151.91 36.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.048 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -63.52 -39.13 93.63 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.115 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.77 123.6 30.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.118 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.461 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -96.31 153.73 17.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.076 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.19 122.34 63.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.256 0.55 . . . . 0.0 110.408 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 32' ' ' LEU . 44.7 tp -114.13 126.56 55.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.504 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.7 mttt -113.3 136.02 53.2 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.503 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.443 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -112.37 124.92 53.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.917 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 92.0 m-85 -100.94 120.35 40.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 25' ' ' LEU . 15.8 m -125.18 159.75 31.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.85 0.357 . . . . 0.0 111.234 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -118.91 97.27 5.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.66 -151.17 50.35 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.534 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -115.41 42.4 2.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.911 0.386 . . . . 0.0 111.112 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.4 p -70.93 156.92 91.38 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -53.85 -37.11 84.89 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.172 1.915 . . . . 0.0 112.667 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -65.37 -45.56 83.63 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.234 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.2 m -67.13 -43.64 81.88 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.185 178.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.42 -44.47 97.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.921 0.391 . . . . 0.0 110.692 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 2.4 tpt180 -62.06 -47.06 86.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.593 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.95 94.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.97 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 14' ' ' VAL . 58.6 mt -63.49 -43.28 97.74 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.85 -40.74 97.29 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.606 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.66 HG23 ' HG3' ' A' ' 83' ' ' ARG . 85.1 m -66.68 -44.79 80.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.222 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 28' ' ' LEU . 0.5 OUTLIER -69.99 -50.79 38.08 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.82 -44.88 95.97 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.86 -44.32 93.47 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.339 -178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.9 mt -63.28 -45.29 98.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.872 0.368 . . . . 0.0 111.251 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.508 HD22 ' HB3' ' A' ' 40' ' ' TYR . 77.0 mt -68.46 -35.74 77.99 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.1 mt-10 -69.82 -29.66 66.98 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -114.2 -55.3 2.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.9 mm-40 -65.36 -40.82 94.07 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -121.36 28.18 7.91 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 24.3 tptm -58.62 126.91 29.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 111.631 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.1 -9.22 78.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.735 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.01 -45.08 6.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 117.5 0.65 . . . . 0.0 111.724 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -114.44 141.7 47.32 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.685 -179.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.18 126.87 51.64 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.466 ' HB2' HD13 ' A' ' 32' ' ' LEU . 67.9 tp -97.65 127.41 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.392 0.615 . . . . 0.0 112.545 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.4 mptp? -122.98 137.85 54.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.881 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.37 131.18 73.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.816 0.817 . . . . 0.0 110.953 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.9 mm -112.94 104.75 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.869 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -77.05 104.65 7.66 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.596 HG13 ' CB ' ' A' ' 54' ' ' ALA . 53.5 t -61.42 -43.18 96.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.282 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.23 -40.47 77.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.46 -38.15 71.29 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.177 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -128.92 72.32 81.77 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.73 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.74 -23.98 76.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.689 2.259 . . . . 0.0 112.808 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.755 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.3 mp0 -63.5 -41.78 98.54 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.11 -37.08 72.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.596 ' CB ' HG13 ' A' ' 47' ' ' VAL . . . -63.57 -42.27 98.32 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.82 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.02 -37.59 84.41 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.376 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.755 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.6 mt-10 -60.2 -39.62 87.2 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.003 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -97.05 10.21 39.91 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.809 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttm 51.55 52.09 15.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.0 mm -86.15 108.01 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.5 mt -104.85 -11.0 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.912 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.93 138.68 37.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.628 0.251 . . . . 0.0 111.057 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.3 p -133.55 148.71 69.8 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.473 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 59.5 Cg_endo -75.03 151.87 97.43 Favored 'Cis proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.79 -1.754 . . . . 0.0 112.665 -1.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -120.07 124.28 45.45 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.609 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -105.49 118.3 36.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.36 138.85 31.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.459 0.647 . . . . 0.0 111.87 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 0.1 OUTLIER -100.8 105.01 16.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 73' ' ' VAL . 28.3 m -80.18 -29.29 12.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.2 mt -135.62 137.18 25.23 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.202 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.65 156.1 95.59 Favored 'Cis proline' 0 C--N 1.347 0.481 0 C-N-CA 123.529 -1.446 . . . . 0.0 112.538 -1.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.99 156.21 66.04 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.783 2.322 . . . . 0.0 112.13 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.8 163.11 89.75 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.193 -1.169 . . . . 0.0 113.585 0.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 68' ' ' VAL . 98.3 t -70.51 127.54 32.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HG2' HD21 ' A' ' 93' ' ' LEU . 17.1 tpt180 -107.04 118.55 37.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.104 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 88.9 mtm180 -104.4 122.16 44.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.363 0.602 . . . . 0.0 110.395 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.692 HD11 HD11 ' A' ' 93' ' ' LEU . 70.0 mt -104.83 117.36 50.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.851 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.2 mm -116.96 126.29 74.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 110.71 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.24 -162.95 36.74 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.868 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -82.28 99.91 9.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.36 -5.41 59.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.187 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 70.9 m -69.57 -20.0 63.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 110.089 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -87.17 118.26 26.45 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.339 178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.66 ' HG3' HG23 ' A' ' 27' ' ' THR . 0.5 OUTLIER -59.91 -35.87 75.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.707 -178.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.14 -44.75 94.7 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -41.2 96.31 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.893 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.8 -46.26 94.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.95 -47.6 77.07 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.671 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.89 -46.8 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -63.58 -40.93 98.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.11 -36.88 82.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.552 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt-85 -62.09 -45.83 91.76 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.03 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.4 -39.42 93.83 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.174 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD11 HD11 ' A' ' 76' ' ' ILE . 86.6 mt -66.47 -40.78 89.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.934 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.4 -36.45 79.14 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.541 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.53 -41.77 97.82 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.521 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -62.75 -40.37 97.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.277 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 8' ' ' ALA . 88.5 mt -66.01 -45.56 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.824 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.84 -35.8 92.48 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.61 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.17 -39.65 93.38 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.688 0.28 . . . . 0.0 111.455 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -80.96 115.42 20.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.186 0.517 . . . . 0.0 110.691 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.65 141.99 44.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.672 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -81.16 120.0 24.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.348 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.9 t0 59.3 52.23 6.17 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.649 0.593 . . . . 0.0 111.904 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.64 13.35 26.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -89.4 103.05 15.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.441 179.867 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.87 121.48 77.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.979 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.36 152.43 60.81 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.62 2.213 . . . . 0.0 112.941 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 73.9 mt -115.09 150.64 35.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -62.35 -38.83 91.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.391 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -63.24 -38.28 90.57 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.982 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -76.3 124.56 27.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.359 0.599 . . . . 0.0 111.709 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.26 19.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.619 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.65 127.25 71.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.142 0.496 . . . . 0.0 111.75 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.446 HD22 HD11 ' A' ' 65' ' ' LEU . 11.1 mt -112.82 133.74 54.67 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.737 ' HE3' HG11 ' A' ' 68' ' ' VAL . 98.0 mttt -113.73 127.36 56.0 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.111 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.08 121.72 44.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.254 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 93.0 m-85 -98.98 117.34 33.28 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 47' ' ' VAL . 31.2 m -126.79 160.57 34.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.063 0.459 . . . . 0.0 111.563 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.47 104.48 11.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.688 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.5 -129.24 44.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.204 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.9 52.45 1.99 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.016 0.436 . . . . 0.0 110.89 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.4 p -74.11 157.53 86.73 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.479 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 73.0 Cg_exo -54.22 -36.84 87.31 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.132 1.888 . . . . 0.0 112.608 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 36.3 m120 -65.45 -46.23 80.67 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.957 0.408 . . . . 0.0 110.209 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.7 m -66.26 -43.75 85.6 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.227 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.497 HG12 ' HE2' ' A' ' 26' ' ' LYS . 55.2 t -64.89 -44.36 96.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.833 0.349 . . . . 0.0 110.636 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 1.7 tpt180 -62.1 -48.25 81.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.634 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.08 -42.23 99.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.248 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 63.8 tp -61.52 -47.32 86.14 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.228 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.497 ' HE2' HG12 ' A' ' 22' ' ' VAL . 57.1 mtmt -64.36 -40.39 95.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.821 0.343 . . . . 0.0 110.95 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.726 HG23 ' HG2' ' A' ' 83' ' ' ARG . 91.2 m -65.22 -45.59 84.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.042 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.52 HD11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -73.6 -45.7 51.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.35 -43.46 98.83 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -64.12 -43.03 96.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.084 -0.247 . . . . 0.0 111.034 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.641 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 64.2 mt -62.88 -45.96 97.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.175 0.512 . . . . 0.0 111.312 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' CB ' ' A' ' 40' ' ' TYR . 87.2 mt -67.87 -37.36 81.72 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.215 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.2 mt-10 -69.13 -37.41 78.31 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -106.2 -57.47 2.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.641 ' OE1' ' HA ' ' A' ' 31' ' ' ILE . 21.1 mp0 -62.84 -40.54 97.73 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.524 ' CD1' HD12 ' A' ' 90' ' ' LEU . 98.4 m-85 -122.8 31.27 6.11 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 40.2 ttmt -50.22 123.9 9.3 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.392 0.433 . . . . 0.0 112.143 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.78 0.85 89.89 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.9 -0.591 . . . . 0.0 114.358 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -106.9 -44.31 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 117.964 0.882 . . . . 0.0 111.7 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.544 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.1 m-85 -116.51 144.73 43.97 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.046 -0.661 . . . . 0.0 111.961 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.02 125.58 51.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.021 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 62.5 tp -98.41 124.54 43.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.155 0.503 . . . . 0.0 111.602 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.5 mptp? -121.78 118.81 29.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.02 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.34 130.56 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.768 0.794 . . . . 0.0 111.174 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.4 mm -112.91 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.177 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.24 105.07 8.12 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 14' ' ' VAL . 25.4 m -69.53 -31.64 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.19 -39.79 75.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -71.01 -37.2 72.64 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.273 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -129.09 85.97 58.39 Favored Pre-proline 0 CA--C 1.515 -0.37 0 CA-C-O 121.108 0.48 . . . . 0.0 110.434 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.28 -28.39 78.91 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.999 2.466 . . . . 0.0 112.489 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.678 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 97.1 mt-30 -63.26 -41.75 99.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.46 -36.26 73.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.888 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.11 96.86 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.084 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -67.28 -38.3 84.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.612 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 79.4 mm-40 -60.31 -40.16 89.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.355 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -98.39 9.12 43.81 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.842 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp 49.03 53.55 12.41 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.38 0.672 . . . . 0.0 112.81 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.403 HG13 ' CD2' ' A' ' 13' ' ' TYR . 46.0 mm -87.78 108.22 18.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.608 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -108.07 1.51 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.69 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.41 148.81 36.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 111.402 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.0 p -147.31 142.21 16.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.291 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 72.1 Cg_endo -79.79 151.12 84.23 Favored 'Cis proline' 0 CA--C 1.531 0.33 0 C-N-CA 123.092 -1.628 . . . . 0.0 112.467 -1.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.1 m -128.75 131.64 47.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.345 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD22 HD11 ' A' ' 28' ' ' LEU . 63.1 tp -106.27 120.28 41.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.549 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 74' ' ' ARG . . . -137.77 134.64 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.241 0.543 . . . . 0.0 111.184 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 22.0 ttpp -91.83 104.14 16.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 HG11 ' HE3' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -82.19 -24.11 9.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.245 -178.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.788 HD12 ' HA ' ' A' ' 70' ' ' PRO . 29.6 tp -139.41 131.89 15.29 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.816 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.788 ' HA ' HD12 ' A' ' 69' ' ' LEU . 6.0 Cg_exo -81.44 152.02 78.65 Favored 'Cis proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.783 -1.34 . . . . 0.0 112.485 -1.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HA ' ' C ' ' A' ' 72' ' ' PRO . 59.2 Cg_endo -71.06 159.49 52.19 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.714 2.276 . . . . 0.0 111.629 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 71' ' ' PRO . 36.9 Cg_exo -63.69 155.21 71.92 Favored 'Cis proline' 0 C--N 1.352 0.757 0 C-N-CA 125.097 -0.793 . . . . 0.0 113.611 0.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 92.9 t -69.25 124.9 26.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.546 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -102.15 116.15 32.06 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.558 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 48.9 mtm105 -99.62 124.97 45.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.272 0.558 . . . . 0.0 110.398 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.677 HD11 HD11 ' A' ' 93' ' ' LEU . 69.0 mt -108.56 117.48 54.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.837 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 mp -119.83 126.71 75.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.842 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 168.0 -163.19 36.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.811 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -82.16 98.81 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.9 mt -86.64 -7.68 58.11 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.4 p -68.21 -19.61 64.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.233 0.539 . . . . 0.0 110.385 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -84.82 116.8 23.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.112 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.49 -36.91 79.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.091 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -60.07 -44.61 94.63 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.83 -41.31 97.87 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.093 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 79.5 t -64.52 -44.76 96.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.256 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.0 tp -66.01 -45.49 81.35 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.356 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -62.12 -46.44 96.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.586 0.231 . . . . 0.0 110.755 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.04 96.23 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.588 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.632 179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -62.44 -45.84 91.26 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.025 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.79 -39.96 95.49 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.217 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 76' ' ' ILE . 89.5 mt -65.53 -41.07 93.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.101 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.56 -38.49 91.19 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.628 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.06 -36.53 81.93 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.79 0.328 . . . . 0.0 110.324 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.27 -40.22 93.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.233 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.1 mt -67.59 -43.0 87.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.6 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -61.09 -34.92 89.81 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.781 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.81 -40.26 92.04 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.737 0.303 . . . . 0.0 111.445 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.01 107.68 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.067 0.46 . . . . 0.0 110.809 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -111.54 142.15 44.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -151.97 173.05 15.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -101.67 101.92 12.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.271 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.2 p-10 -104.14 13.22 32.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.299 179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -89.14 103.89 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.499 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.69 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.913 0.387 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' HB3' ' HD3' ' A' ' 3' ' ' PRO . . . -61.74 -50.3 82.4 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 2' ' ' ALA . 44.2 Cg_exo -60.42 143.04 99.45 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.171 1.914 . . . . 0.0 112.729 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 70.0 mt -114.2 145.19 42.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.715 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -126.47 154.08 44.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm -64.05 -38.8 92.4 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.108 0.48 . . . . 0.0 110.805 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.96 121.52 27.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.997 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 97' ' ' ILE . . . -87.48 151.9 22.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.077 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.4 t -111.82 124.14 68.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.23 0.538 . . . . 0.0 110.121 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.83 128.06 56.25 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.574 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.2 mttt -112.92 130.3 56.16 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.45 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -107.48 124.32 49.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.486 179.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 97.3 m-85 -99.66 117.4 33.94 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 47' ' ' VAL . 27.2 m -125.36 161.02 30.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.076 0.465 . . . . 0.0 111.628 -177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -117.13 100.89 8.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.01 -135.51 50.41 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.839 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -123.72 44.67 2.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.73 0.3 . . . . 0.0 110.979 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -70.62 155.2 93.75 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.8 -38.27 85.27 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.009 1.806 . . . . 0.0 112.805 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -64.85 -43.8 91.85 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.342 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -68.41 -43.55 76.96 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.146 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.41 -46.04 91.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.796 0.331 . . . . 0.0 110.812 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' NE ' ' HB2' ' A' ' 81' ' ' SER . 69.8 ttt180 -61.94 -47.24 85.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.711 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -41.84 97.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.079 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.5 tp -61.27 -45.45 94.44 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.961 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -63.84 -40.64 97.07 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.331 . . . . 0.0 110.403 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.732 HG23 ' HG2' ' A' ' 83' ' ' ARG . 88.7 m -66.0 -45.58 81.08 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.4 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.03 -50.2 36.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.37 -43.95 98.0 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -64.97 -42.63 94.41 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.22 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 75.1 mt -64.3 -45.04 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.342 0.592 . . . . 0.0 110.751 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD13 ' HB2' ' A' ' 42' ' ' LEU . 54.7 mt -68.19 -35.17 77.58 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.916 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HG3' ' O ' ' A' ' 29' ' ' ALA . 93.7 mt-10 -85.78 -5.53 59.24 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -62.21 1.0 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.043 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -64.02 -41.04 97.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.34 30.25 6.37 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -59.79 128.56 37.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.75 -8.44 79.79 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.178 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.81 -42.48 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 117.186 0.493 . . . . 0.0 111.153 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -115.02 143.61 44.91 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.977 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.42 125.57 50.74 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 32' ' ' LEU . 65.7 tp -97.52 126.4 42.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.435 0.636 . . . . 0.0 112.657 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 13.7 mptt -121.74 137.76 54.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.783 177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.37 131.3 72.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.681 0.753 . . . . 0.0 110.998 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -114.65 104.46 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.401 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -77.04 103.72 7.13 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 14' ' ' VAL . 22.0 m -67.94 -33.75 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -70.53 -37.09 74.05 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.516 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.22 -40.82 74.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.65 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -126.97 83.81 64.98 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.873 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -59.98 -31.67 93.91 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.363 2.709 . . . . 0.0 112.595 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.738 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 26.2 mp0 -62.98 -41.54 99.58 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.517 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 92.5 mt -70.39 -36.63 74.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.199 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.95 -41.85 97.47 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.813 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.22 -38.13 84.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.382 178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.738 ' HG3' ' O ' ' A' ' 52' ' ' GLN . 95.1 mt-10 -60.57 -40.56 92.15 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.455 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -97.59 8.93 43.75 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.027 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm 50.97 52.01 15.88 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.442 0.697 . . . . 0.0 112.759 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.22 109.13 18.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.577 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.6 mt -106.03 -6.34 18.8 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.102 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.16 142.26 30.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.535 0.207 . . . . 0.0 111.191 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.0 p -137.33 147.69 59.07 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.384 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 66.5 Cg_endo -76.85 152.99 95.92 Favored 'Cis proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.819 -1.742 . . . . 0.0 112.646 -1.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -121.52 129.74 53.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.131 179.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD23 ' HG ' ' A' ' 12' ' ' LEU . 75.9 mt -103.62 118.53 36.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -141.93 132.0 24.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.63 0.729 . . . . 0.0 111.518 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 73' ' ' VAL . 16.5 ttmt -94.8 104.54 16.45 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.574 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.8 m -80.42 -28.44 11.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.117 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -138.31 140.41 28.34 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 10.1 Cg_exo -74.78 151.42 96.91 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.196 -1.168 . . . . 0.0 112.289 -1.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 70' ' ' PRO . 38.1 Cg_exo -60.87 151.6 76.3 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.944 2.429 . . . . 0.0 112.001 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.79 169.34 73.79 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.583 0.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 67' ' ' LYS . 93.0 t -72.75 126.49 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.024 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 22.1 tpp180 -109.62 119.76 40.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.829 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 47.3 mtm105 -102.68 122.39 44.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.322 0.582 . . . . 0.0 110.961 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.891 HD11 HD11 ' A' ' 93' ' ' LEU . 74.9 mt -103.57 115.37 45.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.675 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.18 127.68 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.734 0.302 . . . . 0.0 110.85 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.38 -159.34 32.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.737 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -81.41 96.03 7.24 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -4.57 57.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.394 -178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.497 ' HB2' ' NE ' ' A' ' 23' ' ' ARG . 97.2 p -68.28 -20.68 64.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -86.72 121.42 29.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.44 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.0 mtm-85 -60.26 -36.37 77.63 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.538 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -60.64 -44.31 96.55 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -65.06 -40.21 94.39 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.552 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.1 -43.73 99.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mt -68.42 -48.49 64.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.82 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.1 mt -61.91 -47.52 92.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 111.722 0.267 . . . . 0.0 111.722 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.1 97.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.668 0.27 . . . . 0.0 111.308 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.43 -39.76 85.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.366 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -61.83 -44.38 96.96 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.581 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.79 -39.1 93.18 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 76' ' ' ILE . 87.6 mt -65.64 -40.42 92.48 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 110.56 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.52 -37.98 89.39 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.704 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.32 -37.71 84.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 110.025 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.14 -41.36 98.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.312 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD13 ' HB2' ' A' ' 8' ' ' ALA . 84.1 mt -70.52 -43.42 77.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.719 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.09 -35.12 91.01 Favored Glycine 0 C--N 1.334 0.465 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.89 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.09 -39.61 90.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.697 0.284 . . . . 0.0 111.484 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.81 117.59 23.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.228 0.537 . . . . 0.0 110.557 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -111.03 138.6 47.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.516 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -139.05 109.08 6.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -156.67 160.19 39.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.172 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -67.0 -29.7 69.6 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -154.36 162.12 41.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.075 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.833 179.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 120.95 0.405 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.77 120.78 75.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.134 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.98 154.83 57.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.771 2.314 . . . . 0.0 112.912 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 75.2 mt -112.95 134.48 54.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.53 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 169.91 19.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.655 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -63.39 -39.02 93.39 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.149 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -83.28 122.2 28.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.358 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.54 18.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.543 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.7 t -108.15 122.07 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.185 0.517 . . . . 0.0 110.559 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD23 HD11 ' A' ' 32' ' ' LEU . 42.0 tp -114.24 125.16 53.6 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HE3' HG21 ' A' ' 68' ' ' VAL . 98.8 mttt -112.29 137.43 50.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.362 -177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD13 HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -114.54 123.8 50.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.11 178.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 94.9 m-85 -98.86 120.92 40.12 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 25' ' ' LEU . 17.0 m -126.38 160.57 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -116.36 106.56 13.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.226 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.23 -130.96 47.64 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.536 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -134.86 48.39 2.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.992 0.425 . . . . 0.0 110.316 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -74.37 158.46 85.26 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.779 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -54.11 -37.51 87.08 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.089 1.859 . . . . 0.0 112.658 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -65.01 -45.26 86.3 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.886 0.374 . . . . 0.0 110.02 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.3 m -66.75 -43.69 83.44 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.058 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.08 -46.4 93.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.933 0.397 . . . . 0.0 110.486 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -62.4 -46.72 87.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.71 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -63.49 -44.39 94.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.081 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD23 HD13 ' A' ' 12' ' ' LEU . 66.8 mt -63.53 -41.75 98.47 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.59 -40.46 96.99 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.291 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 83' ' ' ARG . 85.5 m -66.24 -45.1 81.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.48 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -50.9 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 33' ' ' GLU . . . -61.69 -45.23 94.86 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.39 -43.36 94.72 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.213 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 35' ' ' GLU . 71.3 mt -63.05 -45.1 99.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.824 0.345 . . . . 0.0 111.071 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.471 HD11 HD23 ' A' ' 10' ' ' LEU . 77.6 mt -68.94 -36.22 77.69 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 99.3 mt-10 -70.85 -27.31 63.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -114.27 -58.92 2.09 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 78.7 mm-40 -64.08 -40.93 97.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -120.83 28.7 7.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 88.2 tttt -58.63 127.65 33.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 111.541 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.13 -8.51 79.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.506 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.1 t -108.5 -44.91 6.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 117.455 0.627 . . . . 0.0 111.611 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.541 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 3.0 m-85 -115.04 143.26 45.47 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.889 -0.724 . . . . 0.0 112.091 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.97 125.1 50.6 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 tp -96.89 126.72 42.23 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.274 0.559 . . . . 0.0 112.023 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 1.8 mptp? -123.46 118.13 26.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.951 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -98.07 129.23 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.699 0.761 . . . . 0.0 110.704 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 mm -113.45 105.25 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.3 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -77.78 102.76 7.34 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.2 m -66.67 -33.77 65.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.57 -38.38 70.95 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.01 -0.431 . . . . 0.0 111.603 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -70.76 -40.68 72.51 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.46 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.06 73.67 81.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.612 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.45 -22.91 75.76 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.769 2.313 . . . . 0.0 112.884 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 26.2 mp0 -63.36 -41.04 98.82 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -71.18 -36.42 71.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.847 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.32 97.74 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.275 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.97 -38.48 86.16 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.177 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.685 ' HG2' ' O ' ' A' ' 52' ' ' GLN . 80.0 mm-40 -61.09 -40.03 92.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.425 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -96.68 9.17 42.4 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.88 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.7 mttp 51.08 52.13 15.59 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.5 mm -88.23 108.1 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.484 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.28 -6.53 18.34 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.063 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.61 140.3 31.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.522 0.201 . . . . 0.0 111.149 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.6 p -134.9 149.1 69.58 Favored Pre-proline 0 N--CA 1.454 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.594 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 13' ' ' TYR . 60.9 Cg_endo -75.68 151.29 95.72 Favored 'Cis proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.744 -1.773 . . . . 0.0 112.698 -1.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -119.89 125.31 48.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.73 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.98 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB2' ' HG2' ' A' ' 75' ' ' ARG . . . -142.31 139.65 31.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.514 0.673 . . . . 0.0 112.079 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.68 104.73 15.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG21 ' HE3' ' A' ' 11' ' ' LYS . 27.7 m -80.02 -28.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -136.1 139.22 29.53 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.381 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.04 153.11 96.01 Favored 'Cis proline' 0 C--N 1.349 0.584 0 C-N-CA 124.102 -1.208 . . . . 0.0 112.483 -1.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.69 156.24 64.05 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.664 2.243 . . . . 0.0 111.795 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.64 166.45 82.01 Favored 'Cis proline' 0 C--N 1.351 0.695 0 C-N-CA 124.301 -1.124 . . . . 0.0 113.449 0.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 68' ' ' VAL . 92.9 t -70.3 126.99 31.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.297 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -105.59 114.99 29.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.646 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.571 ' HG2' ' HB2' ' A' ' 66' ' ' ALA . 89.0 mtm180 -102.87 122.03 43.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.256 0.551 . . . . 0.0 110.863 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.69 HD11 HD11 ' A' ' 93' ' ' LEU . 66.0 mt -101.91 115.74 44.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.346 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.67 122.84 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.98 -179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 166.81 -166.15 38.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -87.48 96.22 10.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.113 0.457 . . . . 0.0 109.856 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -89.89 11.11 21.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.823 -179.424 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.6 m -72.66 -21.61 61.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.097 0.475 . . . . 0.0 110.008 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -85.76 124.25 32.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.948 179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.761 ' HG2' HG23 ' A' ' 27' ' ' THR . 96.1 mtm-85 -60.74 -37.32 81.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.727 -178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -59.58 -47.59 84.97 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.97 -39.35 93.95 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.749 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG21 HG22 ' A' ' 27' ' ' THR . 60.8 t -62.13 -44.2 98.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 178.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD21 ' HG3' ' A' ' 35' ' ' GLU . 3.8 mt -66.13 -44.33 84.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.318 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.03 -47.9 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.508 0.194 . . . . 0.0 111.165 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HB1' HD13 ' A' ' 76' ' ' ILE . . . -64.54 -42.44 95.73 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.458 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.43 -38.23 80.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.898 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -61.77 -46.57 88.99 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.596 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 96' ' ' GLU . 86.4 mt -64.67 -39.74 94.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.996 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 76' ' ' ILE . 86.8 mt -66.25 -39.73 89.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.258 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.49 -36.57 79.1 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.553 0.692 . . . . 0.0 109.337 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.51 -39.39 90.83 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.41 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 79.3 mm-40 -61.22 -40.29 93.46 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.708 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.94 -46.54 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.742 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.92 -36.22 93.01 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.518 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -64.06 -40.38 96.15 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.728 0.299 . . . . 0.0 111.415 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -69.84 126.94 31.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.306 0.574 . . . . 0.0 110.637 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mmtm -111.28 143.94 41.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.684 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.13 -42.02 99.42 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -155.26 160.75 41.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.043 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -66.98 -29.82 69.77 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.416 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -154.89 162.5 41.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.205 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.844 179.958 . . . . . . . . 0 0 . 1 stop_ save_